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ABSTRACT 
The HIV I AIDS epidemic affects everyone, every individual, every family, every social 
institution, every organisation and indeed every business, big or small. Although there are 
indications that HIV infection may be spreading faster among the underprivileged sectors 
of the population (poor, marginalised, uneducated, etc.), so far the toll among the urban 
young adult population has been higher. In South Africa it is estimated that as many as 
1 000 people, mostly young people, are infected every day. 
The HIV I AIDS epidemic poses one of the greatest challenges to business development in 
Africa. The epidemic claims some of the best business leaders, managers and a great 
number of workers at all levels of the production system. HIV -related absenteeism, loss 
of productivity and the cost of replacing workers lost to AIDS threaten the survival of a 
number of businesses and industrial sectors in the increasingly competitive world market. 
HIV I AIDS does not affect only workers. By claiming a large part of the urban population 
with disposable income and by impoverishing families and communities, it also effects 
the market base of African business. 
It is clear that no one sector alone can make a significant inroad in the fight against the 
epidemic. A true partnership involving the government, the private sector and the 
community is essential to face the problem. The business community is realising that its 
very survival depends on how effectively it joins forces with other partners, how well it 
understands the legal issues, current statistics and economic impact of HI VI AIDS to face 
the problem. The workplace provides an excellent environment to implement a 
comprehensive HIV I AIDS programme and policy reform. 
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CHAPTER ONE - INTRODUCTION 
1.1. INTRODUCTION 
It is amazing how we have failed to accept and confront pestilences that threaten our lives 
and society timeously. HIV/AIDS typifies, with glaring clarity, how we as people, health 
departments, governments and businesses deal with life threatening challenges presented 
to us. Across Sub-Saharan Africa as the epidemic evolved, in the early 1980's, from the 
emergence to dissemination and finally to escalation, the response has been the same as it 
spread from one country to another. It has been met with denial, ignorance, 
procrastination, xenophobia, discrimination and intellectual paralysis. The approach that 
we have taken thus far in dealing with this pandemic will be overwhelming, it will be a 
burden that will not easily be borne by a nation still consumed with the inequalities of the 
past. 
This study commences with a biomedical description of HIV/AIDS; the structure, 
replication and transmission of the virus; and the progression from initial HIV infection 
to full blown AIDS. Thereafter discussion will focus on the current world-wide statistics. 
The discussion will commence with the global statistics, move to regional statistics and 
filter down to the KwaZulu province. Whilst providing the statistics an attempt will be 
made to highlight the major trends and modes 0 ftransmission 0 f each region. This is 
important as it becomes the starting point of evaluating the suitability and effectiveness 
of any HIV / AIDS intervention programme. 
Thereafter the economic impact of HIV / AIDS will be addressed. Household, Sectoral and 
Macro (National) Level economic impact will be investigated. Emphasis will be placed 
on: 
• the loss of manpower and skills; 
• changes in the population structure and the eroSIOn of whole production and 
consumption bands, with consequent distortion of resource allocation due to changes 
in demand for goods and services; and 
• deterioration in management capacity and governance. 
The study then proceeds with a step-by-step guide through the law, looking at how it 
regulates the action of both employers and employees with reference to RIV/AIDS. The 
Constitution together with labour law as well as chosen case law, is discussed to give the 
reader an indication as to what law governs an employer's and an employee's actions, 
and the responsibilities borne by both. 
Raving established the main issues from a social, economic and legal perspective; an 
evaluation of Rohm and Raas New Germany's RIV/AIDS policy and programmes will 
be undertaken. Strengths and weakness will be identified and recommendations proposed 
to suitably address the pandemic. Also offered is a detailed discussion on the steps to be 
undertaken to develop an effective intervention initiative that includes both the 
company's policy and programmes. 
1.2. BACKGROUND 
As of 2002, more than 28 million Africans are living with RIV. Africa is suffering in 
every sector, from the health of its citizens to the economies of its nations. Workplaces 
in Africa feel the impact from both directions. 
In Sub-Saharan A frica a lone, 55 million deaths are expected between 2000 and 2020. 
"The average life expectancy in sub-Saharan Africa is currently 47 years. Without AIDS, 
it would have been 62 years." "AIDS pushes people deeper into poverty as households 
lose their breadwinners, livelihoods are compromised and savings are consumed by the 
cost of health care and funerals" (UNAIDS). 
"Labour productivity has been cut by up to 50% in the hardest-hit countries. In Zambia, 
nearly two-thirds of deaths among the managerial sector can be attributed to AIDS. By 
2002, over 25% of the workforce may be lost to AIDS in some severely affected 
countries" (UNAIDS press release, 2002). "The vast majority of people living with 
RIV/AIDS worldwide are in the prime of their working lives. By 2005, Zimbabwe will 
have lost 19% of its workforce to AIDS, Botswana 17%, South Africa 11 %, the United 
Republic of Tanzania 9% and Cote d'Ivoire 8%. 
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"AIDS weakens economic activity by squeezing productivity, adding costs, diverting 
productive resources, and depleting skills. The epidemic hits productivity mainly 
through increased absenteeism, organizational disruption, and the loss of skills and 
organizational memory. Production cycles can be disrupted, equipment stands idle, and 
temporary staff may need to be recruited and trained. A study in several southern African 
countries has estimated that the combined impact of AIDS-related absenteeism, 
productivity declines, health-care expenditures, and recruitment and training expenses 
could cut profits by at least 6-8%. 
"Loss of know-how tends to be the most often-cited cost factor on the shop floor. Thus, 
even in high unemployment areas (with an apparently "bottomless" pool of unskilled or 
semi-skilled labour), the drain on visible and invisible skills and knowledge ends up 
being considerable" (UNAIDS, 2002). 
Understanding the background of this pandemic, together with knowledge of the legal 
considerations and appropriate intervention programmes, managers will be equipped 
managers to take an active stance against the devastating effects of RN/AIDS. While 
there are numerous cost studies to show the efficacy of these interventions to be a wise 
business investment it does not take any studies to know that managers must choose to do 
something. 
Companies are recogmzmg that they have a significant role to play in RN/AIDS 
prevention and care. Not only do they have an impetus to act because of the effects of 
RIV / AIDS on company financial health but also they have particular qualities that make 
them ideal to serve as a venue for education and behaviour change. Companies have a 
captive audience to listen to messages regarding RN/AIDS, employees spend the 
majority of their day at work where they can see posters reminding them about STI 
treatment, and positive peer pressure and opened discussion among colleagues can 
influence behaviours. Employees with RN/AIDS a re 1 iving and working longer than 
ever before with improved nutrition and even treatment. As a result, the workplace has 
taken on a new role to reassure all employees as to their safety and to communicate 
intolerance of discrimination and stigmatisation of the RN positive. At the same time, 
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with prevalence rates as high as 25% and higher in some companies, compames are 
mourning for their colleagues not just losing valuable skills. Employees are in need of 
care and counselling and to be empowered to cope with the epidemic. RN/AIDS 
prevention is adynamic process, requiring constant a nd varied campaigns-a 0 ne-day 
employee seminar will not suffice to achieve what is required- a change in personal 
behaviour. 
Some compames have made that WIse choice to implement constant and varied 
campaigns, conducting RN/AIDS awareness and prevention programmes for their 
employees and reinforcing them with activities in their communities. Some companies 
are considering approaches and still others may find the prospect overwhelming. 
1.3. MOTIVATION OF THE STUDY 
Whether an organization employs 30 people or 3,000 people, it will soon encounter RN 
or AIDS at the workplace or in its community, if it has not already. Chances are that the 
disease will affect an employee or an employee's family member. The organization 
should prepare to address this issue. With today' s medical treatments, people with RIV 
are living and working longer. For 50 percent of the people who have RIV, it will take 
more than 10 years to develop AIDS. With medical treatment, they can manage the 
infection as a chronic, long-term condition - similar to many other medical conditions. 
That means people with RIV can work and lead productive lives. The numbers of people 
with RN, and their extended life expectancy, will result in more employees on the job 
with RIV in the future. That could mean that someone you know - a client, a customer, 
a vendor, an employee, or an employee's family member or close friend - is already 
coping with AIDS. 
Employers need to know the applicable laws that provide protection for people with RN 
or AIDS, or those perceived as having RIV or AIDS, from discrimination in employment 
practices. RN/AIDS policies and education for the workplace can help to prevent such 
discrimination through education. 
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1.4. VALUE OF THE STUDY 
Rohm and Haas New Germany is located at the epicentre of pandemic. Conducting this 
study will enable the organisation to better understand the impact the HIV I AIDS 
pandemic will have on the organisation and society. Furthermore by obtaining insight 
into the legal framework, the organisation can develop HIV I AIDS interventions that will 
be suitable and effective. 
1.5. PROBLEM STATEMENT 
To what extent are the company's policies, procedures and programmes aligned to 
respond to the HIV/AIDS pandemic? 
At the company what is the gap between the current a nd t he most suitable policies, 
procedures and programmes to deal with the HIV/AIDS pandemic? 
1.6. OBJECTIVES OF THE STUDY 
This study attempts to tell the story behind the HIV I AIDS pandemic. At the conclusion of 
this examination it is intended to achieve the following objectives: 
• To understand the basics ofHIV/AIDS and the current statistical of the pandemic 
• To determine the economic impact ofHIV/AIDS 
• To establish the legal issues pertaining to HIV I AIDS 
• To establish a clear and concise understanding of Best Practices when developing a 
HIV I AIDS Policy and Intervention Programme. 
• To make recommendations to R&H New Germany with regards to HIV/AIDS Policy 
and Intervention Programmes. 
1.7. METHODOLOGY OF THE STUDY 
The study is both qualitative in nature. The report draws on secondary data from the 
medical science field, the economics arena, legal fraternity, human resource specialists 
and prominent organizations and individuals involved with the HIV I AIDS pandemic. The 
discussions and data that has been presented, is currently very topical given the greater 
understanding organizations have developed with regards to mitigating the impact of 
HIV I AIDS by appropriate company responses. In any study of this nature it is impossible 
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to be sure of accuracy, and consequently there is a great reliance made on current reports 
from the press, medical, economic and human resource journals. 
1.8. LIMITATIONS OF THE STUDY 
The statistics concerning the RIV / AIDS projection for South Africa are based on the 
Doyle Model. Like all projections are some basic assumptions. The most central being 
that populations can be described in terms of their risk group profiles and categorized into 
mutually exclusive groups such as persons with high prevalence of STDs, persons at risk 
of infection and persons not at risk of infection and commercial sex workers and their 
clients. 
An additional limitation was the refusal of the company' management to conduct a KAP 
(Knowledge, Attitudes and Perceptions) Survey. This survey would have added a 
quantitative dimension to the study and further fine tuned the recommendations that are 
made for RIV / AIDS intervention initiatives. Also it would have allowed a more critical 
evaluation of the company's current policy and programmes. 
1.9. STRUCTURE OF THE STUDY 
The study consists of five chapters. The contents is briefly described below. 
Chapter One : Introduction 
This chapter provides the outline of the main objectives of the study. It delineates the 
important and pertinent areas of the study and motivates for this specific investigation. 
Chapter Two: RIV/AIDS Basics and Statistics 
This chapter introduces the virus by describing its composition and replication cycle. 
Thereafter commentary is provided on the progression from RIV infection to full blown 
AIDS and the modes of transmission. Following this is an in-depth discussion on 
RIV / AIDS statistics. This aspect entails discussion on global trends, leading to specific 
regional statistics and features. Maps are included to visually depict the magnitude of the 
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epidemic. Analysis thereafter follows with specific reference to the pandemic in South 
Africa. Provincial indicators are provided and highly affected provinces are identified. 
Chapter Three : Economic Impact of HIV I AIDS 
This chapter intends to show the danger the scourge poses to the capacity of household, 
communities, institutions and nations in coping with the social and economic effects if it 
is allowed to spread unchecked. The adverse economic impact is startling. In high 
prevalence countries the growth rates of gross domestic product are slowly down, the 
manpower losses in key sectors are mounting, the number of orphans is increasing and 
household poverty is deepening. A vicious cycle. Also loss of specialised skills will be 
highlighted as this negatively affects the ability of any nation to break this vicious cycle. 
Chapter Four: HIV/AIDS and the Law 
This chapter provides a step-by-step guide through the law, looking at how it regulates 
the action of both employers and employees with reference to HIV/AIDS. The 
Constitution together with labour law as well as chosen case law, is discussed to give the 
reader an indication as to what law governs an employer's and an employee's actions, 
and the responsibilities borne by both. 
The law remains an important regulating factor in the lives of citizens in any country. 
Laws are sets of rules that govern the way people behave. A business response to 
HIV I AIDS is therefore driven, in part, by a legal framework. It is this framework that 
requires businesses to act in certain ways with regard to H IV I AIDS in the w orkplace. 
Apart from the constraints and the boundaries in which a business may operate within, 
law seeks to entrench particular human rights. Workers are fearful of human violations 
(as a result of the stigma which surrounds this disease) and law is designed, in principle, 
to address these concerns. 
To date, there are close on five million people living with HIV in South Africa. Yet the 
threat of human violations, and most notably - discrimination, makes many people afraid 
to be tested for HIV and they fear disclosure of their HIV status, even to close friends and 
family. Sadly, this means that there is little openness about HIV, which adds to the stigma 
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and misconception. It is notable that this epidemic is having a greater effect on the 
economically active population (i.e. those people who are employable). Employees are 
often not aware of their rights as individuals and rely on the integrity of the employer or 
trade unions too ensure that their rights are not violated. Employees can experience HIV 
- related discrimination from employers, supervisors or even fellow employees. It is to 
this extent that employees need to know and understand the law on HIV / AIDS to 
challenge both discrimination and abuse, which might be prevalent in the workplace. 
Laws are passed to protect employees from acts of discrimination and abuse and so it 
becomes important to understand what these laws are, how they work and then how an 
employee can stand up for hislher rights in the workplace. This chapter looks at the 
Labour Relations Act, the Employment Equity Act, the Occupational Health and Safety 
Act, the Compensation for Occupational Injuries and Diseases Act, Basic Conditions of 
Employment Act, the Medical Schemes Act as well as discussing International and 
Foreign law, while bringing in relevant case law under the applicable Acts. 
Chapter Five: Evaluation, Commentary and Recommendations. 
The initial part of this chapter will describe the Rohm and Haas organization, the markets 
supplied and its true global presence. Thereafter the commentary will migrate to the local 
South African operation based in New Germany, Durban. Business issues will be briefly 
highlighted together with a graphical display of the employee complement and 
breakdown along various characteristics. 
A description of the R&H New Germany HIV/AIDS policy will be provided as well as 
the current intervention programmes. This would lead into an in-depth evaluation of the 
R&H New Germany HIV/AIDS Policy and programmes largely along the following 
dimensions: 
• Policy; 
• Legal issues 
• How to avoid HIV Infection 
• Wellness management; and 
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• Monitoring and evaluation. 
Each dimension will be thoroughly discussed so as to obtain the desired level of 
understanding with regards to its contribution the success of the HIV/AIDS initiatives. 
Strengths and weakness of the company's initiatives will be discussed together with 
supporting reasons. This leads onto generating recommendations based on Best Practices. 
Details on how to develop a HIV/AIDS policy intervention program is explicitly 
discussed. 
This chapter culminates with a proposed operational plan and action items that R&H 
New Germany can undertake to re-invigorate the fight against HIV/AIDS along focused 
and collaborative means. In this way it can be ensured that the organization is equipped 
with the methodology to implement high quality HIV/AIDS programmes that is 
cognisant of the following: 
• economic impacts, 
• legal issues, 
• statistics, 
• cultural differences, 
• people, and 
• ethical issues. 
1.10. SUMMARY 
This study will commence with a biomedical description of the virus; the structure, 
replication and transmission; and the progression from initial HIV infection to full blown 
AIDS. In order to fully grasp the severity of the pandemic, statistics will be reviewed. 
Here we will commence with the global statistics and work our way to the KwaZulu 
province. As this process is undertaken we will simultaneously highlight the main 
transmission modes as this will determine the type of intervention program to be adopted. 
It has been widely touted that the economIC impact of HIV / AIDS is devastating. 
Discussion will center on some social aspects as HIV / AIDS ravages the community. This 
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will be done in parallel to the economic impact review. Any intervention programme that 
an organization undertakes must take cognisance of the legal framework in place. 
Ignorance of the legal aspects will surely result in company decisions which can be 
classified as unfair labour practices. The legal framework also determines the employee 
benefits of the infected individuals. 
Having established the main issues from a social, economic and legal perspective the 
study will proceed to descibe in detail the steps to be undertaken to develop a suitable 
intervention programme. Therafter Rohm and Haas New Germany's HIV/AIDs Policy 
and Programme will be evaluated and the gap to Best Practices highlighted. 
Recommendations will be presented on how the organization can reinvograte the fight 
against this pestilence. 
This study on any organization is invaluable as companies are recognizing that they have 
a significant role to play in HIV/AIDS prevention and care. Not only do they have an 
impetus to act because of the effects of HN / AIDS on company financial health but also 
they have particular qualities that make them ideal to serve as a venue for education and 
behaviour change. Companies have a captive audience to listen to messages regarding 
HIV/AIDS, employees spend the majority of their day at work where they can see posters 
reminding them about STI treatment, and positive peer pressure and opened discussion 
among colleagues can influence behaviours. Employees with HN/AIDS are living and 
working longer than ever before with improved nutrition and even treatment. As a result, 
the workplace has taken on a new role to reassure all employees as to their safety and to 
communicate intolerance of discrimination and stigmatisation of the HN positive. At the 
same time, with prevalence rates as high as 25% and higher in some companIes, 
companies are mourning for their colleagues not just losing valuable skills. Employees 
are in need of care and counselling and to be empowered to cope with the epidemic. 
Let us move onto investigating the nature of this pest by conducting a biomedical study. 
This will be done in the next chapter. 
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CHAPTER 2 - HIV/AIDS: BASICS AND STATISICS 
2.1. INTRODUCTION 
AIDS was first recognised as a disease in the early 1980s. Since then it has spread 
throughout the world. According to the World Health Organisation's 2002 Annual World 
Health Report it is now the leading cause of death in Africa, responsible for one in five 
deaths. Globally, it is the fourth most important cause of death. However, there is 
considerable variation in the pattern of epidemic spread between countries, within 
countries and even quite locally. Consequently there is also variation in the impact of the 
resulting illnesses and premature deaths. In the richer countries of the world, rates of 
infection are low and advances in treatment mean that people can live with AIDS, 
although for how long and in what state of health is currently uncertain. The burden of 
the epidemic falls 0 n the world's poorer countries a nd also 0 n poorer communities in 
some richer countries. 
AIDS is caused by the Human Immuno-deficiency Virus (HIV). This virus is transmitted 
via human body fluids and globally most infections occur through sex between men and 
women. The virus attacks the human immune system and ultimately makes it ineffective. 
Most people die of infections or cancers against which they might well defend 
themselves were it not for their compromised immune sy stems. There is a strong I ink 
between HIV and tuberculosis. Many people are infected with TB, but this is not active. 
Once HIV infection occurs the TB is able to emerge and the result is that TB is one of the 
major opportunistic infections and killers ofHIV infected people. 
Because most infections are the result of heterosexual intercourse, the disease affects 
people in the age group which is broadly defined as "sexually active" between 15 and 50, 
although this is not to say that there are not infections below and above this range. The 
significance of this epidemiological characteristic is that the age groups most susceptible 
to infection are also the most economically and socially active. They are also least likely 
to be ill and/or die in normal circumstances. The issue of social and economic impact of 
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the H IV/AIDS epidemic stems from the unusual rates 0 f severe illness and premature 
deaths that it produces in this age group. 
HIV infection is not an immediate death sentence. Depending upon individual 
constitutions, rates and types of ambient infection, living conditions, diet and other 
factors, an infected person may have years of productive and healthy life before they start 
to fall ill (develop AIDS). It is not certain how long people can live with HIV, but it is 
estimated at 5-8 years on average in poorer countries, possibly many more in richer 
countries. Eventually the person will begin to experience periods of illness that increase 
in frequency, duration, and severity until they die. Many opportunistic infections and 
diseases associated with AIDS can be treated, (or prevented), at relatively low cost and 
allow for prolongation of life. 
Recently developed anti-retroviral therapies may reverse or slow disease progression but 
are expensive, the proven therapies costing R 60 000 to R 100 000 per person per year for 
the drugs plus the cost of testing and clinical oversight of treatment regimes. There are 
some cheaper options, but it is unclear how efficacious or cost effective they are. The 
therapies are complex to administer and are most effective where the person receiving 
treatment has good diet, healthy living conditions and a stress-free environment. The 
financial resources and these conditions are, least likely to be available to the poor. 
In the initial part of this chapter commentary will be provided on biomedical description 
of HI V/AIDS; the structure, replication and transmission of the virus; and the progression 
from initial HN infection to full blown AIDS. The second part will describe the current 
world-wide statistics. The discussion will commence with the global statistics, move to 
regional statistics and filter down to the K waZulu province. Whilst providing the 
statistics an attempt will be made to highlight the major trends and modes oftransmission 
of each region. This is important as it becomes the starting point of evaluating the 
suitability and effectiveness of any HN/AIDS intervention programme. If the 
intervention does not address the major causes of transmission, it is bound to fail. 
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2.2 WHAT IS RIV? 
mv belongs to a class of viruses called retroviruses. Retroviruses are ribonucleic acid 
(RNA) viruses, and in order to replicate they must make a deoxyribonucleic acid (DNA) 
copy oftheir RNA. It is the DNA genes that allow the virus to replicate. 
Like all viruses, mv can replicate only inside cells, commandeering the cell's machinery 
to reproduce. However, only mv and other retroviruses, once inside a cell, use an 
enzyme called reverse transcriptase to convert their RNA into DNA, which can be 
incorporated into the host cell's genes. 
Slow viruses. mv belongs to a subgroup ofretroviruses known as lentiviruses, or "slow" 
viruses. The course of infection with these viruses is characterized by a long interval 
between initial infection and the onset of serious symptoms. 
2.3. STRUCTURE OF RIV 




"' '''''.-- Lipid Membr.ne .r 
Figure 2.1 - Structure of mV-l Virion (Source: www.niad.nih.gov) 
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2.3.1. The viral envelope 
RIV has a diameter of 1/10,000 of a millimetre and is spherical in shape. The outer coat 
of the virus, known as the viral envelope, is composed of two layers of fatty molecules 
called lipids, taken from the membrane of a human cell when a newly formed virus 
particle buds from the cell. Embedded in the viral envelope are proteins from the host 
cell, as well as 72 copies (on average) of a complex RIV protein (frequently called 
"spikes") that protrudes through the surface of the virus particle (virion). This protein, 
known as Env, consists of a cap made of three molecules called glycoprotein (gp) 120, 
and a stem consisting of three gp41 molecules that anchor the structure in the viral 
envelope. Much of the research to develop a vaccine against RIV has focused on these 
envelope proteins. 
2.3.2. The viral core 
Within the envelope of a mature RIV particle is a bullet-shaped core or capsid, made of 
2000 copies of another viral protein, p24. The capsid surrounds two single strands of RIV 
RNA, each of which has a copy ofthe virus's nine genes. 
The ends of each strand of RIV RNA contain an RNA sequence called the long terminal 
repeat (LTR). Regions in the LTR act as switches to control production of new viruses 
and can be triggered by proteins from either RIV or the host cell. 
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2.4. REPLICATION CYCLE OF RIV 
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Figure 2.2 - Replication cycle of HIV (Source: www.niad.nih.gov) 
Entry of HIV into cells. Infection typically begins when an mv particle, which contains 
two copies of the mv RNA, encounters a cell with a surface molecule called cluster 
designation 4 (CD4). Cells carrying this molecule are known as CD4 positive (CD4+) 
cells. 
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Reverse transcription. In the cytoplasm of the cell, RIV reverse transcriptase converts 
viral RNA into DNA, the nucleic acid form in which the cell carries its genes. Nine of the 
15 antiviral drugs approved in the United States for the treatment of people with RIV 
infection -- AZT, ddC, ddI, d4T, 3TC, nevirapine, delavirdine, abacavir and efavirenz --
work by interfering with this stage of the viral life cycle. 
Integration. The newly made RIV DNA moves to the cell's nucleus, where it is spliced 
into the host's DNA with the help ofRIV integrase. RIV DNA that enters the DNA of the 
cell is called a "provirus." 
Transcription. For a provirus to produce new viruses, RNA copies must be made that can 
be read by the host cell's protein-making machinery. These copies are called messenger 
RNA (mRNA), and production of mRNA is called transcription, a process that involves 
the host cell's own enzymes. 
Translation . After RIV mRNA is processed in the cell's nucleus, it is transported to the 
cytoplasm. RIV proteins are critical to this process: for example, a protein encoded by the 
rev gene allows mRNA encoding RIV structural proteins to be transferred from the 
nucleus to the cytoplasm. Without the rev protein, structural proteins are not made. 
In the cytoplasm, the VIruS co-opts the cell's protein-making machinery - including 
structures called ribosomes - to make long chains of viral proteins and enzymes, using 
RIV mRNA as a template. This process is called translation. 
Assembly and budding. Newly made RIV core proteins, enzymes and genomic RNA 
gather just inside the cell's membrane, while the viral envelope proteins aggregate within 
the membrane. An immature viral particle forms and buds off from the cell, acquiring an 
envelope that includes both cellular and RIV proteins from the cell membrane. During 
this part of the viral life cycle, the core of the virus is immature and the virus is not yet 
infectious. The long chains of proteins and enzymes that make up the immature viral core 
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are now cleaved into smaller pieces by a viral enzyme called protease. This step results in 
infectious viral particles. 
2.5. PROGRESSION FROM HIV INFECTION TO AIDS 
After a person has been infected with mv, it takes 2-12 weeks for the immune system to 
develop antibodies which can be detected in the bloodstream. This is called the window 
period. These antibodies are not able to overcome or destroy the virus. It is these 
antibodies that form the basis of the mv antibody blood test used in diagnosing whether 
or not a person has my. If a person is tested for mv during the window period, the virus 
will not be detectable, and the person will test negative, when he or she is really mv-
positive. This is known as a false negative result. 
HIV Infection 
Initial infection with my. This is when the virus enters the 
body. There are no signs or symptoms of infection. 
Window period 
mv infection with no signs or symptoms of disease 
and no detectable antibodies. An mv antibody test will 
be negative although the virus is present. This stage 
usually lasts 2-12 weeks, but may last several months 
or sometimes longer. 
Seroconversion 
This is when antibodies develop in the blood and an mv test 
will detect them. In other words, it is when you convert from 
being mv -negative to mv -positive. It may be accompanied 
by a few days of flu-like illness with slight fever, tiredness, 
aching muscles and joints. Some people experience no illness 
at this stage. 
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Asymptomatic HIV Infection 
Antibody tests are positive, but there are no apparent 
signs or symptoms of illness. This period may last from 
a few months to many years 
HIVIAIDS related illnesses 
The immune system (the cells which fight disease) has 
been damaged by the virus. Symptoms of diseases 
increase but as yet they are not severe enough to 
threaten life. Examples of symptoms are a low-grade 
fever that lasts several weeks, diarrhoea, extreme 
tiredness, weight loss, skin rashes, swollen glands and 
night sweats. Women may get vaginal infections 
(thrush) that never seem to clear up, even with 
treatment. Infections gradually become more 
frequent and more serious. This period may last for 
months or 
AIDS 
Life threatening infections and cancers occur because 
the immune system is severely weakened. Typical 
infections are pneumonia, skin cancers, "slim's" disease 
and Tuberculosis. The patient could die when an 
untreatable life- threatening condition develops. Life 
expectancy depends on the conditions that develop and 
the treatments available 
Table 2.1 - Progression from lIIV to AIDS (Source: Adapted from Helen Jackson, AIDS : 
action now-information, prevention and support in Zimbabwe. 1992 
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2.6. HIV TRANSMISSION 
For mv to be transmitted from one person to another, there must be an exit point for the 
virus to pass out of the infected person and an entry point into the body of the uninfected 
person. Exit and entry points for the virus exist where the skin is not intact and body 
fluids such as blood and sexual fluids can enter through this break in the skin. 
There are three main ways in which mv is transmitted: 
• Sexual Contact: There is a high concentration of the VIruS in blood, semen and 
vaginal fluids and the linings of the genital areas, when they are not intact, allowing 
for the virus to enter the body. The presence of a sexually transmitted disease (STD) 
increases the chances of transmitting or being infected with the virus. This is because 
open sores and the presence of inflammatory cells (which fight infection) increase the 
possibility that the virus will be transmitted. Women are more likely than men to be 
infected with the virus through heterosexual sex, because the lining of the vagina is 
very receptive to the virus. 
• Blood to blood transmission: This can occur when an uninfected person has an open 
wound which comes into contact with infected blood. The blood from the person with 
mv must go through the skin into another person' s body for transmission to occur. 
• From an infected mother to her child during pregnancy, childbirth or breastfeeding. 
There is no risk of mv transmission through casual contact between workers in the 
workplace. 
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2.7. HIV/AIDS STATISTICS 
The AIDS epidemic claimed more than 3 million lives in 2002, and an estimated 5 million 
people acquired the human immunodeficiency virus (HIV) in 2002-bringing to 42 
million the number of people globally living with the virus. 
As the world enters the third decade of the AIDS epidemic, the evidence of its impact is 
undeniable. Wherever the epidemic has spread unchecked, it is robbing countries of the 
resources and capacities on which human security and development depend. In some 
regions, RIV/AIDS, in combination with other crises, is driving ever-larger parts of 
nations towards destitution. The world stood by as RIV/AIDS swept through these 
countries. It cannot be allowed to turn a blind eye to an epidemic that continues to expand 
in some of the most populous regions and countries of the world. 
In Eastern Europe and Central Asia, the number of people living with RIV in 2002 stood 
at 1.2 million. RIV / AIDS is expanding rapidly in the Baltic States, the Russian 
Federation and several Central Asian republics. In Asia and the Pacific, 7.2 million 
people are now living with RIV. The growth of the epidemic in this region is largely 
due to the growing epidemic in China, where a million people are now living with RIV 
and where official estimates foresee a manifold increase in that number over the 
coming decade. There remains considerable potential for growth in India, too, where 
almost 4 million people are living with RIV. 
In several countries experiencing the early stages of the epidemic, significant economic 
and social changes are giving rise to conditions and trends that favour the rapid spread of 
RIV- for example, wide social disparities, limited access to basic services and increased 
migration. Best current projections suggest that an additional 45 million people will 
become infected with RIV in 126 low- and middle-income countries (currently with 
concentrated or generalized epidemics) between 2002 and 2010--unless the world 
succeeds in mounting a drastically expanded, global prevention effort. More than 40% of 
those infections would occur in Asia and the Pacific (currently accounts for about 20% of 
new annual infections). 
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Pinning down HIV trends 
The most common measure of the HIV/AIDS epidemic is the prevalence of HI V 
infections among a country's adult population-in other words, the percentage 
of the adult population living with HIV. Prevalence of HIV provides a good 
picture of the overall state of the epidemic. Think of it as a still photograph of 
HIV I AIDS. In countries with generalized epidemics, this image is based largely 
on HIV tests done on anonymous blood samples taken from women attending 
antenatal clinics. 
But prevalence offers a less clear picture of recent trends in the epidemic, 
because it does not distinguish between people who acquired the virus very 
recently and those who were infected a decade or more ago. (Without 
antiretroviral treatment, a person might survive, on average, up to 9-11 years 
after acquiring HIV; with treatment, survival is substantially longer.) 
Countries A and B, for example, could have the same HIV prevalence, but be 
experiencing very different epidemics. In country A, the vast majority of people 
living with HIV/AIDS (the prevalent cases) might have been infected 5-10 
years ago, with few recent infections occurring. In country B, the majority of 
people living with HIV I AIDS might have been infected in the past two years. 
These differences would obviously have a huge impact on the kind of 
prevention and care efforts that countries A and B need to mount. 
Similarly, HIV prevalence rates might be stable in country C, suggesting that 
new infections are occurring at a stable rate. That may not be the case, however. 
Country C could be experiencing higher rates of AIDS mortality (as people 
infected a decade or so ago die in large numbers), and an increase in new 
infections. Overall HIV prevalence rates would not illuminate those details of 
the country's epidemic. 
So a measure of HIV incidence (i.e. the number of new infections observed over 
a year among previously uninfected people) would help complete the picture of 
current trends. Think of it as an animated image of the epidemic. 
The problem is that measuring HIV incidence is expensive and complicated- to 
the point of it being unfeasible at a national level and on a regular basis in most 
countries. 
None of this means, however, that recent trends are a mystery. Regular 
measurement of HIV prevalence among groups of young people can serve as a 
proxy, albeit imperfect, for HIV incidence among them. Because of their age, 
young people will have become infected relatively recently. Significant changes 
in HIV prevalence among 15-19- or 15-24-year-olds can therefore reflect 
important new trends in the epidemic. 
Source: UNAIDS, 2003 : 7 
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Responses that involve and treat young people a s a priority payoff, as evidence from 
Ethiopia, South Africa, Uganda and Zambia shows. HIV prevalence levels among young 
women in Addis Ababa declined by more than one-third between 1995 and 2001. Among 
pregnant teenagers in South Africa, HN prevalence levels shrank a quarter between 1998 
and 2001. Prevalence remains unacceptably high, but these positive trends confirm the 
value of investing in responses among the young. 
The future trajectory of the global HIV/AIDS epidemic depends on whether the world 
can protect young people everywhere against the epidemic and its aftermath. Just as 
certain sectors of society are at particular risk of HN infection, certain conditions favour 
the epidemic's growth. As the current food emergencies in southern Africa show, the 
AIDS epidemic is increasingly entangled with wider humanitarian crises. The risk ofHN 
spread often increases when desperation takes hold and communities are wrenched apart. 
At the same time, the ability to stall the epidemic's growth also suffers, as does the 
capacity to provide adequate treatment, care and support. 
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2.8. GLOBAL SUMMARY OF THE HIV/AIDS EPIDEMIC: DECEMBER 2002 
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Table 2.2 - Global summary ofHIV/AIDS epidemic: December 2003 (Source: 
UNAIDS, 2002: 12) 
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2.9. REGIONAL HIV/AIDS STATISTICS AND FEATURES: DECEMBER 2002 
Region Epidemic Adults and Adults and Adult % of HIV· Main mode(s) 
started children living children newly prevalence positive adults of 
transmission (#) 
with HIV/AIDS infected with HIV rate (*) who are women for adults 
living 
with HIV/AIDS 
Sub·Saharan late '70s 29.4 million 3.5 million 8.8% 58% Hetero 
Africa early '80s 
North Africa late '80s 550000 83000 0.3% 55% Hetero, IOU 
& Middle East 
South & late '80s 6.0 million 700000 0.6% 36% Hetero, IOU 
South·East Asia 
East Asia late '80s 1.2 million 270000 0.1% 24% IOU, hetero, 
MSM 
& Pacific 
Latin America late '70s 1.5 million 150000 0.6% 30% MSM, IOU, 
hetero 
early '80s 
Caribbean late '70s 440000 60000 2.4% 50% Hetero, MSM 
early '80s 
Eastern Europeearly '90s 1.2 million 250000 0.6% 27% IOU 
& Central Asia 
Western Europelate '70s 570000 30000 0.3% 25% MSM, IOU 
early '80s 
North America late '70s 980000 45000 0.6% 20% MSM, IOU, 
hetero 
early '80s 
Australia & late '70s 15000 500 0.1% 7% MSM 
New Zealand early '80s 
TOTAL 42 million 5 million 1.2% 50% 
• The proportion of adults (15 to 49 years of age) living with HIV/AIDS in 2002, using 2002 population numbers. 
# Hetero (heterosexual transmission), IOU (transmission through injecting drug use), MSM (sexual transmission among men who 
have sex with men). 
Table 2.3 Regional HIV I AIDS statistics and features : December 2002 (Source: 
UNAIDS, 2002:14) 
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2.9.1. Asia and the Pacific 
Almost 1 million people in Asia and the Pacific acquired HIV in 2002, bringing to an estimated 
7.2 million the number of people now living with the virus-a 10% increase since 2001. A 
further 490 000 people are estimated to have died of AIDS in the past year. About 2.1 million 
young people (aged 15-24) are living with HIV. 
With the exception of Cambodia, Myanmar and Thailand, national HIV prevalence levels remain 
comparatively low in m ost countries 0 f Asia and t he Pacific. In vast, populous countries such as 
China, India and Indonesia, low national prevalence rates blur the picture of the epidemic. Both China 
and India, for example, are experiencing serious, localized epidemics that are affecting many millions 
of people. India' s national adult HIV prevalence rate of less than 1 % offers little indication of the 
serious situation facing the country. An estimated 3.97 million people were living with HIV at the end 
of 2001- the second-highest figure in the world, after South Africa. HIV prevalence among women 
attending antenatal clinics was higher than 1 % in Andhra Pradesh, Kamataka, Maharashtra, Manipur, 
Nagaland and Tamil Nadu. 
The epidemic in China shows no signs of abating. Official estimates put the number of people 
living with HIV in China at 1 million in mid-2002. Officially, the number of reported new HIV 
infections rose about 17% in the first six months of 2002. But HIV incidence rates can soar 
abruptly in a country marked by widening socio-economic disparities and extensive migration (an 
estimated 100 million Chinese are temporarily or permanently away from their registered 
addresses), with the virus spreading along multiple channels. 
The onward sexual transmission of HIV by people who became infected when they sold their 
blood to collecting centres that ignored basic blood-donation safety procedures poses a massive 
challenge, as does the need to provide them with treatment and care. Signalling the gravity of the 
situation, one 2001 survey in rural eastern China found alarmingly high HIV prevalence-
12.5%-among people who had donated plasma. 
High HIV infection rates are being discovered among specific population groups (chiefly 
injecting drug users, sex workers, and men who have sex with men) in countries across the length 
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and breadth of Asia and the Pacific. Throughout the region, injecting drug use offers the epidemic 
huge scope for growth. Upwards of 50% of injecting drug users already have acquired the virus 
in parts of Malaysia, Myanmar, Nepal, Thailand and in Manipur in India, while HIV infections 
among Indonesia's growing population of injecting drug users is soaring. 
Male-to-male sex occurs in all countries of the region and features significantly in the epidemic. 
Countries that have measured HIV prevalence among men who have sex with men have found it to 
be high-14% in Cambodia in 2000 and roughly the same level among male Thai sex workers. 
Homophobia or dominant cultural norms mean that many men who have sex with men hide that 
aspect of their sexuality. Many might marry or have sexual relationships with women. 
In Thailand, meanwhile, recent modelling suggests that the main modes of transmission have 
been changing. Whereas most HIV transmission in the 1990s occurred through commercial sex, 
half of the new HIV infections now appear to be occurring among the wives and sexual partners 
of men who were infected several years ago. There are also indications that unsafe sexual 
behaviour is on the increase among young Thais. 
The Asian country with the highest adult HIV prevalence-Cambodia-has reported stabilizing 
levels of infection, along with still-decreasing levels of high-risk behaviour. HIV prevalence 
among pregnant women in major urban areas declined slightly from 3.2% in 1996 to 2.8% in 
2002, according to the latest available data. Prevalence among sex workers declined from 42% in 
1998 to 29% in 2002, according to the latest surveillance data, with the decline most pronounced 
among sex workers under 20. Given the high turnover of sex workers in Cambodia (almost three-
quarters engage in sex work for less than two years), this steady decline suggests that prevention 
efforts focused on sex workers are yielding positive results among the succession of new entrants 
into sex work. Consistent condom use by sex workers appears to be the most important behavioural 
change achieved; it rose from 37% in 1997 to 90% in 2001. Given that many of the factors 
facilitating HIV transmission (including periodic economic upheaval and high rates of population 
mobility) are rife throughout this region, no country is immune to a rapidly spreading and wide-
scale epidemic. 
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2.9.2. Eastern Europe and Central Asia 
The unfortunate distinction of having the world's fastest-growing RIV/AIDS epidemic still 
belongs to Eastern Europe and Central Asia. In 2002, there were an estimated 250 000 new 
infections, bringing to 1.2 million the number of people living with RIV/AIDS. 
In recent years, the Russian Federation has experienced an exceptionally steep rise in reported 
RIV infections. In less than eight years, RIV / AIDS epidemics have been discovered in more than 
30 cities and 86 of the country's 89 regions. Up to 90% of the registered infections have been 
attributed officially to injecting drug use, reflecting the fact that young people face high risks of 
RIV infection as occasional or regular drug injectors. Indeed, almost 80% of registered new 
infections in the Commonwealth of Independent States between 1997 and 2000 were among 
people younger than 29. In the Russian Federation, the total number of reported RIV infections 
climbed to over 200 000 by mid-2002-a huge increase over the 10 993 reported less than four 
years ago, at the end of 1998. 
Throughout Eastern Europe and Central Asia, young people are particularly hard-hit by the 
epidemic. It is estimated that up to 1 % of the population of those countries is injecting drugs, 
placing these people and their sexual partners at high risk of infection. Those injecting drugs can 
be very young-some a mere 13-14 years old. One study among Moscow secondary-school 
students revealed that 4% had injected drugs. In the Russian Federation, and in many of the 
Central Asian Republics, the wave of injecting drug use is closely correlated with socio-
economic upheavals that have sent the living standards of tens of millions of people plummeting, 
amid rising unemployment and poverty levels. Another factor has been the four-fold increase in 
world production of heroin in the past decade, along with the opening of new trafficking routes 
across Central Asia. 
In Estonia, reported infections soared from 12 in 1999 to 1474 in 2001. (Relative to population 
size, Estonia now has the highest rate of new RIV infections in this region-50% higher than the 
Russian rate). A burgeoning epidemic is visible, too, in Latvia, where new reported infections 
rose from 25 in 1997 to 807 in 2001, and where a further 308 new RIV cases had been registered 
by the end of June 2002. 
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Cumulative reported HIV infections per million population, 
Eastern European countries: 1993-2001 
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Source: European Centre for the Epidemiological Monitoring of AIDS. HIVlAIDS surveillance in Europe. End-year report 2001. 
Saint-Maurice: Institut de Veille Sanitaire. 200 1. NO.66 
Figure 2.3 Cumulative reported RIV infections per million population, Eastern European 
countries : 1993-2001 
The other Baltic State, Lithuania, is experiencing a major RIV outbreak in one of its prisons, 
where 284 inmates (15% of the total) were diagnosed RIV-positive between May and August 
2002. This confinns the important, though often overlooked, role of prisons in the spread of RIV 
in many countries of the region. The concentration of large numbers of young people in 
overcrowded prisons or juvenile justice facilities, often marked by an abundance of drugs but a 
scarcity of RIV infonnation, clean needles and condoms, provides fertile ground for the rapid 
spread of RIV among inmates and, upon their eventual release, into the wider population. 
While injecting drug use among young people remams the predominant mode of RIV 
transmission in the Russian Federation and other countries of the region, heterosexual intercourse 
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has now become a prominent mode of transmission in Belarus and Ukraine. The latter, with an 
estimated adult HN prevalence rate of I %, is the most affected country in the region (and, 
indeed, in all of Europe). New diagnoses of HIV in persons infected through heterosexual 
intercourse accounted for 28% of all new cases reported in the first six months of 2002- up from 
15.3% in 1998 (see graph above). In Be1arus, the same proportion of new registered infections in 
2001 was attributed to heterosexual transmission. Although many of these infections may occur 
in the sexual partners of injecting drug users, the trend may also indicate spread into the wider 
population of these countries. 
In some cities of the Russian Federation and Ukraine, for example, up to 30% of female injecting 
drug users are also involved in commercial sex work. More generally, recent studies in Donetsk, 
Moscow and St Petersburg have revealed HN prevalence rates of l3-17% among sex workers. 
There is evidence that young people in several countries are becoming sexually active at an 
earlier age and that premarital sex is increasing. Yet, awareness and knowledge of HIV / AIDS 
remain dismal in many places. In Azerbaijan and Uzbekistan, for example, one-third of young 
women (aged 15- 24) had never heard of AIDS, according to a 2001 survey. Meanwhile, very 
high rates of sexually transmitted infections continue to be found in Eastern Europe and Central 
Asia, pointing to widespread unsafe sex and increased odds of HN infection. In the Russian 
Federation, between 200000 and 400000 cases of syphilis are reported annually. 
In contrast, there is cause for moderate optimism in Central Europe, where countries continue to 
hold the epidemic at bay; HN incidence overall remained exceptionally low in 2001 (7-10 
reported infections per million persons). Prevalence remains low in countries such as the Czech 
Republic, Hungary, Poland and Slovenia, where well-designed national HN/AIDS programmes 
are also in operation. 
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2.9.3. Sub-Saharan Africa 
By far the worst-affected region, sub-Saharan Africa is now home to 29.4 million people living 
with RIV/AIDS. Approximately 3.5 million new infections occurred there in 2002, while the 
epidemic claimed the lives of an estimated 2.4 million Africans in the past year. Ten million 
young people (aged 15-24) and almost 3 million children under 15 are living with RIV. 
A fully-fledged epidemic is only now taking hold in many African countries-as much greater 
numbers of people who acquired RIV over the past several years fall ill. In the absence of 
massively expanded prevention, treatment and care efforts, the AIDS death toll on the continent 
is expected to continue rising before peaking around the end of this decade. This means that the 
worst of the epidemic's impact on those societies will be felt in the course of the next decade 
and beyond. It is not too late to introduce and augment measures that can reduce that impact, 
including wider access to RIV medicines and socio-economic policy steps that genuinely shield 
the poor against the worst of the epidemic's effects. 
The worst of the epidemic clearly has not yet passed, even in southern Africa where rampant 
epidemics are under way. In four southern African countries, national adult RIV prevalence has 
risen higher than thought possible, exceeding 30%: Botswana (38.8%), Lesotho (31%), 
Swaziland (33.4%) and Zimbabwe (33.7%). 
Yet, there are new, hopeful signs that the epidemic could eventually be brought under control. 
Positive trends seem to be taking hold among younger people in a number of countries. In South 
Africa, for pregnant women under 20, RIV prevalence rates fell to 15.4% in 2001 (down from 
21 % in 1998). This, along with the drop in syphilis rates among pregnant women attending 
antenatal clinics-down to 2.8% in 2001, from 11.2% four years earlier-suggests that 
awareness campaigns and prevention programmes are bearing fruit. A major challenge now is to 
sustain and build on such tentative success, not least because RIV infection levels continue to 
rise among older pregnant women, as the graph below shows. 
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Figure 2.4 HIV prevalence by age, South African antenatal clinics: 1991 - 2001 
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20-24 years 
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Source: Summary Report, National HIV and Syphilis Sero-Prevalence Survey of Women 
Attending Public Antenatal Clinics in South Africa, 2001. Department of Health, South Africa, 
2002 
Elsewhere, in west and central Africa, the relatively low adult HIV prevalence rates in countries 
such as Senegal (under 1 %) and Mali (1.7%) are shadowed by more ominous patterns of growth. 
HN prevalence is estimated to exceed 5% in eight other countries of west and central Africa, 
including Cameroon (11.8%), Central African Republic (12.9%), Cote d'Ivoire (9.7%) and Nigeria 
(5.8%)-sobering reminders that no country or region is shielded from the epidemic. The sharp rise 
in HN prevalence among pregnant women in Cameroon (more than doubling to over 11 % among 
those aged 20-24 between 1998 and 2000), shows how suddenly the epidemic can surge. 
31 
Why do young African women appear so prone to HIV infection? 
Despite recent positive trends among young people (especially females) in some African 
countries, overall about twice as many young women as men are infected in sub-Saharan 
Africa. In 2001, an estimated 6-11 % of young women aged 15-24 were living with 
HIV I AIDS, compared to 3-6% of young men. This appears to be due to a combination of 
factors. Women and girls are commonly discriminated against in terms of access to 
education, employment, credit, health care, land and inheritance. With the downward trend of 
many African economies increasing the ranks of people in poverty, relationships with men 
(casual or formalized through marriage) can serve as vital opportunities for financial and 
social security, or for satisfying material aspirations. Generally, older men are more likely to 
be able to offer such security. But, in areas where HIV/AIDS is widespread, they are also 
more likely to have become infected with HIV. The combination of dependence and 
subordination can make it very difficult for girls and women to demand safer sex (even from 
their husbands) or to end relationships that carry the threat of infection. Studies have shown 
that young women tend to marry men several years older, and that their risk of infection 
increases if a husband is three or more years older than they are. Meanwhile, ignorance about 
sexual and reproductive health and HIV I AIDS is widespread. This, combined with the fact 
that young women and girls are more biologically prone to infection (the cervix being 
susceptible to lesions), helps explain the large differences in HIV prevalence between girls 
and boys aged 15-19. 
Source: UNAIDS, 2003 : 10 
The vast majority of Africans-more than 90%-have not acquired HIV. Enabling them to 
remain HIV -free is a massive challenge, with the protection of young people a priority. Treating 
and caring for the millions of Africans living with HIV/AIDS poses an inescapable challenge to 
the continent and the world at large. Relatively prosperous Botswana has become the first African 
country to a dopt a policy to ultimately m ake a ntiretrovirals available to a 11 citizens who need 
them. However, comparatively few people (approximately 2000) are currently benefiting from 
this commitment. In addition, a handful of companies (such as AngloGold, De Beers, and 
Heineken) have announced schemes to provide antiretrovirals to workers and some family 
members. These are valuable efforts. Measured against the extent of need, however, they are 
plainly inadequate. 
32 
2.9.4. Latin America and the Caribbean 
The epidemics in Latin America and the Caribbean are well established. An estimated 1.9 million 
adults and children are living with HIV in this region- a figure that includes the estimated 210 
000 people who acquired the virus in 2002. 
Twelve countries in this region (including the Dominican Republic and Haiti, several Central 
American countries, such as Belize and Honduras, and Guyana and Suriname) have an estimated 
HN prevalence of 1 % or more among pregnant women. In several Caribbean countries, adult 
HN prevalence rates are surpassed only by the rates experienced in sub-Saharan Africa-making 
this the second-most affected region in the world. HIV I AIDS is now a leading cause of death in 
some of these countries. Haiti remains worst affected (with an estimated national adult HN 
prevalence of over 6%) along with the Bahamas (where prevalence is 3.5%). It should be noted, 
however, that the quality of surveillance systems varies widely across the region, making it 
possible that serious, localized epidemics in other parts of the region might be escaping detection. 
Over the past decade, the ratio of men with HN infections to women with HN infections has 
narrowed considerably- to about 3-to-l in Latin America and 2-to-l in the Caribbean. 
Paradoxically, men who have sex with men appear to feature prominently in the increasing 
feminisation of the epidemic: recent research has shown that a large proportion of men who have 
sex with men also have sex with women. While HIV/AIDS programmes focusing on men who 
have sex with men are vital, sexual identities are more fluid than often assumed. Prevention 
efforts need to be tailored to apparently widespread- but hidden-bisexual behaviour in this 
region (as in many parts of Asia, too). 
The spread of HIV through the sharing of injecting drug equipment is of growing concern in 
several countries, notably Argentina, Brazil, Chile, Paraguay and Uruguay (in South America), the 
northern parts of Mexico, and Bermuda and Puerto Rico (in the Caribbean). Injecting drug use 
accounts for an estimated 40% of reported new infections in Argentina and 28% in Uruguay; in 
both countries, an increasing number of women with HIV are either injecting drug users or sexual 
partners of male drug users. 
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Like Argentina, Brazil has adopted a less punitive approach to dealing with the dual challenge of 
injecting drug use and HIV infection-to good effect. Prevention programmes among injecting 
drug users have contributed to a substantial decline in HIV prevalence in this population in several 
large metropolitan areas. In addition, a national survey has shown increasing condom use among 
injecting drug users (from 42% in 1999 to 65% in 2000)-a sign that sustained education and 
prevention efforts are bearing fruit. Argentina authorized its M inistry of Health to introduce a 
national policy on harm reduction in 2001, and is collaborating with Chile, Paraguay and Uruguay 
to set up similar schemes. 
New light is being cast on a hitherto hidden dimension of the epidemic: HIV infection among 
prisoners. A study in three urban prisons in Honduras has revealed an HIV prevalence of almost 
7% among male prisoners in general, and almost 5% among those aged 16-20 years (who, 
because of their young age, are likely to have become infected relatively recently). Less than 10% 
of the men reported regular condom use. The likelihood that similar patterns of transmission 
could be occurring in other countries of the region underscores the need for both more research 
and more systematic programmes that can protect prisoners and their partners against HIV / AIDS. 
Despite a clear need for focused HIV prevention work among prison inmates, institutional 
barriers impede the development and evaluation of such programmes. 
Among the factors helping drive the spread of HIV in the region overall is a combination 0 f 
unequal socio-economic development and high population mobility. Central America's 
worsening AIDS epidemic, for example, is concentrated mainly among socially marginalized 
sections of populations, many of whom are compelled to migrate in search of work and income. 
Unless overcome, the economic difficulties plaguing several countries in the region are likely to 
further entrench a socio-economic context that can facilitate the epidemic's spread. 
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2.9.5. Middle East and North Africa 
Available data point to increasing HIV infection rates, with an estimated 83 000 people having 
acquired the virus in 2002. This brings to 550 000 the estimated n umber of people living with 
HIV/AIDS. The epidemic claimed about 37000 lives in 2002. 
However, systematic surveillance remams inadequate, making it very difficult to deduce 
accurate trends. It is possible that hidden epidemics could be spreading in this region. Better 
surveillance systems (such as those introduced in Iran, Jordan, and Syria) will enable more 
countries to accurately track the development of the epidemic and mount effective responses. 
Significant outbreaks of HIV infections among injecting drug users have occurred in about half 
the countries in the region, notably in North Africa and in the Islamic Republic of Iran. In Iran, 
most HIV transmission is occurring among the country's estimated 200000-300000 injecting 
drug users, about 1 % of whom are believed to be living with HIV. High-risk behaviour is 
widespread in this largely male population: about half of the users share injecting equipment, 
and as many are believed to have extramarital sexual relations. According to some estimates, a 
significant percentage (more than 30%) of them is married. Yet condom use is very rare. In 
addition, about 10% of prisoners are believed to inject drugs and more than 95% of them share 
needles. HIV prevalence among imprisoned drug injectors was 12% in 2001. 
Other infected groups include men who have sex with men, sex workers and their clients. In 
Morocco, the National AIDS Control Programme has noted the relatively high prevalence of 
other sexually transmitted infections-a sign that unsafe sex is more common than routinely 
assumed. 
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2.9.6. High-income countries 
Approximately 76000 people became infected with RIV in high-income countries in 2002. A 
total of about 1.6 million people are now living with the virus in these countries, where an 
estimated 23000 people died of AIDS in 2002. 
Several salient changes have emerged in recent years. The introduction of antiretroviral therapy 
since 1995/1996 has dramatically reduced RIV/AIDS-related mortality, although this trend has 
begun to level off in the past two years. Longer survival of people living with RIV 1 AIDS has led 
to a steady increase in the number of people living with the virus in high-income countries. About 
500000 people were receiving these drugs at the end of2001. 
A larger proportion 0 f new R IV diagnoses ( 59% m ore overall between 1 997 and 2001) in several 
Western European countries is occurring through heterosexual intercourse. More than half of the 4279 
new RIV infections diagnosed in the United Kingdom in 2001 resulted from heterosexual sex, 
compared to 33% of new infections in 1998. In Ireland, a similar trend is visible, with the number of 
heterosexually transmitted RIV infections increasing fourfold between 1998 and 2001. Although 
injecting drug use remains the main mode of transmission in Spain, about one-quarter of all HIV 
infections have been heterosexually transmitted. 
Most high-income countries are contending also with concentrated RIV epidemics, including in 
the United States 0 fA merica where injecting drug use is a prominent route 0 f R IV infection 
(accounting for 14% of all reported RIV diagnoses). Reported RIV prevalence among injecting 
drug users in Spain in 2000 was 20-30% nationwide, while, in France, prevalence rates ranged 
between 10% and 23%. Portugal's serious epidemic among injecting drug users accounted for 
more than half the newly diagnosed RIV infections in both 2000 and 2001, though the number of 
reported RIV infections among injecting drug users declined significantly in 2001 . 
Reported RIV infections among young people can indicate overall trends in incidence, since 
those persons are likely to have become exposed to RIV relatively recently. In the 34 areas of the 
United States with confidential RIV reporting, the bulk ofRIV infections among 13- 19-year-olds 
reported in July 2000- June 2001 were among females (56%), a disproportionate percentage of 
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them African-American. Most young women had acquired the VIruS through heterosexual 
intercourse. 
Latest available data show that the epidemic's shift into poorer and marginalized sections of 
society is continuing. African-Americans accounted for an estimated 54% of new HIV infections 
in 2000 (but constitute only 13% of the population of the United States). AIDS-related illnesses 
remained the leading cause of death for African-American men aged 25-44 and the third-leading 
cause of death for Hispanic men in the same age group. (In Canada, meanwhile, aboriginal 
persons accounted for 9% of new HIV infections in 1999, although they constituted less than 3% 
of the general population.) HIV prevalence levels are exceptionally high among African-
American men who have sex with men-up to 30% among 23-29-year-olds, according to one 
six-city survey. About 64% of the women diagnosed with HIV in 2001 in the United States were 
African-American. A significant number of these women acquired the virus from men who also 
have sex with men. 
Underscoring the need for renewed prevention efforts, especially among young people, are recent 
findings of increases in high-risk behaviours, less frequent condom use and higher rates of sexually 
transmitted infections in several countries. In the United Kingdom, for example, rates of gonorrhoea, 
syphilis and chlamydial infections have more than doubled since 1995, while increases have been found 
in other Westem European countries, too. 
In Japan, where a record 621 people (most of them males) acquired HIV in 2001, the virus is spreading 
increasingly among young people. A reportedly growing trend of casual sex with multiple partners 
(known as sukusutomo or 'sex friends'), along with falling condom sales, suggests that new patterns of 
RIV spread could widen significantly. Nearly 40% of new HIV infections in 2001 were among people 
in their teens and twenties-a development that seems to match reports of increased rates of sexually 
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2.10.2. Adults and children estimated to be living with HIV/AIDS, end 2002 
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2.11. SOUTH AFRICA 
2.11.1. Introduction 
South Africa has never experienced an epidemic of the magnitude of the HN / AIDS 
epidemic. The routine surveillance conducted by the Department of Health has shown 
that among pregnant women attending public health clinics for antenatal care, the 
prevalence has increased from less than 1 % in 1990 to 25% in 200l. The rapid mortality 
surveillance system established by the Burden of Disease Unit of the Medical Research 
Council (MRC) and Centre for Actuarial Research at the University of Cape Town 
(UCT) has shown that there has been an increase in young adult mortality and that by the 
year 2000, AIDS had become the biggest single cause of death. 
2.11.2. The course of the epidemic 
Nationally, the epidemic can be considered to be entering the mature phase. Assuming a 
worst-case scenario with no changes in behaviour and no interventions, are that 6,5 
million people are infected with HIV in the year 2002. Figure 2.5 on the next page shows 
that the total number of people infected with HN is reaching its peak, which is the 
natural course of the epidemic. This is because the number of new infections has slowed 
down and because people who are infected are dying, as shown in Figure 2.6. Incidence, 
the number of people who are newly infected, peaked in about 1998 and has begun to 
decrease. However, the number of people dying from AIDS each year has only now 
started to increase. Without interventions to reduce mortality, it will peak in about 2010. 
In turn, this mortality will result in increasing numbers of children who are orphaned. The 
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HIV/AIDS profile of the provinces of South Africa-indicators for 2002) 
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Figure 2.6 - New Infections and AIDS Deaths (Source: Dorrington R E et al. 
HIV/AIDS profile of the provinces of South Africa-indicators for 2002) 
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2.11.3. Provincial variations 
The antenatal data reveal that the spread of the epidemic has differed between the 
provinces. The provinces differ in terms of ultimate plateaux, ranging from a low of 14% 
for the Western Cape to a high of nearly 40% for KwaZulu-Natal. Four of the nine 
provinces appear to be following similar epidemics while the epidemic in KwaZulu-Natal 
appears to have started earliest and is expected to peak at the highest level. The epidemic 
in the Northern Province, Northern Cape and the Western Cape are expected to level off 
at lower levels than the others. The Eastern Cape is beginning to reveal a distinctive 
pattern, with a much slower increase and no plateau by the year 2010. 
2.11.4. Births 
Statistical modelling predicts a total of over 1,1 million births for the period 1 January to 
31 December 2002. KwaZulu-Natal accounts for over one-fifth (21,6%) of these births. 
Of all babies born during this period, about 69 000 (5,9%) are estimated to have been 
infected at birth, while more than a further 20 000 will become infected through mother's 
milk during the year. The percentage of babies infected ranges from a high of 8,3% in 
KwaZulu-Natal, to a low of 1,5% in Western Cape. 
Births EC FS GT KZ LM MP NC NW WC SA 
Uninfected births 192 233 62517 176272 237774 153512 77083 20922 86 710 91452 1098476 
HIV-+births 11280 4366 10500 21430 8344 5746 746 5435 1364 69213 
Infected by 
3304 1295 3123 6404 2460 1712 224 1611 443 20162 
mothers milk 
Table 2.4 Infections with mv at birth (Source Adapted from Dorrington. 2002. 
mY/AIDS profile of the provinces of South Africa) 
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2.11.5. People living with HIV/AIDS 
The estimates are that there were 6,5 million people in South Africa living with 
mY/AIDS on 1 July 2002. Of these, over 6,1 million (95,1%) were in the age group 18-
64 years. This is also the age group which is most likely to form part of the labour force . 
An estimated 3,2 million women of child-bearing age (15-49 years), were living with 
mY/AIDs. This group accounted for around half (49,5%) of all infections. In all adult 
age groups, there were more women than men living with mv/ AIDS. The gender 
imbalance is most stark among youth, aged 15-24 years, where there were close on four 
infected young women for every infected young man. The numbers of children under the 
age of 15 years infected is relatively small when compared with the numbers for other 
age groups below the age of 65 . The main source of infection for children is perinatal and 
mother's milk, rather than the sexual transmission which is the main source for adults. 
KwaZulu-Natal accounts for 27% of total infections, and between 25,7% and 27,6% of 
infections in all the adult groups. It accounts for 30% or more of infections among youth 
and children. Gauteng accounts for 22,4% of infections overall, and as much as 26,0% of 
infections among adult men aged 18-64 years. These patterns are more a reflection of the 
age and race profiles of the different provinces than the differences between the epidemic 
in the provinces. The patterns also affect the spread of the disease in each province in 
subsequent years. 
People living with HIV I 
EC FS GT KZ LM MP NC NW WC SA 
AIDS 
Total HIV infections 805879 487772 1449899 1745 490 600 713 518156 78426 582089 192946 6461372 
Adulls (18-64) 758 570 467542 1404473 1639263 562178 490228 75612 556640 187073 6141578 
Adult men(18-64) 316231 244344 782996 775787 251296 241951 35883 287988 79604 3016080 
Adult women(18-64) 442339 223197 621477 863 475 310882 248277 39729 268 652 107469 3125498 
Child bearing age 
455 965 227703 627254 888120 322 930 254155 40 179 274970 108217 3199 493 
Women (15-49) 
Youth (15-24) 197875 84772 163 283 371676 151959 99211 12779 104439 24754 1210749 
Male Youth (15-24) 38213 17802 35814 85742 34428 21835 2556 22536 4144 263 069 
Female youth (15-24) 159661 66970 127470 285 934 117532 77376 10224 81903 20610 947680 
Child-en (0-14) 29018 12776 31488 68208 23204 18379 1904 15830 4327 205134 
. . 
Table 2.5 ProvmcIal mdIcators - people hvmg WIth mY/AIDS (Source : Adapted from 
Dorrington. 2002. mY/AIDS profile of the provinces of South Africa) 
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2.11.6. Prevalence rate 
The prevalence rate is the percentage of a group who are infected at a particular point in 
time. Overall, in July 2002, the estimates are that 14,2% of people in South Africa were 
infected. The figure is as high as 18,4% in KwaZulu-Natal, and at a low of 4,2% in 
Western Cape. In all provinces except Western Cape and Northern Cape, more than one 
in every ten people is infected. 
Prevalence is highest among women of child-bearing age, at 25,9% overall, and 34,5% in 
KwaZulu-Natal. Among those attending antenatal clinics, prevalence is predicted to be 
29,0% for the country as a whole, and 38,7% in KwaZulu-Natal. Prevalence is much 
higher for female youth than male youth, at 21,6% and 5,8% respectively. Among adults, 
however, the gender difference varies between provinces. For the country as a whole, 
prevalence is marginally higher for adult women than adult men. However, prevalence is 
lower for women than men in Free State, Gauteng, KwaZulu-Natal and North West. 
Prevalence EC FS GT KZ LM MP NC NW 
Total population 11.3% 16.7% 160% 18.4% 11 .0% 16.5% 7.9% 15.1% 
Adults (18-64) 20.5% 26.5% 23.8% 31.4% 20.9% 28.1% 12.9% 24.8% 
Adult men(18-64) 19.0% 27.4% 25.6% 31.6% 20.2% 28.0% 12.4% 25.7% 
Adult YtOOlen(18-64) 21 .9% 25.5% 21.9% 31.3% 21 .5% 28.2% 13.4% 23.9% 
Child bearing age 
23.8% 28.3% 25.0% 
Women (1549) 
34.5% 22.7% 30.2% 14.8% 26.3% 
Youth (15-24) 12.5% 15.6% 13.0% 19.7% 12.1% 15.9% 6.7% 14.4% 
Male Youth (15-24) 4.9% 6.7% 5.9% 9.1% 5.3% 7.0% 2.7% 6.4% 
Female youth (15-24) 20.1% 24.1% 19.8% 30.2% 19.4% 250% 10.6% 22.2% 
Antenatal clinics 26.5% 32.6% 29.8% 38.7% 22.3% 33.1% 17.2% 27.7% 
Table 2.6 Provincial indicators - mv Prevalence rate (Source 











11 .4% 29.0% 
Adapted from 
2.11.7. Incidence rate 
The incidence rate is the percentage of people who are uninfected at the beginning of the 
period who will become infected over the twelve months. It is a better measure of where 
we are in the epidemic than prevalence. For the total population, the incidence rate is 
estimated to be 2% for the twelve months starting 1 July 2002, and has peaked in all 
provinces. The incidence rate is highest for new births, at 6%. It is next highest for babies 
in their first year who become infected primarily through mother's milk. 
Although KwaZulu-Natal has the highest prevalence rates, its incidence rates are not the 
highest. For example, the incidence of infection in Free State is higher than that in 
KwaZulu-Natal for all age groups except babies. Western Cape has the lowest incidence 
rates for all age groups. 
Incidence EC FS GT KZ LM MP NC NW WC SA 
Total population 2.1% 2.3% 2.1% 2.3% , 1.9% 2.3% 1.3% 2.1% 0.7% 2.1% 
Adults (18-64) 3.4% 3.4% 2.9% 3.3% 3.1% 3.5% 2.0% 3.2% 1.1% 3.1% 
Adult men(18-64) 1.5% 1.7% 1.5% 1.6% 1.5% 1.7% 0.9% 1.6% 0.4% 1.5% 
Adult women(18-64) 3.2% 2.9% 2.4% 2.5% 2.6% 2.9% 20% 2.6% 1.4% 2.7% 
Perinatal (of births) 5.5% 6.5% 5.6% 8.3% 5.2% 6.9% 3.4% 5.9% 1.5% 8.0% 
Mother's milk (of infants) 3.5% 4.1% 3.5% 5.4% 3.2% 4.4% 2.1% 3.7% 1.0% 3.8% 
Table 2.7 Provincial indicators - mv incidence rate (Source : Adapted from Dorrington. 
2002. mY/AIDS profile of the provinces of South Africa) 
2.11.S. Stages of infection 
A person who is mv -positive typically passes through several stages of infection. The 
table below shows the proportion of those infected in each of four stages according to the 
WHO staging system. Those in stages 1 and 2 will be relatively asymptomatic, those in 
stage 3 will be suffering weight loss and bouts of illness from opportunistic infections, 
and those in stage 4 will have full-blown AIDS. Typically, a person not recelvmg 
treatment will die within a year to a year and a half of reaching this stage 4. 
Overall, 55% of all infected people in South Mrica were in the first stage in July 2002, 
with a further 20% in the second stage, 18% in the third stage, and 7% having full-blown 
AIDS. Thus about 75% are asymptomatic, which explains why so few of the people who 
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are infected know they are infected. In those provinces with more advanced epidemics, 
the percentages in the early stages are close to 50%. On the other hand, in Western Cape, 
Eastern Cape, Northern Cape and Limpopo, more than 60% of infected people are in the 
first stage. 
Stages of infection EC FS GT KZ LM MP NC NW WC SA 
%instage 1 62% 55% 54% 50% 61% 51% 62% 56% 63% 55% 
%instage 2 18% 20% 21% 21% 19% 20% 18% 20% 18% 20% 
%instage 3 15% 18% 19% 21% 15% 20% 15% 18% 15% 18% 
%in stage 4 5% 7% 7% 8% 5% 8% 5% 6% 5% 7% 
Table 2.8 Provincial indicators - stages of infection (Source : Adapted from Dorrington. 
2002. mY/AIDS profile of the provinces of South Africa) 
2.11.9. People who are sick with AIDS 
As mentioned above, AIDS represents the last stage of my infection. The next table 
shows, for each province, the estimated number of new AIDS cases occurring in 2002, as 
well as the total estimated number of people who are sick with AIDS, i.e. in stage 4, on 1 
July 2002. For all provinces, the number of new AIDS cases during the year is only a 
little less than the number of total AIDS sick at mid-year; this is because people in this 
stage usually do not survive much more than a year after becoming AIDS sick, unless 
they receive treatment. ) 
AIDS sick EC FS GT KZ LM MP NC NW WC SA 
New AIDS sick 
35796 
over the year 
28290 87727 113541 27859 33513 3598 32673 8908 371007 
Total AIDS sick 
37011 31111 95 521 128979 29108 39156 3628 35293 9307 409113 
mid-year 
Table 2.9 Provincial indicators - people sick with AIDS (Source Adapted from 
Dorrington. 2002. mY/AIDS profile of the provinces of South Africa) 
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2.11.10. Deaths 
Without therapy mv/ AIDS is invariably fatal. In 2002, AIDS will account for two-fifths 
(40%) of all deaths. In KwaZulu Natal (52%) and Mpumalanga (51%), it will account for 
over half of all deaths. At July 2002, AIDS would have resulted in over 688 000 deaths in 
the country. Approximately a third (34%) ofthese deaths will have occurred in KwaZulu 
Natal, and 20% in Gauteng. 
Deaths EC FS GT KZ LM MP NC NW WC SA 
Non-AIDS death 
64875 25320 72936 76993 41008 23996 8681 32227 39004 396 538 
over the year 
AIDS deaths over 27125 19173 56414 82373 21306 24483 2397 22127 5904 262337 
the year 
Accumulated AIDS 67715 49766 139249 231265 55190 71424 5465 56 407 14166 688 493 
deaths mid-year 
Table 2.10 Provincial indicators - mY/AIDS deaths (Source : Adapted from Dorrington. 
2002. mY/AIDS profile of the provinces of South Africa) 
2.11.11. Mortality statistics 
By causing additional deaths, mv/ AIDS impacts on mortality statistics. In 2002, the 
infant mortality rate is 59 per 1 000 live births for the country as a whole, while the child 
mortality rate - the number of children per 1 000 births who die before reaching age five 
- is 100. Adult mortality as measured by the probability that a person aged 15 will not 
reach the age of 60 years (45qj) is 43% for women, 56% for men, and 50% for both sexes 
combined. Male life expectancy at birth is 50 years while female life expectancy is 55 
years. On each of the mortality measures except infant mortality, KwaZulu-Natal 
performs worse than all other provinces while Western Cape performs best on all 
measures. 
All the mortality measures show a marked increase over the last few years. For example, 
in 1990 the infant mortality rate was estimated to be 52 per 1 000 births, childhood 
mortality stood at 71 per 1000, adult mortality was 30% and life expectancy was over 61 
years. 
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Mortality statistics EC FS GT KZ LM MP NC NW WC SA 
Infant mortality rate 72 63 46 68 53 59 46 56 30 59 
Child mortality rate 112 106 82 124 87 106 72 95 46 100 
Adult mortality 45% 515 47% 59% 46% 56% 38% 49% 33% 50% 
Adult male mortality 51% 57% 53% 64% 53% 62% 44% 56% 39% 56% 
Adult female mortality 39% 44% 40% 53% 40% 50% 32% 43% 26% 43% 
Life expectancy 53.5 51.7 54.8 47.5 54.4 49.5 58.8 50.3 59.3 49.9 
Male life expectancy 51 .1 49.4 52.2 45.9 51.8 47.6 55.8 50.3 59.3 49.9 
Female life expectancy 56.0 54.1 57.4 49.2 57.0 51 .4 61 .9 55.2 66.1 55.0 
Table 2.11 Provincial indicators - mortality statistics (Source: Adapted from Dorrington. 
2002. mY/AIDS profile of the provinces of South Africa) 
2.11.12. Maternal orphans 
Defining an orphan as a person under the age of 18 years whose mother has died, it is 
estimated that there were over 885 000 orphans in South Africa in July 2002. Of the 
overall total, 38% would have been orphaned as a result of AIDS. In Mpumalanga and 
KwaZulu-Natal, approximately half of all maternal orphans were orphaned as a result of 
AIDS. KwaZulu-Natal and Gauteng between them currently account for over half (53%) 
of all AIDS orphans. Although it is common practice to use age 15 as the limit, using age 
18 gives a better measure of the burden to be borne by the provinces. For comparative 
purposes we have used age 15 in the individual provincial profiles later. 
During the year starting 1 January 2002, over 204 000 children will be newly orphaned. 
In all provinces except Western Cape, more than half of all orphans are due to AIDS. 
Overall, AIDS will account for close on three-quarters (73%) of all new orphans. It will 
account for 81% ofthe new orphans in KwaZulu-Natal. 
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2.12. SUMMARY 
The Acquired Immune Deficiency Syndrome (AIDS), was first recognised as a specific 
condition in 1981. The cause of AIDS, the Human Immunodeficiency Virus (HN), was 
only identified in 1984 (Loewenson & Whiteside, 1997: 5; Gathiram, 2000). The virus 
has since alluded all attempts to find a cure or vaccine and thus prognosis for those 
affected remains bleak. 
The virus may enter the body via sexual intercourse and, to a lesser extent, by sharing of 
unsterilised needles amongst drug users (World Bank, 2003: 17). Once in the body the 
virus may remain dormant for many years. It is this incubation period that the chances of 
infection of others increases significantly as an infected person may unknowingly pas on 
this pestilence to a sexual partner or fellow drug user. 
The HIV I AIDS pandemic had by the end of 2002 resulted in the infection of over 42 
million people worldwide. The estimated number of adult and children deaths due to 
HIV I AIDS during 2002 is 3.1 million. The spine chilling estimate is that in 2002 the 
number of adults and children newly infected with HIV was 5 million. The infection rate 
is clearly not decreasing. 
Of the total global HIV infected population of approximately 42 million, 29.4 million 
reside in Sub-Sahara Africa. Simplistically 70% of the global population estimated to be 
living with HIV/AIDS in 2002 are from Sub-Sahara Africa. Consequently Sub-Sahara 
Africa can be termed the epicentre of the pandemic. Within this framework of infection 
rates, KwaZulu Natal, has emerged as the fore-runner for new infections in South Africa. 
South Africa has never experienced an epidemic of the magnitude of the HIV I AIDS 
epidemic. The routine surveillance conducted by the Department of Health has shown 
that among pregnant women attending public health clinics for antenatal care, the 
prevalence has increased from less than 1 % in 1990 to 25% in 2001. The rapid mortality 
surveillance system established by the Burden of Disease Unit ofthe Medical Research 
Council (MRC) and Centre for Actuarial Research at the University of Cape Town 
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(VeT) has shown that there has been an increase in young adult mortality and that since 
the year 2000, AIDS had become the biggest single cause of death. 
Nationally it is estimated that 6,5 million people were infected with HIV in the year 
2002. The total number of people infected with HIV is reaching its peak, which is the 
natural course of the epidemic. This is because the number of new infections has slowed 
down and because people who are infected are dying. Incidence, the number of people 
who are newly infected, peaked in about 1998 and has begun to decrease. However, the 
number of people dying from AIDS each year has only now started to increase. Without 
interventions to reduce mortality, it will peak in about 2010. In turn, this mortality will 
result in increasing numbers of children who are orphaned. The number of maternal 
orphans who are under 15 years of age will peak in about 2015. 
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CHAPTER 3 - ECONOMIC IMPACT OF HIV/AIDS 
3.1. INTRODUCTION 
The adverse economic impact of RIV/AIDS is becoming increasingly evident. In high-
prevalence countries the growth rates of gross domestic product are slowing down, the 
manpower losses in key sectors are mounting, the number of orphans is increasing and 
household poverty is deepening. These countries are facing the formidable challenge of 
mitigating the economic impact ofRIV/AIDS. 
There are three important contributory reasons for this: 
• First, the paucity of data precludes recognition of the extent of the impact of the 
epidemic and its economic cost. 20 years into the pandemic, reliable data on 
prevalence, infection and impact remains hard to come by. Relative to the steady 
spread of the disease into the new century, available studies and data are remarkably 
outdated while more routine economic research is comparatively insensitive to 
RIV / AIDS issues. 
• Second, existing levels of systemic dysfunction are often so endemic in high-
prevalence countries that they mask the real impact of the disease until it is too late. 
Even informed high RIV / AIDS prevalence countries apparently remain unconvinced 
of the longer term impact, and have not yet developed strategies to cope with the 
obvious and incontrovertible impact ofRIV/AIDS, such as the increase in the number 
of orphans and decline in the size of the labour force. 
• And third, much of the responsibility for national RIV/AIDS mobilization and 
response is vested in the health sector, leading to the assumption that it is a passing 
health issue. 
54 
Economic Impact - A Vicious Cycle: 
This section makes three points. 
First, that RIV / AIDS has an impact at all levels of the economic system - macro, me so 
and household - and these interrelated impacts feed on each other to create a vicious 
cycle. 
Second, RIV/AIDS impact at all levels is evidenced by three main indicators: 
• The loss of manpower and skills; 
• Changes in the population structure and the erOSIOn of whole production and 
consumption bands, with consequent distortion of resource allocation due to changes 
in demand for goods and services; 
• Deterioration in management capacity and governance. 
And third, the most direct impact of RIV / AIDS mortality and morbidity is at the 
household level, the base building blocks of the economy. It reduces their ability to 
work, generate adequate income, save and invest, and increases their dependency on the 
state. These factors change the extent and nature of demand for the services and output of 
different sectors such as agriculture, education and health, and will place unprecedented 
strain on social service delivery. In addition, the lead-time involved in replacing skilled 
manpower losses due to RIV / AIDS and the associated loss of experience and institutional 
memory, will reduce sectoral capacity to produce goods and services and meet the needs 
of households and the macro-economy. This will in turn reduce or slow economic 
growth. This vicious cycle constrains the ability of the system to reduce household 
poverty, as the following chart will illustrate: 
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Figure 3.1 Economic Impact ofHIV/AIDS : A Vicious Cycle 
Source: Adapted from Alan Whiteside's Presentation 




I MORTALITY I 
~ 
Note: Sectors here are defined as functional spheres managed by all the stakeholders 
including governmental and non-governmental organizations. 
The destructive erosion ofHIV/AIDS is not occurring on neutral ground: Its advent 
coincides with a number of complicating socio-economic and development factors, and 
its primary impact is to exacerbate these as well as existing and residual levels of societal 
and sectoral dysfunction. The assumption that technology alone may resolve these 
problems is also misleading and requires instead a systematic process of training and 
empowerment, based on need, rather than simple supply-driven interventions. Indeed, the 
move to technology enhanced economic growth has slowed, and in some sectors 
obliterated job creation in the developing world, providing an uncomfortable reminder 
that development has its costs. Globalisation and changing trade dynamics too have 
contributed significantly in some developing economies to deepening poverty and 
unemployment, and economic gaps may in fact be widening along these fracture lines, 
further stressing the micro and me so economy. 
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3.2. EVIDENCE OF THE IMPACT OF HIV/AIDS 
A key failure both within the sectors involved and those development agencies that 
support them has been the lack of attention to the collection of data and development of 
management information systems. Few systematic studies have been carried out on the 
impact of RN I AIDS at the household, sector or macro levels and this failing has 
contributed in large measure to the lack of awareness and understanding in sectoral 
management - often misinterpreted as denial. Due to limited number of impact 
assessments the same evidence is quoted over and over by different authors. While 
quantitative estimates of impact are available for the increase in orphan numbers, the 
decrease in the size of the labour force, increased mortality rates and changes in size, age 
and structure of the population, these are often not taken seriously by sectoral 
management. These estimates can and should provide the basis for developing systematic 
management and mitigation strategies but in many high-prevalence countries still require 
the evidence of hard data to make the case for intervention. 
3.2.1. Household Impact: 
Apart from the loss of breadwinners and the growmg realization of reduced life 
expectancy, t he most serious issue for the household, the community and society a s a 
whole, is the increase in the number of orphans. As illustrated in the following chart 
(Figure 3.2), the percentage of orphaned children in selected high-prevalence countries 
increased from 2% in 1980 to 15-17% in 2000, and will increase to almost 20-30 % in 
2010. In South Africa, for example, figures suggest that one in five children of school-
going age will be orphaned by 2010, rising in some higher-prevalence provinces to one in 
four. 
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Figure 3.2 Percentage of orphans from all Causes 
Source: Children on the Brink, 2000; U.S. Census Bureau 
In these high-prevalence countries, almost three-quarters of the households in the 
community take in and care for orphans, reducing their own consumption per head as 
well as their ability to save and invest. The burden of this large number of orphans is 
sending shock-waves through the communities concerned: Africa' s traditional extended 
family system, exemplary at absorbing members under stress, is confronted with impact 
on every constituent part of its network and may reach breaking point without some 
assistance. The ability of these emerging populations to absorb this level of stress is 
limited, given that they function off a very low - often non-existent - social security base 
to begin with. Adding the impact of mv/ AIDS to this strain may have the effect of not 
only accelerating the reversal of development gains but of fragmenting the very societal 
structure that has so far sustained marginal societies. 
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Thus, mVI AIDS may generate a new class of poor and push those who are already living 
at the margin closer to the edge. 'In Zambia, for example, AIDS led to a rapid transition 
from relative wealth to relative poverty in many households. In two-thirds of families, 
when the father died monthly disposable income fell by more than 80%. 
3.2.2. Sectoral Impact: 
While most of the sectoral assessments available are confined to the impact such inputs 
as labour, financial resources and management capacity, analysis on mv I AIDS impact 
on output or outcomes is rare. However, estimates of the decline in labour force size, a 
few ad hoc studies on the loss of specialized skills and some anecdotal evidence of 
impact on management capacity are available, and are mentioned below. This is not an 
exhaustive inventory but shows the magnitude of the problems, which are illustrated by 
the following points: 
3.2.2.1. Labour Force: 
According to data from the ILO and the UN Population Division, about 10% to 30% of 
the labour force in identified high-prevalence countries will be lost during the next 15 
years, necessitating a major overhaul of development strategy and process thinking: 




Botswana -17.2 -30.8 
Lesotho -4.8 -10.6 
Malawi -10.7 -16.0 
Mozambique 
-9.0 -24.9 
Namibia -12.8 -35 .1 
South Africa -10.8 -24.9 
Tanzania -9.1 -14.6 
Zimbabwe -19.7 -29.4 
Table 3.1 Southern Africa Labour Force Losses due to HIV/AIDS (%) 
Source: Africa Recovery and United Nations 
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3.2.2.2. Loss of specialized skills: 
Education: According to a report by the World Bank, HIV/AIDS is killing teachers faster 
than nations can train them, undermining an international effort to enrol all children in 
school by 2015 and confirming the redundancy of many well-intentioned declarations in 
the AIDS-era. The report states that in parts of Uganda and Malawi, nearly a third of all 
teachers are HIV -positive. In Zambia, teacher deaths nearly doubled, to 1,300 in the first 
10 months of 1998 from 680 in 1996. In the Central African Republic, 85% of the 340 
teachers who died between 1996 and 1998 had AIDS, and vanished from their classrooms 
an average of 10 years before they would have normally retired. 
The HEARD Mobile Task Team on the impact of HIV I AIDS on education has found that 
HIV/AIDS exacerbates existing high attrition rates. In the KwaZulu Natal province of 
South Africa their research suggests that the impact of HIV I AIDS on an existing attrition 
rate of 7% (in 1999) will require the replacement of almost 70 000 of 75 000 teachers in 
service by 2010. The South African Democratic Teachers Union, SADTU, has evidence 
that the average age of death for teachers in the same province has now declined to just 
36, suggesting the need for a complete policy revision in respect of dramatically 
shortening pre-service training. 
Health: Estimates based on different stages of the epidemic suggest that a country with a 
stable 15% prevalence rate can expect that each year between 1.6% and 3.3% of its 
healthcare providers will die from AIDS. Given that antenatal HIV prevalence rates range 
between 19% and 32% across high prevalence southern African countries, the 
implications will be obvious, not least because the health sector also seems convinced 
that RIV / AIDS is a health issue. It is also important to recognize that HIV / AIDS impact 
is variable over a given area and that these averages mask the extent of impact in certain 
hospitals and clinics. 
Agriculture: In Malawi, death rates among employees of the Ministry of Agriculture and 
Irrigation have doubled, almost all because of HIV/AIDS. In Namibia, studies indicate 
that agricultural extension workers spend a tenth of their time attending funerals. 
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Mining: Approximately 25% of miners in South Africa are living with HIV / AIDS, 
according to the country's Medical Research Council, which expects this to increase to 
30% by 2005. In neighbouring Botswana, with the continent's highest prevalence rate, 
data produced by HEARD indicates a comparative rate of over 30% in 2001. 
Natural Resource Management: The Forestry Department of Kenya has estimated that 
since 1988 it has lost an average of36 employees a year (2-4 employees/month) due to 
HIV / AIDS. Environment professionals such as wildlife veterinarians, silviculturalists 
and plant pathologists are highly educated professionals, with the cost oftraining 
replacement personnel as high as R 300 000 per person. 
Budget and Management: 
The budget and management constraints are made worse due to HIV/AIDS: 
Capital and Recurrent Budget Imbalance: Many sectors have little to spend on capital 
proj ects because of recurrent commitments and this will worsen as HIV / AIDS inflates 
health care, training and replacement costs in the recurrent budget. The education sector 
routinely budgets between 90% and 95% on teacher salaries alone, leaving little to reduce 
backlogs and address capital needs. The cost of teacher training in South Africa, 
involving a four-year degree track, may run to between three and four times the cost of 
building a modem classroom, for example. In spite of comparatively high remuneration 
for qualified teachers , competition for these skills is intensifying as the private sector 
seeks to replace its own AIDS losses and puts pressure on increasing wage demands. 
Increasing Expenditure Bottlenecks: I nadequate a bsorption capacity a t all levels of the 
sectoral system leads to under-spending and rollovers; this may also be true of external 
(donor agency) funds placed in sectoral hands. Loss of skills (permanent and temporary) 
will lead to capacity failure at all levels while mid- and local-level structures may 
collapse and lose yet more of their capacity to receive and disburse. The perennial 
rollover of unspent sectoral funds also has the effect of persuading the finance sector that 
HIV/AIDS projections are unfounded given the inability of the sectors concerned to 
spend the money. 
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Management - Human Resource Shortages: The shortage of skilled and experienced 
decision-makers is growing at all levels of the system both for reasons of AIDS-mortality 
and increased recruitment by the private sector. While m any sectors are seen to be 
'personnel-heavy' (evidenced by the share of recurrent budget) there remains a limited 
pool of top managers; RIV / AIDS will reduce the number of candidates for entry into this 
pool and create pressure for extension of service. There may also be an increasing gulf 
between the attitudes and value-systems of older managers and the influx of much 
younger entrants to their ranks, due to evident losses in the group 35 to 50. 
Planning and Projection Problems: The inability to calculate and project basic demand 
and supply equations and model a sustained response has long been evident at the 
sectoral level. There is a limited culture of decision-making informed by hard data and 
information, and planning is all too often based on political agendas and promise. The 
lack of functional management information systems compounds this problem, as does the 
uncertainty about the value of RIV / AIDS indicators. Informed planning and adequate 
data collection holds the key to management response and mitigation. 
Training Under-Provision or Inadequacy: Failure to provide for appropriately trained 
replacement stock to meet system demand is the issue. Combined with a lack of informed 
planning, the failure to adequately project demand for new personnel and factor 
competition from other quarters could paralyse a given sector. The additional problem of 
training for entry into the 'emergency' environment of the RIV/AIDS era must be faced, 
including the prospect of dramatically foreshortening pre-service training time and 
having to provide additional levels of in-service support. 
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3.2.3. Macro or National Level Impact 
African economies could be devastated by the forecast 10 million AIDS-deaths in 
southern Africa over the next 15 years. The apparent high mortality rate among the 15-29 
age group and women in particular has profound implications for the provision of 
services and related productivity. 
The SADC's Regional Human Development Report for 2002, estimated that the potential 
loss of 6,3 million lives from 1995 to 2005 would slash the gross domestic product 
(GDP) in countries across the region. It reported that Zambia's GDP had, for example, 
already fallen by an estimated 8% in 2002 as a direct result ofHIV/AIDS. 
The UN Development Program (UNDP), in its Botswana Human Development Report, 
cites government studies showing that HIV/AIDS will result in GDP being between 24% 
and 38% lower by 2021. It also predicted that in 25 years, GDP could be 40% lower than 
without HIV/AIDS. 
UNAIDS h as estimated that when H IV prevalence rates rise tom ore than 20%, gross 
domestic product (GDP) in the countries affected can be lowered by as much as 2% a 
year. In South Africa, the investment bank ING Barings has projected that HIV/AIDS 
could drag down GDP by 0.3-0.4 percent a year. Another study has indicated that by the 
end of the decade, AIDS could have reduced South Africa's GDP by 17%, or the 
equivalent of $22 billion. 
HIV / AIDS also exacerbates the systems' inability to allocate and utilize resources in an 
optimal manner. For example, HIV/AIDS direct and indirect impact on the macro-
economy and sectoral budgets will increase the problem of lack of capital and/or 
recurrent budget at a national or sectoral level through diversion and increased 
consumption in competing sectors. Similarly, limited numbers of competent financial 
managers are already under stress and their numbers may be thinned further, with 
performance compromised by personal and institutional circumstances. 
63 
3.3. CONCLUSION 
This section concludes that: 
• The vicious cycle of low growth, unemployment, low social and economic status, 
depression and poverty will become increasingly virulent over the coming years as 
RIV / AIDS mortality and morbidity spirals in high prevalence countries. The 
dysfunctionality of current systems, the lack of sustainable management capacity and 
the inefficiency of allocation and resources utilization at every level of the economy-
macro, meso and micro - are likely to paralyse public and private systems as they 
operate at the margin of collapse. 
• The key point of departure is to accept and understand RIV / AIDS as a systemic 
management challenge rather than a public health problem. RIV / AIDS will impact 
every aspect of systemic functioning, over the long-term, and will exacerbate existing 
problems of capacity and sustainability. To respond strategically to this challenge it 
is necessary to move beyond the continuum of awareness, prevention and care and 
frame a management approach that uses hard data and appropriate indicators to 
inform decision-making. The objective should be to mitigate - at all levels, and in all 
sectors - by managing better and focusing on those issues that both drive and impede 
the economy. 
• The time required to replace increasing manpower losses and associated effects, 
including the loss of experience and institutional memory, reinforces the need to take 
urgent action to mitigate RIV / AIDS impact and prevent countries from accelerating 
deeper into the vicious economic cycle. Thus rapid response is essential. 
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Chapter 4 - HIV/AIDS AND THE LAW 
4.1. INTRODUCTION 
The law remains an important regulating factor in the lives of citizens in any country. 
Laws are sets of rules that govern the way people behave. A business response to 
RN/AIDS is therefore driven, in part, by a legal framework. It is this framework that 
requires businesses to act in certain ways with regard toR N / AIDS in the w orkplace. 
Apart from the constraints and the boundaries in which a business may operate within, 
law seeks to entrench particular human rights. Workers are fearful of human violations 
(as a result of the stigma which surrounds this disease) and law is designed, in principle, 
to address these concerns. 
To date, there are approximately 6.5 million people living with RIV in South Africa. Yet 
the threat of human violations, and most notably - discrimination, makes many people 
afraid to be tested for RIV and they fear disclosure of their RN status, even to close 
friends and family. Sadly, this means that there is little openness about RN, which adds 
to the stigma and misconception. 
It is notable that this epidemic is having a greater effect on the economically active 
population (i.e. those people who are employable). Employees are often not aware of 
their rights as individuals and rely on the integrity of the employer or trade unions too 
ensure that their rights are not violated. Employees can experience RN - related 
discrimination from employers, supervisors or even fellow employees. It is to this extent 
that employees need to k now and understand the law on RN/AIDS to challenge both 
discrimination and abuse, which might be prevalent in the workplace. 
Laws are passed to protect employees from acts of discrimination and abuse and so it 
becomes important to understand what these laws are, how they work and then how an 
employee can stand up for his/her rights in the workplace. 
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This chapter provides a step-by-step guide through the law, looking at how it regulates 
the action of both employers and employees with reference to HIV/AIDS. The 
Constitution together with labour law as well as chosen case law, is discussed to give the 
reader an indication as to what law governs an employer's and an employee's actions, 
and the responsibilities borne by both. 
Furthermore this chapter also looks at the Labour Relations Act, the Employment Equity 
Act, the Occupational Health and Safety Act, the Compensation for Occupational Injuries 
and Diseases Act, Basic Conditions of Employment Act, the Medical Schemes Act as 
well as discussing International and Foreign law, while bringing in relevant case law 
under the applicable Acts. 
The Labour Court and other statutory bodies that arbitrate on employment disputes are 
considered from the following legal bases: 
• the Constitution, which is based upon the principle of equality for everyone in South 
Africa. 
• Labour Law together with case law which are established in the Labour Courts, the 
Commission for Conciliation, Mediation and Arbitration (CCMA) and the old 
Industrial Courts, and which follow the principles of non-discrimination, fair labour 
practices and the reasonable rights and duties of employers and employees. 
• the latest scientific and medical knowledge about HIV/AIDS, especially that: 
- HIV cannot be transmitted by casual contact between people at work. 
- People with HIV are usually as healthy and productive as employees who are 
not infected. 
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4.2. THE CONSTITUTION 
The South African Constitution (Act 108 of 1996) is the supreme law of the country and 
all other laws must comply with the Constitutional provisions. The Bill of Rights within 
the Constitution sets out a number of provisions, which protect the rights of employees. 
The Bill of Rights is the foundation of the South African democracy. This is because all 
people have these rights and they must be respected by Parliament, different levels of 
government, the courts, private organisations (such as companies) and individuals. 
One of the most important rights entrenched in this Bill, is the right to equality, often 
referred to as "the Equality Clause". Under the constitution equality denotes that 
everybody shares the fundamental rights and freedom that are listed in the Bill of Rights. 
The Equality clause lists 17 grounds for non-discrimination. The Equality clause and the 
Equality Act (law introduced by the state to enforce equality - full name is Promotion of 
Equality and Prevention of Unfair Discrimination Act - Equality Act for short) state that 
you cannot discriminate against someone using grounds that are not listed. It prohibits 
discrimination based on 'other' grounds that may not be listed, but which are used 
unfairly with the purpose to discriminate - such as RIV infection. The constitution 
reaffirms this premise. Accordingly the state is required by the constitution to 
substantiate this right. The Promotion of Equality and Prevention of Unfair 
Discrimination Act of 2000 was passed (Equality Act) is one such attempt. 
The Equality Clause and the Equality Act can protect people living with RIV or AIDS in 
a number of ways: 
• RIV / AIDS may be interpreted as a disability. 
• RIV / AIDS may be added to new laws as a separate listed ground for non-
discrimination. 
• RIV / AIDS may be treated as an "other ground". 
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4.2.1. HIV/AIDS as a Disability 
HIV or AIDS is not listed specifically in the Equality Clause as a ground for non-
discrimination. However, it is stated clearly that no one may discriminate on the grounds 
of a person's disability. 
It is important to note that disability does not equal incapacity as the latter refers to a 
person who is unable to fulfil a particular function. There is an argument that HN should 
be protected under t he Equality Clause and the Equity Act 0 n the grounds that it is a 
debilitating disease because: 
• people with HIV have a medical condition that may affect their day-to-day activities 
even when they do not look or feel ill. 
• people with HN, or people who are thought to have HN, often face discrimination 
that makes it m ore difficult for them to I ive and work together with 0 ther people. 
They face social barriers because of fear and prejudice about their condition. 
This is not a new concept. The United States as well as a number of other countries have 
supported the idea that asymptomatic HN and AIDS should be protected as a disability. 
In the case of Bragon v Abbot, the United States Supreme Court decided that HN is a 
protected disability and that people with HN have a right to anti-discrimination 
protections under the Americans with Disabilities Act of 1990. 
4.2.2. HIV / AIDS as a ground for non-discrimination in the Equality Act 
The Equality Act recognizes that "HN/AIDS status" can lead to discrimination. The 
Employment Equity Act states that no one may discriminate on the grounds of an 
individual's HN status. 
There are strong reasons for HIV to be treated as separate listed ground (included in the 
list of established grounds which consist of race, creed, religion ethnic group etc) for non-
discrimination under the Employment Equity Act (EEA). They include: 
• HN / AIDS is a national epidemic that affects an increasingly large number of people 
in South Africa. 
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• people living with or affected by RN or AIDS face a wide range of unfair 
discrimination and stigmatisation in all aspects of life, and the Equality Act should 
recognize this to ensure non-discrimination on the basis of RN/AIDS. 
• by making RN status a separate prohibited ground, it is easier for a person living 
with RN or AIDS to show in a court of law that they were unfairly discriminated 
against. The applicant would need to prove that there was discrimination while the 
respondent would repudiate these claims 
• A person living with RN or AIDS could claim they were unfairly discriminated 
against on: 
- The grounds of RIV status, or 
- On the grounds of disability. 
4.2.3. HIV/AIDS as an 'Other Ground' 
Both the Equality Clause and the Employment Equity Act prohibits unfair discrimination 
on the basis of 'other grounds'. This is any ground, which has not been explicitly stated 
within the above Clause or Act. In the case of Rarksen v Lane and others the 
Constitutional Court developed a good test for deciding whether a person had been 
unfairly discriminated against on any grounds, including a ground that was not 
specifically listed in the Equity Clause. The Court said: " The right to equality is violated 
whenever a person is treated differently in a way that is unfair discrimination" 
The test for unfair discrimination is as follows: 
1. the applicant must show that they were treated in a way that was different from others. 
2. if a person was treated differently on a listed ground for non-discrimination (e.g. 
gender), then the court will accept that there was discrimination. The onus then lies with 
the respondent to prove that the discrimination was fair. 
3. if the applicant was treated unfairly on the basis ofhislher RN status then he/she must 
show that the basis for differential treatment might seriously harm his/her sense of 
dignity or otherwise affect himlher in a serious manner. 
4. the onus lies with the applicant to prove that the discrimination is unfair on the basis 
that it had an effect on himlher or others of a similar status. 
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4.2.4. Court Established Precedents 
The most common fonns of discrimination experienced by those with the virus include: 
• workplace policies that unfairly discriminate against people living with HIV or AIDS; 
• medical aid schemes that deny effective treatment and care to people living with HIV 
or AIDS; 
• insurance companies who refuse to offer life insurance to people living with HIV 
or AIDS; 
• social stigma within their communities of people living with HIV. 
The Constitutional Court has set a precedent, which will act as a rule of law for those 
cases of a similar nature, through the judgments in the following cases: 
• in National Coalition for Gay and Lesbian Equality and Others v Minister of Home 
Affairs (2000)27, the Constitutional Court said that discrimination could be on more 
than one ground. This means that our courts may decide that a person is unfairly 
discriminated against on the grounds ofHIV status and disability. 
• in Harksen v Lane and Others (1997), the Constitutional Court stated that the right to 
equality is violated when someone is treated differently in a way that constitutes unfair 
discrimination. 
• in Prinsloo v van der Linde and Another (1997), the Constitutional Court stated that 
not all cases of different treatment were unfair discrimination. The different treatment 
must also hurt a person's sense of dignity. 
• in Hoffman v South African Airways (2000), the Constitutional Court said that 
refusing employment to a person simply because he was living with HIV affected his 
dignity and was unfair discrimination. 
70 
4.3. THE LABOUR RELATIONS ACT 
The Labour Relations Act (LRA) No 66 was passed in 1995 with a view to govern issues 
such as the rights and duties set out for both employers and employees as well as the 
rights given to Trade Unions and Employer Organisations. 
The LRA covers all employees and employers. This means that domestic workers now 
have the same rights as factory workers, and people working for the government have the 
same rights as those working in the private sector. The only employees not covered by 
this Act are people working for the South African Defence Force (SANDF), the National 
Intelligence Agency (NIA) and Secret Services. However, these employees are protected 
by the Constitution and therefore retain rights to fair labour practices and equality. 
Unfair labour practices and unfair dismissals are the two main protections afforded by the 
LRA to employees. 
There are three reasons for dismissal, which are in accordance with the LRA: 
1. dismissals for misconduct (bad behaviour) 
2. dismissals for incapacity (including inability to do a job due to ill-health) 
3. dismissals due to operational requirements (e.g. retrenchment) 
If the reason for a dismissal is deemed unfair, or a fair procedure is not followed, the 
employee can claim that he/she was unfairly dismissed. The LRA stipulates dismissals to 
be "automatically unfair dismissals", if there is incontrovertible evidence of "unfair" 
discrimination (e.g. r ace or g ender). A dismissal, solely because an employee is HIV 
positive or has AIDS is likely to be found automatically unfair in accordance with section 
187, because it is a dismissal based on discriminatory conduct by the employer, or simply 
unfair in tenns of section 188 (and it does not fall into one of the listed categories). 
However, if an employee with AIDS is dismissed for incapacity, the decision is likely to 
be upheld, provided steps outlined in the Code of Good Practice on Dismissal have been 
followed. 
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In other words, it is unlawful for an employer to dismiss an employee because he/she 
suspects that you may have AIDS, but cannot show any evidence of incapacity. It is the 
duty of the employer to ensure that a dismissal for incapacity is fair and in order to 
achieve this the employer must investigate the extent of the incapacity or injury. A 
decision must be made to determine the extent of the incapacity, whether it be long or 
short term. It is the duty of the employer to investigate the alternatives to dismissal and 
consider the possibilities of "adapting the duties or work circumstances of the employee 
to accommodate the employee's disability". 
The rights of the worker, in the case of possible dismissal on the grounds of incapacity, 
are as follows: 
1. get help from a trade union or a fellow employee 
2. respond to the employer 
3. ask for reasonable accommodation (suitable alternative work) 
Employers are expected to find ways to adapt to circumstances to help the employee to 
continue working. This is referred to 'reasonable accommodation' in the LRA. However, 
an employer is not expected to face 'undue hardship' in making it possible for an 
employee to continue working. 
Factors to assess whether an employer made 'reasonable accommodation' 
1. the size and the type of business. 
2. the nature and the cost of adapting the employee's job or in finding alternatives. 
3. the effect this will have on other employees. 
4. the nature and the cause of the employee's incapacity (e.g. ifit is temporary or 
permanent) 
5. the employee's position within the company, length of service and work record. 
6. the length of time the worker was off sick. 
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4.4. EMPLOYMENT EQUITY ACT 
The Employment Equity Act No 55 was passed in 1998 in an attempt to create an 
environment of equality and non-discrimination in the workplace. It is particularly 
relevant because it is the only act that refers specifically to HIV/AIDS. The EEA will, 
because of its express protection for employees against unfair discrimination on the basis 
of 'HIV status', become the most important point of reference for decisions relating to 
the management of HIV I AIDS in the workplace. 
Section 5 of the Act alms to promote equal opportunity by eliminating unfair 
discrimination, directly or indirectly, and it prohibits unfair discrimination, directly or 
indirectly, against an employee in any employment policy or practice, on a number of 
grounds, of which one is HIV status. An employer cannot, therefore, refuse to employ a 
person simply because they are known or suspected to have HIV, this unfairly 
discriminates against them on the grounds of HI V status. 
Section 7 of the Act prohibits medical testing of an employee except in circumscribed 
circumstances. Testing of an employee to determine that employee's HIV status is 
prohibited unless such testing is determined to be justifiable by the Labour Court. 
However, voluntary testing is allowed. 
Rand Water has become the first South African company to be granted a court order for 
on-site voluntary HIV testing for all of its 3000 employees. Rand Water's reasoning 
behind the application was to assess the extent of the disease, the effectiveness or 
otherwise of planned interventions, the effect of the epidemic on the corporation as well 
as the likely cost scenarios. 
In terms of the court order, Rand Water is permitted to conduct on-site voluntary HIV 
testing for a year, under the following conditions: 
• testing is done voluntarily and with the informed consent of the employees to be 
tested; 
• testing will not be requested as a condition of employment, promotion or any other 
benefits; 
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• testing will not be a job requirement; 
• no prejudicial inference will be drawn from a refusal to submit to testing, nor will the 
company be informed or request to be informed of employees who have undergone 
testing; 
• testing will only be done after pre-test counseling has been given and will be followed 
by post-test counseling; 
• the contractors conducting the tests will at no time reveal the results to anyone but the 
employee; 
• the contractors will be required to sign a confidentiality agreement; and 
• the result of any test will not be made known to any decision maker required to 
decide on any employment policy or practice concerning the employee. 
Section 59 of the Act states that any person who discloses any confidential information 
acquired in the performance of a function in terms of this Act, commits an offence. With 
confidentiality, the rules are the same as in the medical profession. If an employee 
informs the employer a bout their status, h e/she can 0 nly inform 0 ther people with the 
employee's consent. Telling other employees without the necessary consent is a breach of 
confidentiality and means that the employee can claim damages from hislher employer. 
An important issue to take into consideration is that should HIV I AIDS be classified in the 
future as a disability, there will be other implications arising from the Act. For example, 
employers have responsibilities related to affirmative action in respect of people from 
'designated groups'. These responsibilities include 'reasonable accommodation' which is 
defined as any modification or adjustment to a job or to the working environment that 
will enable a person from a designated group to have access to or participate or advance 
in employment. Designated groups are defined as 'black' people, women and people with 
disabilities. 
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4.5. OCCUPATIONAL HEALTH AND SAFETY ACT 
The Occupational Health and Safety Act (OHS A) No 85 passed in 1993 and covers all 
employees, except those in the mining industry, who fall under the Mine Health and 
Safety Act. Its relevance here is the clause which requires that an employer: 
"Provide a nd m aintain as far as reasonably practicable, a working environment that is 
safe and without risk to the health of his employees." 
It is therefore, imperative, that employers ensure that employees are not exposed to 
harmful substances or dangerous machinery. Ifblood is spilt in the workplace, employees 
must be aware of the precautionary steps to take so as to limit the exposure to the 
possibility of infected blood. 
This places a duty of care on employers to ensure that: 
a) steps are taken to assess the risk of occupational RIV infection; 
b) the risk of possible HIV infection is minimized; 
c) staff training is undertaken on safety steps to be taken following an accident; and 
d) universal infection control procedures are used in any situation where there IS a 
possible exposure to blood or blood products. 
Furthermore, the Department of Labour has since issued regulations which are that: 
employers have a duty to ensure that safety equipment such as rubber gloves are in every 
first aid box and that all staff be trained in universal precautions and should have access 
to the equipment needed to use these precautions. The Act requires specification and 
placement 0 f worker representatives whose duties include I iasing with management to 
ensure adherence to Health and Safety regulations. The OHSA stipulates that a 
representative must be designated for every workplace consisting of 20 or more workers. 
In t he case 0 f s hops and 0 ffices, 0 ne representative must bed esignated for every 1 00 
workers or part thereof. For example, one representative must be designated in the case of 
21 to 100 workers. But two representatives must be designated where 101 to 200 workers 
are employed. In the case of other workplaces, one representative must be designated for 
every 50 workers or part thereof. For example, one representative must be designated in 
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the case of 21 to 50 workers. But two representatives must be designated where 51 to 100 
workers are employed. 
These representatives are required to communicate with employers on issues affecting the 
health and safety of employees. This communication can take the form of official 
recommendations made to the employer on the issue of workplace health and safety. 
If employees (including health care workers) feel that their work environment is not safe: 
• they have the right to refuse to work, and 
• they may request an inspector from the Department of Labour to look at their 
workplace. 
4.6. COMPENSATION FOR OCCUPATIONAL INJURIES AND DISEASES ACT 
The Compensation for Occupational Injuries and Diseases Act (COIDA) No. 130 passed 
in 1993 gives employees the right to compensation for accidents and illness that they got 
while working. Should an employee become infected with HIV as a result of a workplace 
accident, the employee can claim within the framework of this Act. 
In order to claim compensation, the employer must take the following steps to show that 
the infection was as a result of an occupational accident. The steps to be followed initially 
after the accident are: 
1. report the accident to the Occupational Health Inspector. 
2. request counselling for the affected employee 
3. ensure the affected employee take an HIV test immediately 
4. in cases where there was transmission of blood from one person to another, ask the 
person who was the source of the blood to take an HIV test - for example: needle stick 
injury for nurse while working with a patient. 
5. if the 'source' person refuses to take the test, ensure that all efforts to ask hislher, are 
written down and then reported to the head of Occupational Health and Safety in the 
workplace. This person must then write an affidavit saying that attempts were made to try 
and get information on the source patient's HIV status, but they were unsuccessful. 
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6. take an HIV test again 6 weeks to 3 months later, to see if one has sero-converted 
(become HIV positive) as a result of the accident. 
The employee may claim for compensation ifhe/she can show that: 
• personal protective equipment was not available; and 
• infection was due to the negligence of the employer, who did not provide a safe 
working environment. 
It i s important ton ote that if a n accident is not reported toe ither a n employer 0 r the 
Compensation Commissioner within 12 months, an employee loses the right to claim for 
compensation. 
4.7. BASIC CONDITIONS OF EMPLOYMENT ACT 
The Basic Conditions of Employment Act (BCEA) 75 passed in 1997 sets out the 
minimum working standards for all working relationships, such as: 
• leave and sick leave 
• hours of work 
• how often employees can take tea and lunch breaks. 
With the onset of AIDS, companies are facing increasing pressure to adjust policies 
around sick leave and family responsibility leave. As employees become infected with 
opportunistic diseases in the advanced stages of AIDS, they are unable to work and are 
forced to either spend time in clinics or hospitals or, alternatively, be taken care of at 
home. Likewise, as relatives of employees who are die or become seriously ill, 
employees will attend funerals more often, or attend to the sick at home (usually women). 
The BCEA stipulates that: 
• every employee has a right to 6 weeks paid sick leave over any 3-year cycle. 
• in the first 6 months of employment, an employee is allowed 1 day of sick leave for 
every 23 days worked. 
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• a medical certificate is needed for absences of longer than 2 days and for repeated 
absences. 
The Act goes on to say that employees have a right to three days of family responsibility 
leave a year, which they can use when: 
• a child is born 
• a child is sick 
• there is a death of a spouse (husband or wife), life partner, parent, grandparent, child, 
grandchild, brother or sister. 
It is important to note that although the BCEA sets out the minimum number of days of 
sick leave employees may claim, the Act stipulates that employers and employees can 
renegotiate sick leave to get more sick leave at, perhaps, reduced pay. 
There are a number of other pieces of legislation and protections found within the 
common law, which protect an individual's personal rights. Although not directly 
employment-related they impact on the management of RIV/AIDS in the workplace. 
These are: 
• the Medical Schemes Act No. 131 of 1998 
• common law protection of the right to privacy and dignity 
4.8. THE MEDICAL SCHEMES ACT OF 1998 
Many companies offer employees medical aid benefits. This Act prohibits medical 
schemes from discriminating against people living with RIV or AIDS: 
• a medical scheme may not be registered if it discriminates directly or indirectly 
against any person on the basis of their health status. 
• all schemes must offer a minimum level of benefits to employees with RIV or AIDS. 
At the moment, the minimum benefits say: 
- they must treat all opportunistic infections for RIV or AIDS. 
- they do not have to provide anti-retroviral treatment. 
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4.9. INTERNATIONAL AND FOREIGN LAW 
Under the Constitution, a court interpreting the Bill of Rights must take note of 
international law, and may consider foreign law. International law is the body of laws and 
principles that all countries must follow in their relations with each other (e.g. Universal 
Declaration of Human Rights, 1948). Foreign law refers to judgments and statutes from 
other countries (e.g. Americans with Disabilities Act of 1990). The relevance of both 
International and Foreign law is that some companies which operate in South Africa will 
take cognisance of the applicable international standards and norms that are recognised 
transnationally. 
South Africa has become a signatory to a number of international agreements and codes 
such as the International Labour Organisation (lLO) Convention 111 on Discrimination 
(Employment and Occupation), 1958. However the only one which relates specifically to 
HIV / AIDS in the workplace is the South African Development Community (SAD C) 
Code of AIDS and Employment, which was approved by the Council of Ministers in 
September 1997. 
4.9.1. International Law 
International law appears to support the three views that HIV status is a disability, it can 
be a separate ground for non-discrimination and that HIV status is an 'other' ground for 
non -discrimination. 
The UNAIDSIUN International Guidelines on HIVIAIDS and Human Rights advise 
governments that: 
"General anti-discrimination laws should be enacted or revised to cover people 
living with asymptomatic HIV infection, people living with AIDS and those 
merely suspected of HIV or AIDS. Such laws should also protect groups made 
more vulnerable to HIV/AIDS due to the discrimination that they face. Disability 
laws should also be enacted or revised to include HIV/AID in the definition of 
disability. " 
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The UN Standard Rules on the Equalisation of Opportunities for People with Disabilities 
state that: "The tenn disability summarises a great number of functional limitations 
occurring in any population in any country in the world. People may be disabled by 
physical, intellectual or sensory impainnent, medical conditions or mental illness. Such 
impainnents, conditions or illnesses may be pennanent or transitory in nature." 
Two of the most important rights agreements are: 
• equal protection for all people by the law, and 
• freedom from discrimination on any ground such as race, sex, religion, "or other 
status". 
The UN Commission on Human Rights has con finned that "other status" should include 
health status, including HIV / AIDS. 
4.9.2. Foreign Law 
Foreign law can best be illustrated using precedent set through judgments in particular 
court cases: 
• in Bragdon v Abbott (1998), the United States Supreme Court decided that the non-
discrimination sections of the Americans with Disability Act, protected people living 
with HIV. 
• Canada protects people on the basis of disability with its Charter of Rights and 
Freedoms. In Canada v Thwaites (1994), the court stated that discrimination on the 
basis of a person's HIV status violates the Charter and the Canadian Human Rights 
Act. 
• in Australia, the Disability Discrimination Act recognizes HIV infection, or even the 
belief that a person has HIV infection, as a disability. In X v Commonwealth (1999), 
the High Court of Australia confinned the decision of the Australian Human Rights 
and Equal Opportunity Commission, deciding that the dismissal of an employee on 
the basis of his HIV status is prohibited by the Disability Discrimination Act. 
Hong Kong, the Philippines and New Zealand have similar laws. 
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4.12. CONCLUSION 
In summation we can say that the legal framework within which an organization must 
adhere, is derived from the Constitution. This legal framework finds more concrete 
expression in legislation such as the Labour Relations Act, the Employment Equity Act 
as well as the Occupational Health and Safety Act. 
Organisations should not engage in nor permit any personnel policy or practice that 
discriminates against workers infected with or affected by HIV / AIDS. 
In particular, any company should: 
• not require HIV / AIDS screening or testing; 
• ensure that work is performed free of discrimination or stigmatisation based on 
perceived or real HIV status; 
• encourage a person with HIV and AIDS-related illnesses to work as long as he/she is 
medically fit for appropriate work; and 
• provide that, where a worker with an AIDS-related condition is too ill to continue to 
work and where alternative working arrangements including extended sick leave have 
been exhausted, the employment relationship may cease in accordance with anti-
discrimination and labour laws and respect for general procedures and full benefits. 
Companies should have established procedures that can be used by workers and their 
representatives for work-related grievances. These procedures should specify under what 
circumstances disciplinary proceedings could be commenced against any employee who 
discriminates on the grounds of real or perceived HIV status or who violates the 
workplace policy on HIV / AIDS. 
It is imperative that HIV/AIDS-related information of workers should be kept strictly 
confidential and kept only on medical files, whereby access to information complies with 
national laws and practices. This is clearly stipulated in section 59 of the Employment 
Equity Act. Access to such information should be strictly limited to medical personnel 
and such information may only be disclosed if legally required or with the consent of the 
person concerned. 
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The company must ensure a safe and healthy working environment, including the 
application of Universal Precautions and measures such as the provision and maintenance 
of protective equipment and first aid. To support behavioural change by individuals, 
employers should also make available, where appropriate, male and female condoms, 
counseling, care, support and referral services. Where size and cost considerations make 
this difficult, employers and/or their organizations should seek support from government 
and other relevant institutions. 
In those workplaces where workers come into regular contact with human blood and 
body fluids, the company must take additional measures to ensure that all workers are 
trained in Universal Precautions, that they are knowledgeable about procedures to be 
followed in the event of an occupational incident and that Universal Precautions are 
always observed. Facilities should be provided for these measures. 
The company, in consultation with the worker(s) and their representatives, should take 
measures to reasonably accommodate the worker(s) with AIDS-related illnesses. These 
could include rearrangement of working time, special equipment, opportunities for rest 
breaks, time off for medical appointments, flexible sick leave, part-time work and return-
to-work arrangements. 
The above highlights good practices as supported by the ILO code of good practice on 
RIV I AIDS and the world of work. The onus is on the company to keep abreast of the 
changes within legislature. It is important that these changes are cascaded down to line 
managers to ensure that the company continually operates within the legal framework of 
the country. 
Knowledge of the laws surrounding the issue ofRIV/AIDS is necessary for any company 
as well as those individual employees within a company. It is imperative that companies 
respect the rights afforded to its employees by these laws and endeavour to protect them 
from the threat of human rights violations. Companies must realize that an unfair labour 
practice will lead to dire consequences while employees must both understand and defend 
their legal rights through the structures that have been established. 
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CHAPTER 5 - EVALUATION, COMMENTARY AND 
RECOMMENDATIONS 
5.1. INTRODUCTION 
The initial part of this chapter will describe the Rohm and Haas organization, the markets 
supplied and its true global presence. Thereafter the commentary will migrate to the local 
South African operation based in New Germany, Durban. Business issues will be briefly 
highlighted together with a graphical display of the employee complement and 
breakdown along various characteristics. 
A description of the R&H New Germany HIV/AIDS policy will be provided as well as 
the current intervention programmes. This would lead into an in-depth evaluation of the 
R&H New Germany HIV I AIDS Policy and programmes largely along the following 
dimensions: 
• Policy; 
• Legal issues 
• How to avoid HIV Infection 
• Wellness management; and 
• Monitoring and evaluation. 
Each dimension will be thoroughly discussed so as to obtain the desired level of 
understanding with regards to its contribution the success of the HIV/AIDS initiatives. 
Strengths and weakness of the company's initiatives will be discussed together with 
supporting reasons. This leads onto generating recommendations based on Best Practices. 
Details on how to develop a HIV/AIDS policy intervention program is explicitly 
discussed. 
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This chapter culminates with a proposed operational plan and action items that R&H 
New Germany can undertake to re-invigorate the fight against HIV/AIDS along focused 
and collaborative means. In this way it can be ensured that the organization is equipped 
with the methodology to implement high quality HIV/AIDS programmes that is 
cognisant of the following: 
• economic impacts, 
• legal issues, 
• statistics, 
• cultural differences, 
• people, and 
• ethical issues. 
5.2. BUSINESS 
The Rohm and Haas Company (R&H), is a global specialty materials company that 
reported 2002 net sales of approximately $5.7 billion. R&H is a public corporation, incor-
porated in 1917 under the laws of the State of Delaware, whose shares are traded on the 
New York Stock Exchange under the symbol "ROH." 
The corporate office is located at: 
1 00 Independence Mall West 
Philadelphia, PA 19106-2399 
Phone number: (215) 592-3000 
R&H is a company that strives to operate at the highest levels of integrity and ethics. In 
support of this, R&H's internal Code of Business Conduct requires that all salaried 
employees receive compliance training and certify compliance with the code. With 
respect to our Board of Directors governance, all but two of the fifteen Directors are non-
employees. The audit, nominating and compensation committees of the Board are all 
composed entirely of outside directors. 
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5.2.1. Number of employees 
At the end of 2002 the organizational head count was approximately 21 000. However 
due to operational restructuring in light of the global economic slowdown the number of 
employees has been trimmed to approximately 17 000 at the end of August 2003. 
5.2.2. Strategy 
By leveraging broad technology base globally within key markets, R&H brings 
technology and innovation to the market that enhances the performance of the end-use 
consumer products made by their customers. 
R&H is committed to: 
• ongoing investment III research and development to develop new technology 
platforms and leverage existing ones; 
• continually bringing innovative solutions to the marketplace; 
• repositioning geographically to enhance the ability of their customers to serve their 
market needs; 
• ongoing improvement in the efficiency of the R&H cost structure; 
• a culture that is customer oriented, market focused, disciplined, data-driven and 
responsIve; 
• sustainability in all forms, including technology, safety, environmental impact and 
financial performance. 
5.2.3. Segments 
R&H is a geographically diverse company, with over 100 manufacturing and technical 
locations in over 25 countries. In 2002, approximately 39% of net sales were made 
outside of North America and operated six global businesses. R&H's technology can be 
found in a wide range of end-use markets as described below: 
Coatings (33 % of 2002 net sales): This segment is comprised of three businesses: 
Architectural and Functional; Powder; and Automotive Coatings. Architectural and 
Functional Coatings produces acrylic emulsions, additives and colorants that are used to 
make industrial and decorative coatings, varnishes and specialty finishes. This business 
also provides similar technology for use in the paper industry, graphic arts applications, 
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leather gannents, fibre-filled materials and textile finishes. Automotive Coatings 
fonnulates paints for the plastic interior and exterior components of cars and trucks. 
Powder Coatings produces a comprehensive line of thennoset and thennoplastic coatings 
used on everything from backyard grills to kitchen cabinetry and industrial shelving. 
Adhesives and Sealants (11 % of 2002 net sales): This segment provides adhesives and 
other products, based on a wide range of technologies, used to make carton sealing tapes, 
pressure-sensitive labels, flexible packaging, automotive components and other specialty 
laminates. 
Electronic Materials (17 % of 2002 net sales): This segment provides cut-ting-edge 
technology for use in telecommunications, consumer electronics and household 
appliances. Microelectronics provides an extensive assortment of critical imaging and 
non-imaging chemicals needed to reproduce complicated circuitry designs on integrated 
circuits. Rodel provides high-tech pads and slurries used to make ultra smooth and uni-
fonn layers on integrated circuits. The Printed Wiring Board business provides essential 
chemistry for use in the manufacture of high-density printed circuits and circuit boards, 
and the Electronic and Industrial Finishing business provides chemical processes used to 
metallize electronic components and devices. 
Performance Chemicals (21 % of 2002 net sales): This segment includes the sales and 
operating results of Plastics Additives, Inorganic and Specialty Solutions, Consumer and 
Industrial Specialties, Ion Exchange Resins and other smaller business groups. These 
businesses provide products that serve a diverse set of markets, from consumer products, 
to additives used to manufacture plastic and vinyl products, to water treatment and 
purification processes for food and pharmaceutical markets, to newsprint processing. 
Salt (12 % of 2002 net sales): Some of the most recognized consumer brand names and 
product symbols are found here, including the leading brand of table salt in the United 
States - Morton Salt, with its little Umbrella Girl, and Windsor Salt, Canada's leading 
brand. Even though the consumer salt business is best known, this segment extends well 
beyond this market and includes salt used for water conditioning, highway ice control, 
food processing, chemical/industrial use and agriculture. 
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Monomers (6% of 2002 net sales, excluding intersegment sales) : This segment produces 
methyl methacrylate, acrylic acid and associated esters as well as specialty monomer 
products. Monomers serve as the building block for many ofR&H's acrylic technologies 
and are sold externally for applications such as super-absorbent polymers and acrylic 
sheet. 
Summary of Business Segments 




Architectural $1 ,531 Building and construction An array of versatile acrylic House paints Traffic 
and Functional Home improvement, emulsion polymers and other paints Metal coatings 
Coatings particularly "do-it-yourself' technologies A range of Coated papers 
and contractor markets Paper additives, such as thickeners, Printing inks Non-
Graphic arts Apparel Home and extenders and opacifiers woven fibers Textile 
office goods Transportation finishes Insulation 
Leather 
Automotive $ 109 Transportation Solvent and water-based Cars Trucks 
Coatings coatings for exterior and 
interior plastic parts 
Powder $ 226 Home and office goods Epoxy, polyester and acryl ic Shelving Tables and 
Coatings Recreation Lawn and garden powder coatings Lamineer- chairs Office 
Transportation a low temperature curing furniture Cabinetry 
coating Machinery Gas grills 
Adhesives and $ 592 Pressure-sensitive adhesives A full range of adhesives and Pressure-sensitive 
Sealants Packaging Transportation coatings based on acrylics, tapes and labels Car 





arts Caulks and 
sealants 
Laminated panels 
Electronic $ 987 
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Materials: 
Printed Wiring $ 288 Electronic devices Enabling technology for all Cellular phones 
Board Communication Computers aspects of the manufacture of Personal computers 
Transportation Recreation printed wiring boards; Cars and trucks 
products such as: Home appliances 
photoresists, solder mask, Office equipment 
electroless and electrolytic Electronic games 
copper 
Electronic and $ 146 Electronic devices Materials and technology for Cellular phones 
Industrial Communication Computers integrated circuit packaging, Personal computers 
Finishes Transportation Plating or connectors and industrial Cars and trucks 
plastic/EMI Connector finishing Home appliances 
finishing Office equipment 
Electronic games 
Steel and metal 
finishing 
Microelectronics $ 553 Electronics and communication Essential technology for Cellular phones 
(\) devices Transportation Home creating state-of-the-art Personal computers 
and office goods Recreation integrated circuits: photo Cars and trucks 
resists, developers, Home appliances 
removers, anti-reflective Office equipment 
coatings, chemical Electronic games 
mechanical 
planarization (CMP) pads 
and slurries 
Performance $1,217 Building and construction A wide range of additives PVC pipe Vinyl 
Chemicals (2): Packaging Home and office that impart desired properties siding Wall systems 
Plastics $ 430 goods Transportation into the end plastic or help Vinyl windows 
Additives machinery run more Fencing and decks 
efficiently (acrylic-based Plastic packaging 
impact modifiers and Interior auto parts 
processing aids, tin-based Appliances and 
stabilizers and lubricants) business machines 
Business 2002 Net Markets Products/ Technology End Uses 
Sales 
(in millions 
Inorganic and $ 161 Paper Sodium borohydride Paper and recycled 
Speciality Industrial processing and related technologies Newsprint 
Solutions Lubricants Sulfur-based intermediates Corrosion inhibitors 
Fuels Salt-forming bases Pharmaceutical 
Products, Dyes 
88 
Consumer and $ 388 Household products Personal Antimicrobials, dispersants, Laundry and 
Industrial care Industrial processing acrylic emulsions and a dishwasher 




Ion Exchange $ 214 Water processing Food Anion and cation ion Soft drinks and juices 
Resins processing Electronics exchange resins Adsorbents Ultrapure water 
Bioprocessing Chemical Catalysis 
processing Pharmaceuticals 
Salt $ 706 Food and food related Salt produced through Table salt 
Transportation Vacuum pan production, Home water 
Industrial processing Solar evaporation or Conditioning salt 
Water processing Mines rock salt Highway salt 
Chemical 
Processing salt 
Salt blocks for 
animal feed 
Monomers $ 970 Building and construction Methyl methacrylate Adhesives 
Personal care Acrylic acid Paints and coatings 
Automotive Associated esters Floor polishes 
Packaging Speciality monomers Hair sprays 
Super absorbent 
products 
Table 5.1 Summary of Business Segments 
Source: Rohm and Haas Company Annual Financial Report, 2002 
5.2.4. Research and Development 
R&H's principal research and development laboratories are located in Spring House, 
Pennsylvania. A complete list of the technical and research centres throughout the world 
can be found in the table below. R&H is committed to ongoing investment in research 
and development a saw ay to differentiate t heir existing products, while bringing new 
technologies and innovative, high value products tom arket. R &H spent $ 260 million, 
$230 million and $224 million in 2002, 2001 and 2000, respectively, for research and 
development. Approximately 70% of the spending is targeted to three major growth 
businesses: Coatings; Electronic Materials; and Adhesives and Sealants. 
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5.2.5. Properties 
R&H operate more than 100 manufacturing facilities, mmes and salt evaporation 
facilities in over 25 countries. The facilities and the segment for which they are 
productive are detailed below: 
Manufacturing Locations 
Argentina: Zarate(l) United States 
Australia: Geelong(l) Arizona: Glendale(5) 
Bahamas: Inagua(l) California: Hayward(l); La Mirada(1); Long 
Beach (5); Newmark(5) 
Brazil: Jacarei(1 ,2,4) Argentina: Newark(3) 
Canada: Iles-DE-La Madeleine(5): Florida: Cape Canaveral(5) 
Lindbergh(5); Ojibway(5); 
Pugwash(5); ReginaIBelle Plaine(5); 
West Hill(l); Windsor(5) 
China: Beijing(l); Dongguan(3); Illinois: Chicago( 4,5); Elk Grove(2); 
Hong Kong(3) ; Kankakee( 1 ); Lansing( 1 ); 
Shanghai(4); Songjiang(1) Ringwood(1 ,2) 
Colombia: Barranquilla( 1 ) Indiana: Warsaw(l) 
France: Chauny(4); Lauterbourg(l,4); Kansas: Hutchinson( 5) 
Semoy( 1 ,2); Villers-Saint-Paul( 4) 
Germany: Bremen(l); Marl(6); Kentucky: Louisville( 1 ,4) 
Strullendorf(l,2); Amsberg(l) 
Indonesia: Cilegon(l) Louisiana: Weeks Island( 5) 
Italy: Castronno(3,4); Mozzanica(l); Massachusettes: Marlborough (3) 
Mozzate(2); Parona(2) North Andover(3) 
Japan: Kurosaki(3); Orniya(3); Michigan: Manistee(4,5) 
Nagoya(l ,4); Nara(3); Ogaki(3) 
Saitama(3); Sasagarni(3); Soma( 4) 
Mexico: Apizaco(1 ,4); Toluca(2) Mississipi: Moss point (3) 
Netherlands: Amersfoort(2); Delfzijl( 4) New Jersey: Perth Amboy(5) 
New Zealand: Auckland( l) New York: Freeport(3); Silver Springs(5) 
Philippines: Las Pinas(l) North Carolina: Charlotte(l ,2) 
Singapore: Singapore(2,3,4) Ohio: Cincinnati(4); Fairport(5); 
Painsville(4); Rittman(5); 
South Africa: New Germany(l) Pennsylvania: Bristol(l ,2,4,6); Croydon(l,2); 
Philadelphia(4); Reading(1) 
South Korea: Chonan(3) South Carolina: Spartanburg(3) 
Spain: Castellon(1); Tudela(l) Tennessee: Knoxville( 1 ,2,4,6) 
Sweden: Landskrona( 1 ) Texas: Bayport(4,6); Deer Park(l,2,4,6); 
Grand Saline( 5) 
Switzerland: Buchs(4); Littau/Luceme(3) Utah: Grantsville(5) 
Taiwan: Min-Hsiung( 1,4); Chiayi Hsien(3); Virginia: Blacksburg(3); Wytheville(l) 
Ta Yuan(3); Taoyuan Hsien(3) 
Thailand: Maptaphut(l ,4) Washington: Elrna(4) 
United Aldridge(l) ; Buxton(3); 
Coventry(3); 
Kingdom: Dewsbury(l); Grangemouth(4); 
Jarrow(4); Warrington(3) 
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Research and Technical Facilities' 
Research Spring House, Pennsylvania 
Headquarters USA( 1,2,4,6) 
Australia: Geelong(1) 
Brazil : Jacarei(1,2,4) 
China: Hong Kong(3); Shanghai(l) 
France: Valbonne( 1 ,2,4) 
Nara(3); Kanagawa( 4); 
Japan: 
Omiya(3); Sasagami(3); Tokyo(3) 
Singapore: Singapore(2,4) 
South Korea: Chonan(3) 
Taiwan: Taoyuan Hsien(3) 
(1) Coatings 
(2) Adhesives and Sealants 
(3) Electronic Materials 























Marlborough(3); North Andover(3); 
Woburn(1) 
Rochester Hills( 1) 
Freeport(3 ) 
Charlotte(1 ) 




Table 5.2 Summary ofR&H Manufacturing Locations and Research and Technical 
Facilities 
Source: Rohm and Haas Company Annual Financial Report, 2002 
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5.2.6. Geographical Locations 
R&H's global business is divided into four regions as follows together with the regional 
head office location. 
Region Regional Head Office 
North American Region (NAR) Philadelphia - USA 
European Region (ER) Paris - France 
Latin American Region (LAR) Col. Bosques de las Lomas - Mexico 
Asia - Pacific Region (APR) Taipei - Taiwan 
Note: the Philadelphia office also functions as the Global Corporate Headquarters. 
Table 5.3 Regional Rohm and Haas Company Head Offices 
Source: Rohm and Haas Company Annual Financial Report, 2002 
5.3. SOUTH AFRICAN OPERATION 
R&H's only manufacturing operation in Africa is located at the New Germany site in 
KZN. The South African operation includes both a Manufacturing capability and Sales 
and Marketing activities. This subsidiary reports into the European Region Headquarters 
in Paris. The primary reasons for this is two-fold: 
similar time zones which allows timeous communication and rapid decision making. 
Secondly the EU is far South Africa's largest trading partner and as such knowledge with 
regards to intercontinental transacting are well developed. 
5.3.1. Markets served 
The following market segments are serviced by the New Germany organization. 
• Coatings 
• Adhesives and sealants 
• Ion Exchange Resins 
• Performance Chemicals 
• Consumer and Industrial Specialties 
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Products are supplied these markets by either locally manufacturing and importing from 
other R&H manufacturing facilities around the globe. Currently 60% of total volume 
sales emanates from the local manufacturing facility . 
5.3.2. Manufacturing volumes and revenues 
The New Germany manufacturing operation is designed to manufacture 15 000 tons of 
emulsion per annum. This output can be increased by adding an additional shift and for 
by working overtime. The product mix also impacts upon manufacturing volume as there 
are some products which require significantly less reactor time than others. 
F or the financial year ending December 2002, the total annual revenue was 
approximately R 190 million. 
5.3.3. Rohm and Haas New Germany Employee Statistics 
Currently the organization consists of 64 employees, two of which are home based. In 
addition there are 10 Black contract employees . 










Total Employees by Race 
Figure 5.1 Employee Statistics : Total Employees by Race 















Hourly Paid vs Salaried 
Figure 5.2 Employee Statistics: Hourly Paid vs. Salaried 
Source : R& H New Germany Human Resource Department 
Blacks 
15 













Figure 5.3 Employee Statistics: Salaried Employees by Race 












Employees by Gender 





Figure 5.4 Employee Statistics: Employees by Gender 





5.4. ROHM AND HAAS NEW GERMANY AND THE HIV/AIDS PANDEMIC 
5.4.1. Introduction 
mv / AIDS is affecting businesses in profound and costly ways. The epidemic poses a 
serious threat to global competitiveness for the South African private sector. Disease 
prevention and health promotion are not commonly thought to be business concerns, but 
mv / AIDS is forcing a re-examination of these perceptions. 
The impact of mv/ AIDS on the workplace varies, depending on skills mix, geographic 
location and social context. It is further suggested that the spread and treatment of 
mY/AIDS will be affected by people's access to quality health services and the nature 
and form of the treatment that they receive. Stigma and discrimination will play a big role 
and will influence a person's choice to disclose their mv status. 
The corporate sector's primary objective is to make a profit by selling goods and services 
for more than it costs to produce them. mY/AIDS affects profitability through factors 
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internal and external to a business. The external factors include changes in markets, such 
as increases in wages or decreases in demand, and rising costs associated with the 
breakdown in institutions. These will be difficult for firms to manage. It is the internal 
effects, such as increasing absenteeism, higher pension payouts, and breakdowns in 
worker discipline and morale, which require responses from firms. The cost of producing 
goods is a function of the cost of inputs such as labour, materials and utilities. The impact 
of mY/AIDS may raise costs and reduce productivity for a number of reasons: 
• absenteeism includes more than employees missing work due to ill health. Women' s 
roles as caregivers will necessitate time off and funerals become be a major source of 
lost time. Employees may force themselves to come to work for fear of losing jobs, 
but be effectively absent. 
• workers whose health is failing will be less productive and unable to carry out 
physically or emotionally demanding jobs. 
• replacements for employees who die or retire on medical grounds may be less skilled 
and experienced. The recruit incurs training costs. 
• employers may increase the size of the workforce and hence payroll costs to cover for 
absenteeism. 
Figure 5.8 (Distribution of Increased Labour Costs due to mY/AIDS by Category) below 
highlights the relative incidence of the above factors. This illustration shows that the 
greatest cost to a company is my absenteeism at 37% followed by AIDS absenteeism at 
15%. 
A IDS Ab . .. nt ..... rn ,. ... 
T' .i ini .. u 
7'" 
HIV Ab •• nt •• I. m 
37 " 
Figure 5.5 Distribution oflncreased Labour Costs due to HIy/AIDS by category 
Source: Roberts and Rau, African Workplace Profiles: Private Sector AIDS Policy, Arlington , USA 2002. 
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In addition mVI AIDS will increase the cost of employee benefits, such as group life 
insurance, pensions and medical aid. The impact ofIllV/AIDS on employee benefits is 
usually sudden and of large magnitude. Figure 5.9 shows how three benefits - a lump 
sum payment on death, a spouse pension, and disability pension are likely to rise in the 
face of increased mortality and morbidity. In 1995 these benefits cost about 7% of payroll 
costs. By 2010 they would cost around 18%. 
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Figure 5.6 Illustrative Impact of AIDS on Employee Benefits in South Africa 
Source: Kramer (2001). 
The benefit costs will depend on the level of staff, and on what benefits are provided. 
Due to the sophisticated labour legislation, South African employers in the private and 
public sector will be adversely affected as they provide more in benefits to their staff. The 
point though is that companies have room to manoeuvre. Benefits are negotiable and it is 
not axiomatic that they will increase or necessarily cost the firm more. The extra costs 
could be borne by increased deductions from the employees or alternatively benefits can 
be reduced. 
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5.4.2. Location of operation 
The South African operation IS located in New Germany within the provmce of 
KwaZulu-Natal. The demographics of the area is representative of the province and 
therefore some of the startling facts that apply to the province will apply to the 
community within which the Rohm and Haas South African operation is located. 
Here are some of the pertinent issues: 
• Infections at birth: For the year ending 2002, the highest infection rate occurs in 
KZN at 8.30% 
• People living with HIV/AIDS : It estimates are that there were 6,5 million people in 
South Africa living with HIV/AIDS on OIJuly 2002. KZN accounts for 27% of this, 
the highest of any province. 
• Prevalence rate : The prevalence rate is the percentage of a group who are infected at 
a particular point in time. Overall, in July 2002, the estimates are that 14,2% of 
people in South Africa were infected. The figure is the highest for KZN at 18.4%. 
• Deaths : In 2002, AIDS accounted for 40% of national deaths. In KZN it accounted 
for approximately 52% of all deaths - the highest provincial percentage. 
• Mortality statistics: On each of the mortality measures, KZN performs the worst than 
all other provinces. 
• Maternal orphans: During 2002, nationally AIDS accounted for 73% of all new 
orphans. It accounted for 81 % of the new orphans in KZN. 
5.4.3. Rohm and Haas New Germany HIV/AIDS Policies and Programmes 
It is within this climate of a HIV/AIDS ravaged community that R&H South Africa must 
conduct its operations. During the course of 2002 various informal discussions were held 
to raise awareness of the pandemic. It was in July 2003 that a policy document has been 
generated relating specifically to this issue. The following is a copy of the policy 
document. 
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ROHM AND HAAS (SOUTH AFRICA) (PTY) LTD 
AIDS POLICY 
AIDS has reached pandemic proportions in South Africa, particularly in KwaZulu Natal. 
The company has decided that we need to take active and aggressive steps to help address 
the problem and to this end the following will be our official AIDS policy. 
1. OBJECTIVES 
1.1 We acknowledge the impact of the virus at macro and micro levels of health, 
economic and social welfare of all South African citizens, with a special emphasis 
on the welfare of our company employees. 
1.2 The company endeavours to provide a healthy and safe working environment for 
all employees and to take all reasonable steps to protect all employees from the 
virus, while promoting an atmosphere conducive to dealing with the virus. 
1.3 The purpose of this policy is to ensure that any actions or issues relating to the 
virus and sexually transmitted infections (STI's) are managed in a manner that is 
uniform, fair, compassionate, commensurate with operational requirements of the 
business of this company, corrective and in compliance with any relevant 
legislation. 
1.4 This policy will guide the development of a workplace programme in keeping 
with the provisions of the code of good practice schedule of the LRA and 
Employment Equity Act. 
2. SCOPE 
This policy shall apply to all permanent employees ofRohm and Haas South Africa. 
The company may at its own discretion apply this policy to outsourced workers. 
3. EMPLOYMENT PRACTICES 
3.1 CONFIDENTIALITY 
Job applicants or employees will not be asked to disclose HIV-related personal 
information. Co-workers are also not obliged to reveal such personal information 
about their peers. 
Access to personal data relating to an employee ' s HIV status is bound by rules of 
confidentiality consistent with the code of good practice schedule of the LRA. 
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The programme of testing, counselling and treatment will be undertaken by the 
company clinic and except for information on the number of employees that are HIV -
positive, this information will be kept confidential within the clinic. 
3.2 VOLUNTARY TESTING 
Employees are encouraged to use their own initiative to be tested as part of the 
voluntary testing programme run by the company clinic. 
Voluntary testing is also available to spouses of employees through Mc Cord 
Hospital. All costs incurred for voluntary testing will be borne by the company. 
3.3 PRE I POST TEST COUNSELING 
The company encourages employees living with HIV I AIDS to use the expertise and 
assistance of the clinic for counselling. 
The company will provide employees living with HIV I AIDS reasonable time away 
for counselling and treatment. 
3.4 NON-DISCRIMINATION 
No employee living with HIV IAIDS shall be unfairly discriminated against within 
the employment relationship or within any employment policies or practices, 
including with regard to: 
• Recruitment procedures, advertising and selection criteria; 
• Appointments and the appointment process, including job placement; 
• Job classification or grading; 
• Remuneration, employment benefits and terms and conditions of employment; 
• Worker assistance programmes; 
• Job assignments; 
• The workplace and facilities; 
• Occupational Health and Safety; 
• Training and development; 
• Performance evaluation systems; 
• Promotion, transfer and demotion; 
• Disciplinary measures short of dismissal; and 
• Termination of service. 
3.5 ALLOCATION OF COMPANY BENEFITS 
An employee who is living with HIV I AIDS is eligible to enjoy all benefits that are 
enjoyed by fellow employees. 
In addition the company commits to funding the appropriate treatment regimes for 
those employees who are HIV positive. These regimes will be at the discretion of the 
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company doctor and will include vitamin supplements and anti retroviral treatments. 
Together with the treatment, the clinic will provide all necessary associated testing. 
All information from the above benefits regarding the medical status of an employee 
will be kept strictly confidential and within the clinic. 
The company will develop a clear after care programme, jointly with the HN I AIDS 
committee in the event that severance of employment due to illness shall occur. 
4. PREVENTION 
4.1 PROMOTION AND TREATMENT 
The company will from time to time in consultation with the HN I AIDS committee, 
embark on a promotion drive of events related to the elimination of stigmatisation, 
encourage consented medical testing and a systematic use of medically recommended 
treatment, or debate and dissemination of new information on the subject and health 
care quality and cost. 
4.2 AWARENESS, EDUCATION AND TRAINING 
The company will from time to time, in consultation with the HIV I AIDS committee, 
embark on an awareness, education and training drive including new researched 
information on new discoveries and precedence set by the legal system. 
5. DISCIPLINE 
In the event of untoward behaviour and attitude towards any employee living with 
HIV I AIDS, breach of confidentiality or disclosure of information in relation to HN 
I AIDS, or interference with employees' conditions of employment and benefits, 
appropriate disciplinary action will be taken. 
Source: Rohm and Haas Company New Germany Human Resources Department 
Complementing this policy, the organization implemented various ad-hoc programmes 
which were intended to create awareness and foster behavioural change. The intervention 
programmes evolve around HIV prevention. These consist primarily of displayed posters 
and the distribution of condoms at the company clinic. 
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Clinic 
The company has a clinic that largely provides primary health care. It operates for 4 
hours a day (week days only) and in attendance is a qualified nurse. A general 
practitioner is in attendance once a week for an hour to attend to and prescribe 
medication to employees. Voluntary testing is conducted at the clinic but it does not 
conduct pre- or post-testing counselling 
Employee Benefits 
Medical Aid cover is provided to all employees. This is done by way of equal 
contribution; the employer and employee each pay 50% of the total amount. Discovery 
Health and Sizwe Medical Aid is offered to salaried and hourly paid staff respectively. 
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5.5. EVALUATION OF R&H NEW GERMANY HIV/AIDS POLICY AND 
PROGRAMMES 
5.5.1. Introduction 
There are a number of elements that makes up a successful workplace HIV / AIDS Policy 
and Programme. The first and most important element is to set up a committee through 
which discussion and consultation can occur. The members of this committee must 
include representatives from all levels of the organization, from shop stewards and other 
staff representatives through to senior management. The setting up of the committee is 
therefore the first step in the process. 
Once it has been established, the HIV/AIDS committee can begin to address the other 
elements ofthe programme. These elements include : 
• Policy; 
• Legal issues; 
• How to avoid HIV infection; 
• Wellness management; and 
• Monitoring and evaluation 
These elements form the basis whereby the R&H New Germany HIV/Aids Policy and 
Programme will be evaluated. 
5.5.2. Policy 
A workplace policy on HIV/AIDS is central to developing and implementing an effective 
workplace programme. It provides the framework for action. The policy that the R&H 
Haas New Germany has recently implemented has been developed by the local 
Environmental, Health and Safety Department (EHS). Having written up the policy the 
EHS Department forwarded the document to the local Human Resources department to 
be included into the company's policies and procedures manual. 
Herein lays the first shortcoming of the policy document. Whilst the document makes 
103 
reference to a HIV / AIDS committee; there is no formal committee III place. It is 
important to remember that the fight against HIV / AIDS is best fought in a collaborative 
manner. The collaborating partners must include business, labour, government and non-
government organizations. The fight will only be effective if all these sectors combine 
their efforts and resources and actively contribute to the development of the company's 
HIV / AIDS policy and programmes. 
There is open dialogue between management and shop stewards in relation to issues not 
only relating to, but also including the issue of HIV/AIDS. The dialogue takes the form 
of quarterly meetings between the union representatives and management. HIV/AIDS 
issues are tabled at this forum and invariably they are sacrificed to attain short term 
benefits by either management or the union - it is used as a bargaining tool. 
Consequently there are stumbling blocks in this process and these include: 
1. it is felt that some senior management staff are making the process difficult in that 
they tend to deal with issues in a piece meal fashion. There is no recurring budget set 
aside for HIV/AIDS education and research, which makes it difficult to plan long term 
strategies. The senior management place the onus on middle management to address 
issues which arise around HIV/AIDS. 
2. the operationalisation and execution of the policy or plans from middle management 
become difficult and slow, as they do not receive support from top management. If top 
management fail to buy into this process, it is difficult to justify the allocation of funds to 
this particular exercise. 
The establishment of a HIV/AIDS committee through which the policy can be generated 
is crucial as it also addresses concerns and outlines responsibilities of the various 
stakeholders. These being: 
• concerns of employees 
• concerns of employers 
• responsibilities of managers 
• responsibilities of employees 
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• responsibilities of supervisors 
• responsibilities of shop stewards and trade unions 
The contributions of the above-mentioned parties will by explicitly detailed III the 
recommendations section of this paper. 
5.5.3. Legal issues 
An organisation's policy must be comprehensive and must reflect the organisation's 
position on HIV I AIDS. The policy must cover all employees, prospective employees and 
all workplace situations and contracts of employment. In addition, the policy should 
address the following issues: 
Personnel issues 
• Job access for applicants with HIV; 
• Job security of employees with HIV; 
• A position on HIV testing of employees and applicants; 
• Confidentiality and disclosure; 
• Protection against discrimination; 
• Employee benefits; 
• Access to training, promotion and benefits; 
• Performance management; and 
• Grievance procedures 
The policy must ensure that it conforms to the principles and intentions borne by the 
following; 
• Constitutional Rights 
• Labour relations Legislation including ILO Conventions 
• Basic conditions of Employment 
• Occupational Health and Safety Legislation 
• BenefitslPension Fund and other relevant legislation. 
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Every employee has a common law right to privacy. This means that an employee does 
not have a legal duty to inform their employer of their HIV status, nor may a healthcare 
worker reveal their HIV status to their employer without their consent. 
The R&H New Germany policy meets all the legal requirements stipulated. It is strongly 
stated that disciplinary action will be taken against any employee who infringes upon a 
fellow employees constitutional rights. The development of the current policy can be 
classified as the most tangible achievement in the fight against HN/AIDS. However the 
understanding thereof and the subtleties contained within the policy needs to be 
communicated to all employees. This is extremely important as the organization cannot 
hold any of its employees responsible if they do not understand the legal framework that 
is in place to ensure that constitutional rights are not infringed. 
5.5.4. How to avoid HIV Infection 
There are many possible types of prevention programmes, but in the workplace context 
there are a few which have been shown to be successful if they are implemented 
correctly. 
These prevention programmes include: 
• Awareness programmes; 
• Education programmes; 
• Condom distribution programmes; 
• Universal precautions; and 
• STD management 
The effective diagnosis, treatment and prevention of STDs is one of the more important 
ways in which transmission of HN can be reduced. It is thus one of the important 
prevention techniques. 
The aspects of prevention programmes listed above are not successful if implemented 




• A condom distribution programme will fail dismally if it is not accompanied by 
raIsmg awareness and using education to change attitudes towards existing sexual 
practices. 
• Providing information alone, without developing skills and confidence in people to 
enable them to protect themselves, will not result in any behaviour changes required for 
reducing the risk of HIV transmission. 
Various programmes will be briefly described and commentary provided on the existence 
and success at the New Germany site. 
• Risk reduction programmes 
Chapter 3 (Economic Impact of HN I AIDS), highlighted the socio-economic conditions 
that increased the risk of HN transmission. It is important to look at the extent to which 
the organization creates these factors through its housing policy, recreation possibilities, 
support for families of employees and so on. Therefore, to start reducing the risk of 
transmission, this issue needs to be thoroughly investigated by the HIV/AIDS committee. 
However the absence of such a committee at the New Germany site means that risk 
reduction programmes cannot be identified and suitable intervention programmes 
implemented. 
5.5.4.1. Awareness programmes 
People need to be well informed about AIDS, so they can understand clearly how the 
virus is transmitted and what activities and interactions are safe. This in itself is 
undoubtedly not enough to promote widespread, effective behaviour change, but it is an 
essential part of what is needed. Greater understanding and awareness should remove 
irrational fears and lead to supportive attitudes towards infected people. If people living 
with HIV I AIDS can expect to be accepted and supported, they need no longer keep their 
diagnosis a close secret. They also need to feel that they are not going to be blamed for 
having become infected in the first place. Creative awareness-raising campaigns are an 
important component of a prevention programme. Awareness programmes should 
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provide information that is relevant, accessible in terms of language and literacy levels of 
employees and which is culturally sensitive. 
The HIV I AIDS and STD committee has a crucial role in making sure that these principles 
are kept. The information should also be provided on an ongoing basis in order to make 
any impact. Awareness-raising activities can include exhibitions and theatre productions 
on HIV/AIDS and STD themes, campaigns linked to World AIDS Day, National 
Condom Week or AIDS Memorial Day. Awareness-raising activities are valuable in that 
they create awareness around HIV I AIDS and STDs in an informative, fun, non-
threatening way. Awareness-raising activities can also be included in awareness 
campaigns, thereby increasing the number of people reached by the programme. 
Since January 2002 to August 2003, R&H New Germany has conducted two awareness 
activities. The first was on the 20th December 2003 which constituted of each permanent 
employee being given a tee shirt as part of the sites National AIDS Day. Presentations 
were delivered by external guest speakers in English. The attendance was shockingly low 
(around 40%) as the manufacturing department was not informed of the talks and as such 
scheduled normal production for the day. Furthermore of those attending, many of the 
non English speaking employees battled to grasp the essence of the presentations and 
consequently lost interest. 
The second awareness drive held during quarter two of 2003, resulted in a slightly higher 
turnout (around 50%). This again was shockingly low but to be expected as word went 
around after the first awareness talk. Furthermore the awareness campaign was held at a 
time when the two other shifts were unavailable and as such excluded 30% of the 
possible attendees. 
The failure of the awareness programmes is again a consequence of the absence of a 
HIV I AIDS committee or the non functioning thereof. When these awareness programmes 
are scheduled they are determined by management. If however they were determined by 
the committee the awareness drive would be better co-ordinated and be delivered in a 
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manner which will be effective by taking culture and language preference into account. 
5.5.4.2. Education programmes 
Education programmes go beyond just providing information through campaigns. 
Education programmes must aim to provide people with skills that can help them adopt 
behaviours that will protect them from HIV and STDs (e.g. negotiation and assertiveness 
skills). Education is a two-way process of sharing information and understanding beliefs, 
attitudes and feelings. HIVS/ AIDS education can take place most effectively in the 
workplace, even though most HIV transmission occurs outside the workplace. The 
workplace is where employees spend a large part of their time, where they are trained and 
where they interact with their peers. 
Some of the more obvious reasons for conducting education programmes: 
• Preventing the spread ofHIV and STDs 
• Preventing unfair discrimination against employees with HIV 
• Facilitating the fair management of employees living with HIV 
• Demonstrating management's commitment to addressing HIV / AIDS in the workplace 
Currently R&H New Germany does not appear to have a formal education programme. 
The organization combines its educational initiatives into awareness activities. There are 
posters in English at various locations the manufacturing set-up and there is a general 
belief by management that this is adequate. This further exacerbates the belief that 
HIV / AIDS is only an issue that affects the manufacturing employees (predominantly 
Black). 
The absence of peer educators further substantiates the conclusion that education 
initiatives a re 0 verlooked. Peer educators a re employees who provide information and 
education to fellow workers, their families or other community members. 
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5.5.4.3. Condom distribution Programmes 
It is important to remember that condom distribution must be done as part of an education 
programme. Employees who are well informed about the function of condoms and how 
to use them will not be offended by their sudden appearance in the workplace. Peer 
educators can play important roles in initiating discussions on the advantages of using 
condoms and in supporting the condom distribution programme. Many people are self-
conscious about being seen buying or taking condoms from a dispenser or from a health 
worker. Various creative strategies for making condoms more acceptable and accessible 
can be used, such as workplace advertising campaign or industrial theatre. Different ideas 
should be listed by the RIV/AIDS committee and investigated thoroughly to find the best 
one(s). A multi-faceted strategy might be possible in a larger workplace. This strategy 
could include free distribution at the workplace clinic, social marketing through condom 
vending machines and peer educators who distribute condoms. Smaller workplaces may 
appoint a specific person who can distribute condoms confidentially, or may simply 
choose to provide information to employees about nearby outlets (for example, a family 
planning clinic or pharmacy). An increase in the number of condoms distributed, 
occurring together with a decrease in the incidence of STDs, could indicate that 
employees are changing their sexual practices as a result of the education programme. 
The organization must carefully consider whether condoms should be distributed free of 
charge or whether a nominal fee will be charged. One important advantage of charging 
for the condoms is that people will tend to make better use of them, when compared to 
free distribution. Social marketing of condoms includes encouraging people to use 
condoms effectively and consistently through: 
• Education and information around condoms and safer sex (for example, done by peer 
education); 
• Providing accessible condoms where and when they are needed at a cost that is 
affordable; 
• Targeting information and access to condoms at people in the broader community 
(such 
as sex workers and indeed all women); 
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• Using tried and tested advertising techniques to "sell" the concept of condom use; and 
• Marketing both the female and male condoms as this provides women with more 
control over their use. 
The R&H New Germany operation provides free condoms at its on-site clinic. However 
is located in an area which is visible to anyone in the waiting area. Consequently those 
employees who would feel embarrassed tot ake condoms if noticed tend to shy a way. 
However recent statistics on consumption rates indicate higher usage rates and more 
during the week leading to the month end. There are two plausible explanations for this. 
Firstly many of the manufacturing staff employees would return home to their spouse and 
in order to protect their spouse from HIV or a STD would use a condom. Secondly, 
month end is when all employees are paid. Consequently it is when those employees who 
would engage the services of a sex worker would most likely have money to pay for the 
servIce. 
Nevertheless, consumption is increasing; which is most encouragmg. However since 
there is no data reflecting a decrease in STDs or HIV infections, the usage of condoms 
must be continued to be aggressively encouraged. 
An additional shortcoming of the present distribution point is that it only available when 
the company clinic is open; which is for four hours per normal working day. 
Consequently those employees who are not on site during the clinic hours will not have 
access to the free condoms. Based on the current shift rotation system, anyone shift will 
only have access to the clinic for one week out of every three. Not very convenient. 
Whilst it may be argued that those employees who cannot access the free condoms due to 
their working shift hours may request their colleagues to acquire them on their behalf and 
supply it to them when they come on site; there would also be those who would shy away 
from such a practice due to personal and cultural reasons. 
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5.5.5. Wellness Management 
Wellness management is a useful concept to use in relation to HIV/AIDS and STD, as it 
clearly highlights the need and importance of keeping a person with HIV I AIDS healthy. 
It also highlights the need to keep a person with an STD healthy to prevent the spread of 
HIV. This section answers the question: "What is done to keep employees as healthy as 
possible and therefore as productive as possible for as long as possible?" 
Early diagnosis and effective, complete treatment of an STD can reduce the risk of sexual 
transmission of HIV. This diagnostic and treatment service will only be effective if it is 
done together with an education and primary prevention programme (as discussed 
earlier). 
Most employees prefer to use private doctors or public health services if they have an 
STD, even if services are available in the workplace, as they fear discrimination by their 
colleagues and/or employer. If STD services are to be provided in the workplace, they 
should be integrated with other health services, such as basic health care, maternal and 
family planning services. The users are not easily identified as STD patients. STD 
services must be user-friendly and confidential if they are to be utilised effectively by 
employees; health workers should have a non-judgmental approach to counselling and 
treatment and be prepared to give patients advice and listen to their views. 
5.5.5.1. Counselling people with HIV/AIDS or STDs 
All counsellors, even health workers, need specialised training, and the mInImum 
standard is a two week counselling training programme. The effectiveness of an STD 
management programme increases when health workers counsel STD patients. The 
counsellor should aim to provide information and support in such a way that the person is 
encouraged to change his/her behaviour and face the issue of having an STD or HIV in a 
positive manner (in other words, take constructive action). Specific skills are required in 
order to be an effective counsellor. The HIV/AIDS and STD committee should 
investigate the possibility of either using outside agencies to provide counselling or to 
select employees to undergo training in counselling skills. These could be the same 
employees who are trained as peer educators. Counselling should not just provide 
112 
information but should enable the person to choose various 0 ptions while providing a 
psychologically and emotionally supportive relationship. A person living with RIV will 
require counselling at various stages. At the initial diagnosis stage, the person with RIV 
requires much support to come to terms with the realisation of having the disease. Later, 
when the person with RIV starts developing consistent symptoms such as recurrent 
opportunistic infections, shelhe will require further counselling and support. This signals 
the early stages of the AIDS phase. During the period of AIDS, the person will require 
support and counselling to help herlhim come to terms with living with constant illness 
and facing death. 
5.5.5.2. Counselling around testing issues 
It is important to ensure that a person has access to counselling both before shelhe 
undergoes an RIV test as well as after the test results are known, whether negative or 
positive. 
The counsellor should discuss with the employee all the potential advantages and 
disadvantages 0 fknowing hislher R IV status during pre-test and post-test counselling. 
Other issues which should be covered are: 
• Dealing with a negative test result; 
• Understanding the consequences of a positive test result; 
• Dealing with a positive test result; 
• Identifying support systems; and 
• Referral for further counselling or other resources. 
In cases where employees test positive, they must have access to on-going counselling. 
Doctor/patient confidentiality must be observed and the test results revealed only if the 
patient has given consent. The issue of confidentiality should be discussed with patients, 
including all the potential advantages and disadvantages of disclosing their RIV status to 
employers, colleagues, families and friends . Patients should be made aware that they are 
not legally obliged to disclose their RIV status to anyone. RIV/AIDS can cause severe 
emotional distress to people who have RIV, their families, friends and fellow workers. If 
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an employer does not provide a counselling service, the employee should be referred 
outside the workplace and given appropriate support by the employer (such as time to 
attend counselling sessions.) It might be best to provide counselling services outside of 
the workplace to ensure confidentiality and remove any stigma associated with "going for 
counselling". Counselling should last as long as is necessary for the employee. A 
counselling or referral service for family members, friends and colleagues should also be 
considered. 
5.5.5.3. Partner notification and disclosure 
Generally, employees w ill inform their partners and families that they have HIV. The 
potential benefits and disadvantages of disclosure and how to do this should be discussed 
between the employee and herlhis counsellor. 
5.5.5.4. Care for people with HIV / AIDS 
As the epidemic grows, many more employees will become infected and develop the 
clinical and symptomatic phases of the disease. Costs can be contained if effective 
primary care services can be provided to manage HIV and its related conditions. 
HIV I AIDS can be kept an affordable condition by keeping people with HIV I AIDS out of 
hospital, by early intervention for opportunistic infections and prophylaxis for these 
infections. 
5.5.5.5. Links with other programmes in the workplace 
HIV I AIDS and STD programmes should be integrated into other workplace health and 
education services. Examples of important and useful linkages are those with 
occupational health and safety programmes and tuberculosis (TB) control. 
5.5.5.6. Counselling services 
Employees who are HIV -infected are more likely than other people to get sick with TB. 
As part of post-test counselling, employees infected with HIV should be counselled to 
seek care if they develop symptoms of TB. Employees who have TB or who are HIV-
infected should be counselled on their legal rights. Specifically, they should be made 
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aware that it is illegal to fire a person because they have TB or because they are infected 
with HIV. Confidentiality should be ensured for TB patients and people infected with 
HIV. 
Whilst the R&H New Germany Policy document states the employees are encouraged to 
use t he expertise a nd assistance 0 f t he 0 n site clinic for counselling; there i sas trong 
belief amongst a vast majority of the employees that the current nurse is not capable of 
doing this. When a random sample of those employees who undertook voluntary HIV 
testing, were asked if they were counselled prior to the test; all replied negative. 
Employees are encouraged to seek external counselling if necessary; however the 
availability and location has not be published. Furthermore the absence of peer 
educators/counsellors exacerbates the lack of support for a wellness management 
programme. 
The company policy also mentions that there will a clear after care programme developed 
in the event that severance of employment due to illness shall occur. This is extremely 
disturbing as it is obvious that no clear policy and procedure is place to deal with this 
eventuality - there could be nothing more disconcerting for an employee who is HIV 
positive. 
5.5.6. Monitoring and evaluation 
Monitoring is a systematic and continuous assessment of a programme over a period of 
time. An evaluation on the other hand, is an assessment of the impact of the programme 
at one point in time. Monitoring and evaluation complement each other. There are two 
aspects to be monitored: 
• The impact of HI V/AIDS in the workplace; and 
• The effectiveness and impact ofthe HIV/AIDS and STD programme 
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5.5.6.1. Importance of monitoring and evaluation 
Monitoring and evaluation have an important role to play in ensuring that a programme is 
appropriate and effective. We cannot continue running a programme without, at some 
point, standing back and checking on what we are doing. Monitoring and evaluation are 
ways of assessing how well the programme is running, the effect of the programme on 
the workplace and how effective it is in changing people's behaviour with regard to 
RIV/AIDS and STDs. 
5.5.6.2. Baseline information 
It is important to have baseline information on RN/AIDS and STDs in the workplace in 
order for the RIV/ AIDS committee to develop a good monitoring and evaluation 
component to the RN/AIDS and STD programme. Baseline information can be obtained 
by doing a baseline study. This is a survey of the indicators of interest (for example, 
number of condoms distributed) at the start of the programme. This provides the starting 
point against which all future measures of the indicators can be compared. The difference 
between the baseline measure and future measures tells how effective the RN/AIDS and 
STD programme has been. It is much more difficult to see the impact of the programme 
if the baseline information has not been gathered. The baseline must include 
measurements on all indicators of interest. Much of the information needed for the 
baseline can be obtained from the needs analysis which is undertaken as part of the policy 
and programme development process. 
5.6.6.3. Indicators 
Indirect indicators 
Prevalence of STDs and the number of condoms distributed : these two indicators 
together can indicate behaviour change with regard to safer sex practices. 
Number of employees volunteering to become peer educators : this could indicate levels 
of a wareness a nd m otivation a round RN/AIDS and S TDs in the w orkplace and is an 
indirect indicator of behaviour change. 
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Direct indicators 
• Number of condoms distributed : this can indicate the effectiveness of an 
education programme 'on the use of condoms. 
• Number of employees attending/participating III HIV/AIDS and STD education 
programme: this could indicate whether the programme is reaching those targeted 
(for example, all employees). 
5.5.6.4. Monitoring the impact of HIV / AIDS in the workplace 
The impact of HIV/AIDS can be monitored by maintaining records on sickness or 
absence and looking at causes of the absence; how often employees take special or 
compassionate leave; staff turnover by reason for departure (including early retirement); 
and death by cause. These records will help identify the possible impact of HIV early on 
and enable the company to respond appropriately. The kinds of question to ask include: " 
Are there any key personnel whose loss would cripple the plant?" If the answer is yes: 
"How do we respond?" The actual cost of AIDS cases to employers will vary greatly 
depending on the conditions of employment, the level of staff and the way in which they 
are treated. 
5.5.6.5. Monitoring the HIV/AIDS & STD programme 
There are some important considerations to bear in mind when monitoring a programme: 
• Decide which indicators you will measure. In other words, how will behaviour 
changes be measured? 
• Decide how the indicators will be measured, for example, in-depth interviews with a 
sample of employees or a questionnaire handed out to all employees. What questions 
will be included in the questionnaire? Will the company keep records of attendance at 
work, sick leave, compassionate leave and so on? 
• Calculate the costs of the monitoring process steps. 
• How often will monitoring take place to give the maximum amount of information 
with the least disruption and cost? 
• Quantitative indicators include the number of people attending the education 
programme and the number of condoms distributed. (it is important to identify a 
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range of indicators). Qualitative infonnation requires input from all role players as to 
the effectiveness and efficiency of the programme. 
5.5.6.6. Evaluating an HIV/AIDS & STD programme 
Evaluations usually measure the impact of an intervention or programme to see if it has 
an effect or not. Evaluations are usually done after the programme has been in existence 
for some time. The infonnation gathered through ongoing monitoring can be very useful 
as part of the evaluation. Evaluations also provide infonnation which can be put together 
with other sources of infonnation to provide a picture for the whole country. However, it 
is not easy to detennine the exact effect of a programme. All that can be done is to 
measure various changes and try to establish whether they are related to the 
implementation of the programme. It is very difficult to pinpoint exactly which factors 
mayor may not have had an impact. For example, one cannot assume that people are 
using more condoms just because more condoms are being distributed in the workplace; 
you also need to look at whether the incidence of STDs is decreasing. 
Currently the organisation does not utilise any structured monitoring and evaluation 
techniques. The only measurements currently used are: 
• Monthly condom consumption rates 
• Head count when the ad-hoc HIV / AIDS awareness sessions are held. 
This stems largely from the absence of a functioning HIV/AIDS committee that can 
identify the indicators (both direct and indirect) and ensure that they are monitored and 
evaluated. There exists a total reluctance to divulge the prevalence of a STD as the 
majority of the workforce believes that management will use the results to infer HIV 
status. There is consequently a lack of trust and the absence of any valid measurements, 
renders any HIV / AIDS programme highly susceptible to failure. This is so since 
modifications and fine-tuning to ensure appropriateness of the programme cannot be 
done. 
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Furthennore attempts by the author to conduct a KAP Study (Knowledge, Attitudes and 
Perception) were rejected by management even though scientific research techniques 
would have been followed coupled with anonymity. The KAP study would have proven 
immensely valuable as currently the organisation does not have any baseline infonnation 
to monitor and evaluate its RIV I AIDS programmes. 
5.6. RECOMMENDATIONS: 
5.6.1. Introduction 
The RIV I AIDS epidemic affects everyone, every individual, every family, every social 
institution, every organisation and indeed every business, big or small. Although there are 
indications that RIV infection may be spreading faster among the underprivileged sectors 
of the population (poor, marginalized, uneducated, etc.), so far the toll among the urban 
young adult popUlation has been higher. In South Africa it is estimated that as many as 1 
000 people, mostly young people, are infected every day. 
The RIV I AIDS epidemic poses one of the greatest challenges to business development in 
Africa. The epidemic claims some of the best business leaders, managers and a great 
number of workers at all levels of the production system. RIV -related absenteeism, loss 
of productivity and the cost of replacing workers lost to AIDS threaten the survival of a 
number of businesses and industrial sectors in the increasingly competitive world market. 
RIV I AIDS does not affect only workers. By claiming a large part of the urban population 
with disposable income and by impoverishing families and communities, it also effects 
the market base of African business. 
It is clear that no one sector alone can make a significant imoad in the fight against the 
epidemic. A true partnership involving the government, the private sector and the 
community is essential to face the problem. The business community is realising that its 
very survival depends on how effectively it joins forces with other partners to face the 
problem. The workplace provides an excellent environment to implement a 
comprehensive RIV/AIDS programme and policy refonn. 
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5.6.2. Principles for policy and programme development 
These principles are important because they have been shown to have a significant 
impact on whether or not an HIV/AIDS programme is effective: 
• HIV/AIDS and STD issues must be integrated into everyday activities of the 
organisation. Induction programmes for staff should include a module on HIV / AIDS 
and STDs to raise awareness. Social events (for example, open days) organised by the 
workplace could include an aspect ofHIV/AIDS (for example, a stand that promotes 
using condoms). 
• The management of the organisation should demonstrate a clear commitment to the 
HIV/AIDS and STD strategy. It is very important for workers to see this commitment 
in concrete form through non-discrimination and support for people with HIV / AIDS 
and STDs (a policy in a manager's drawer is not a concrete commitment). Concrete 
commitment will go far in developing mutual trust between employers and employees 
and facilitating an a tmosphere where people are willing to undergo voluntary H IV 
testing and possibly disclose their HIV status. 
• Transparency is necessary. For example, policy documents should be available and 
the documents should be written in a way that is accessible to employees. 
• Any component of the strategy must be thoroughly investigated and an 
implementation plan developed on the basis of this investigation. Implementation 
plans should be accountable in their action, be fully costed and have clear 
responsibilities and time lines. 
• In order to fully understand the impact of the HIV/AIDS epidemic on the workplace, 
a number of factors have been taken into account. These include the HIV prevalence 
rate in Africa as well as the effect of the epidemic on benefit schemes and health care. 
Other information is available from relevant experts in the field of benefit 
management and health care. 
5.6.3. Importance of a policy 
• A workplace policy on HIV/AIDS and STDs IS central to developing and 
implementing an effective workplace programme. It provides the framework for 
action. 
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• An mY/AIDs policy defines your organisation' s position and practices in relation to 
employees with mY/AIDS and to preventing the spread ofmv. 
• The policy prepares the organisation for the time when it will face the presence of 
my infection and AIDS, if this has not happened already. The policy must be 
developed through consultation with all levels of workers. 
• An mY/AIDS and STD policy also demonstrates your organisation's concern and 
commitment in taking active steps to manage the illV/AIDS epidemic. However, a 
commitment in the form of policy must be taken further into concrete action in the 
form of an mY/AIDS and STD programme. 
5.6.4. Procedure for developing an RIV/AIDS & STD policy 
Developing a policy takes time if proper consultation takes place. This section provides a 
step by step account of how to go about the process. Although these steps suggest that a 
policy must precede any programme development, this is not necessarily the case. The 
first two steps could lead directly to the development of a programme before a policy is 
formulated . It is up to the individual organisations to decide how they will proceed. 
wM Elect the HIV I AIDS and STD committee 
This should have representation from shop stewards, supervIsors, management, the 
occupational health nurse (or other health worker if your organisation has one) and other 
interested/skilled individuals. It is especially important to have representation of top 
management on the committee. This gives the committee greater decision making powers 
and demonstrates that management is commitment to the process. 
w!B The HIV I AIDS and STD committee investigates the needs of the 
organisation in relation to mY/AIDS and STDs 
This investigation will form part of a baseline study of the indicators for the evaluating 
and monitoring. Important factors in determining the organisation' s needs are: 
• The number of employees; 
• The health, information and education facilities already available; 
• The extent to which these facilities are being used; 
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• The attitudes of employers and employees to HIV/AIDS and STDs; and 
• The extent to which management is willing to commit themselves to managing the 
impact ofHIV/AIDS. 
The HIV I AIDS and STD committee meets to discuss and 
formulate a draft policy. (see examples 1-4) 
Circulate the draft policy for discussion and comment and then 
revise. 
#iN.. Adopt the policy 
mWJ The HIV I AIDS and STD committee uses the policy to develop the 
implementation phase of the strategy 
d. Communicate the policy and programme implementation to 
everyone in the organisation 
This could be done during the induction of new employees, during education and training 
sessions or by displaying the policy throughout the workplace. 
mifJ Monitor and evaluate the programme to determine is 
effectiveness 
This helps in making changes to the programme. 
Review the policy regularly in light of new information about the 
epidemic and treatment for mv and AIDS. 
Reviews could take place annually or at any time, as necessary. 
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5.6.5. Contents of a HIV/AIDS Policy 
The policy must be comprehensive and must reflect the organisation's position on 
RIV I AIDS. The policy must cover all employees, prospective employees and all 
workplace situations and contracts of employment. In addition, the policy should address 
the following issues: 
Personnel issues 
• Job access for applicants with RIV; 
• Job security of employees with RIV; 
• A position on RIV testing of employees and applicants; 
• Confidentiality and disclosure; 
• Protection against discrimination; 
• Employee benefits; 
• Access to training, promotion and benefits; 
• Performance management; and 
• Grievance procedures 
Programme issues 
• Organisational risk reduction; 
• First aid/universal precautions; 
• Education and awareness programmes; 
• Other prevention programmes; and 
• Wellness management 
Monitoring and evaluation 
There should be regular evaluation, monitoring and review of the policy and programme. 
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5.6.6. Human Resource Issues 
Perfonnance management 
Employees living with HIV will be productive for a longer period if they receive the 
medical, social and psychological support they need. An employee may not be dismissed 
simply because they are HIV -positive. An employee who develops AIDS should be 
treated in the same way as any other employee with a life-threatening illness. If 
procedures for assessing and managing the perfonnance of employees do not already 
exist, these must be developed pro-actively and transparently so that, as the impact of 
AIDS becomes more apparent, employers are able to respond rationally. 
It is advisable to develop procedures for perfonnance assessment and m anagement, so 
that all supervisors and managers are clear on the criteria for dealing with: 
• Absenteeism; 
• Sick leave; 
• Transfer to lighter duties; 
• Ill-health; 
• Early retirement; 
• Employee counselling and so on. 
Employees with HIV may need support in the following areas: 
• Facilitating the employee's access to health services outside the workplace if these 
are not available in the workplace; 
• Giving the employee time off to attend clinics or counselling; 
• Transferring the employee to lighter or less stressful duties, where it is both necessary 
and possible; and 
• When employees are no longer able to work, they should be given early retirement 
with the benefits nonnally due to those who retire due to ill health. Employees who 
retire due to ill-health must be infonned in advance of the benefits for which they 
mayor may not be eligible (i.e. medical aid, life insurance and so on). 
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5.6.6.1. Guidelines for Human Resource Department 
With regard to the selection of job applicants it is the relevant recruitment officer's 
responsibility to ensure that a medical examination takes place and that consideration is 
given to the examination results before a selection decision is made. 
With regard to employees who develop a life threatening disease it is the task of the 
human resources manager to advise and guide managers in the management of these 
employees as well as to provide access to educational material and a network of medical 
professionals. 
Human Resources should, therefore, ensure that it is fully and comprehensively informed 
on matters relating to the employment of employees with life threatening illnesses. 
It is recommended that Human Resources form a multi-disciplinary advisory body that 
may be referred to for technical information as and when it is required. Such a body 
could compromise advisors from areas such as the legal field, industrial relations, pension 
fund, medical aid society, medical fraternity (e.g. experienced in HIV/AIDS) and the 
trade union. 
In providing a professional service to line management, Human resources should be 
aware of the following points: 
• A degree of judgement will be necessary in handling most cases and as such human 
resources managers should be guided by the core corporate values of fair employment 
practice. 
• Human resource managers must be aware of the industrial relations implications that 
apply to an employee with a life threatening illness. 
• Confirmation that a person has a life threatening illness can have a devastating 
psychological impact on that person. Psychological counselling is therefore essential, 
if desired. It is recommended that if an employee suspects that he/she has life 
threatening illness, particularly HIV/AIDS, he/she should be referred for pre-test 
counselling and only then to a medical practitioner for actual testing. It is further 
essential that the employees avail themselves of post-test counselling. 
• The greatest possible care must be given to observing the strict confidentiality 
applicable to employees with a life threatening disease. 
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• Human resources managers should be sensitive to an employee's continued need for 
psychological counselling and should, therefore, monitor the behaviour of afflicted 
employees in conjunction with the manager concerned. 
• Should the employee's condition deteriorate to the extent that a threat is posed to 
fellow workers or that the employee simply cannot perform adequately, then the 
employee's incapacity will have to be addressed, for example, consideration be given 
to early retirement. 
5.6.6.2. Guidelines for managers/supervisors 
When approached by a subordinate with a life threatening illness the manager/supervisor 
must be sensitive to the employee's condition and respect the confidentiality of the 
information given to him/her by the subordinate. When dealing with employees with life 
threatening illnesses the manager/supervisor should: 
• Be aware that he/she is the manager/supervisor controlling the situation and that it 
falls to himlher to manage the situation. The role of HR is to provide a professional 
service that enables the manager to manage the problem as effectively as possible. 
• Make sure that he/she is fully informed of the employee's rights, conditions of 
employment, industrial relations implications and the range of professional services 
provided by the human resources manager. 
• Be sensitive to the fact that continued employment for an employee with a life 
threatening illness m ay sometimes bet herapeutically important in the remission 0 r 
recovery process, or may help to prolong that employee's life. 
• Continuously ensure that the afflicted employee does not pose a threat In the 
workplace to himself, his co-workers or to customers. 
• Be sensitive and responsive to co-workers concern and emphasise employee 
education that is available through Human resources. 
• Not give special consideration beyond normal transfer requests for employees who 
feel threatened by a co-worker's life threatening illness, provided that the co-worker 
does not pose a valid threat. 
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• If warranted, to make reasonable accommodation for employees with life threatening 
illnesses in conjunction with the advice given by the relevant Human resources 
manager. 
• Be aware that co-workers may only be informed of an afflicted person's condition 
with the written consent of that person. 
• Encourage employees who suspect that they have a life threatening illness to seek 
immediate medical attention. 
• Encourage all employees to avail themselves of the educational material provided by 
Human resources. 
5.6.7. Education Programmes 
Education programmes go beyond just providing information through campalgns. 
Education programmes aim to provide people with skills that can help them adopt 
behaviours that will protect them from HIV and STDs (e.g. negotiation and assertiveness 
skills). Education is a two-way process of sharing information and understanding beliefs, 
attitudes and feelings . 
5.6.7.1. Reasons for conducting an education programme 
Preventing the spread of HIV and STDs 
• There is presently no vaccine or cure for HIV/AIDS. The most effective way to slow 
down the spread of HIV I AIDS is to reduce the rate of transmission from infected to 
uninfected people. The first step towards lowering a person's risk of becoming 
infected is providing knowledge and awareness of HIV. Knowing about and 
practicing safer sex is the best way of remaining HIV negative, since the most 
common way of being infected with HIV is through sexual intercourse. 
• HIV I AIDS education can take place most effectively in the workplace, even though 
most HIV transmission occurs outside the workplace, even though most HIV 
transmission occurs outside the workplace. The workplace is where employees spend 
a large part of their time, where they are trained and where they interact with their 
peers. 
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• However, HIV may be transmitted in the workplace through contact with another 
persons blood (for example, if there has been a workplace accident). Education 
programmes should include training around what to do if there is an accident in the 
workplace and how employees can perform first aid and handle blood spills safely in 
an emergency. (see Section 5.5 for further details) . 
• STDs are important in the HIV / AIDS epidemic because there is a greater chance of a 
person being infected with HIV if they already have an STD. Because STDs are 
curable, STD prevention and treatment is an effective way to slow down the spread of 
HIV/AIDS. 
Preventing unfair discrimination against employees with HIV 
Many people experience intense confusion and anxiety about how HIV could affect their 
job security and their relationships in the workplace (with managers and colleagues) and 
outside it (with their families and friends). Many people have heard of others who have 
lost their jobs or pensions because they have HIV. Some people living with HIV/AIDS 
have been discriminated against by their employers, co-workers, friends or family. These 
irrational responses and prejudices and the fear they produce in employees can have a 
serious impact on productivity and industrial relations. Fear and prejUdice can be reduced 
by appropriate education around the employer's attitude to HIV/AIDS, the facts of 
transmission and the rights of employees in relation to HIV. 
Facilitating the fair management of employees living with HIV 
An education programme for employees at all levels of a company or organisation, 
including managers, can greatly facilitate the management of those employees who have 
HIV. Taking active steps to prepare for the full impact of HIV / AIDS will allow a more 
reasoned, appropriate and effective response. 
Demonstrating management's commitment to addressing HIV / AIDS in the workplace 
• Management support for the HIV/AIDS programme demonstrates that management is 
sincere about addressing HIV / AIDS in the workplace, the welfare of employees and 
the well-being of the company. 
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• In this context, management should provide a budget specifically for the RIV / AIDS 
and STD programme. 
• Management should participate in the AIDS committee and in RIV / AIDS education 
and training programmes. 
Contents of a successful education programme 
In this section we highlight some of the characteristics of a successful RIV / AIDS and 
STD education programme: 
• Education should be on-going, rather than a once-off or annual training course. This 
allows the effectiveness of the programme to be monitored as it takes place and the 
content changed as necessary. It also keeps people thinking about RIV / AIDS, so that 
the issue remains accepted and visible in the workplace. 
• Education and awareness-raising around RIV can easily be integrated into existing 
training courses such as industrial relations, personnel management, first aid, 
occupational safety, literacy, induction and supervisory and management courses. 
This entails no extra costs if RIV -related examples are used to get people thinking 
about RIV could effect their situation in the workplace.' 
• Education should take place in small groups in an informal setting so that employees 
feel comfortable to ask questions and discuss their feelings openly. 
• Peer educators can b e used in a lmost any w orkplace, whether small 0 r large. Peer 
educators are employees who are trained to deliver RIV/AIDS education and/or 
counselling to fellow-workers. Peer educators should be volunteers or be selected by 
their colleagues, but should have certain qualities such as empathy, maturity, good 
communication skills and popularity among their colleagues. Peer educators are well-
placed to initiate a condom distribution programme. 
• Another source of peer education is contact with peers with RIV from within or 
outside the workplace. Contact with peers with RIV can remove myths and fears very 
effectively, but should be handled very sensitively, in small groups and only as one 
part of the comprehensive education programme. This type of education is only 
possible if some employees with RIV are prepared to disclose their RIV status. 
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• The specific content of an education programme should be decided in consultation 
with the HIV I AIDS committee and/or outside agencies which specialise in workplace 
HIV/AIDS and STD education. 
5.6.7.2. Principles of an education programme 
These principles should underlie any education programme that is implemented. 
• Start where people are, with their existing knowledge, beliefs, fears and hopes, 
attitudes and practices. 
• Take into account the socio-economic and cultural context of people's lives. 
• Correct information in a supportive way. 
• Help people express their feelings and describe their own experiences. 
• Help people to identify, understand and articulate their own problems and to explore 
opportunities for change and development. 
• Do not try to take responsibility away from people by telling them what to do. 
The decision must be theirs. Peer educators are employees (or members of employee's 
families) who provide information and education to fellow workers, their families or 
other community members. They should fulfil the criteria set out below 
Selecting & training peer educators 
• The a ge, language, social and work status 0 f peer educators should correspond, to 
some degree, with those of their co-workers. For example, each peer educator could 
be responsible for education in his/her specific section or 'floor" of the workplace. 
• Peer educators need to be highly motivated since they perform a difficult task on a 
voluntary basis. Group training sessions will help them remain motivated through 
sharing the experiences and problems they encounter. 
• You should consider cultural and gender issues when selecting peer educators. Some 
of the issues relating to HIV I AIDS and STDs are highly personal and people may 
only be comfortable discussing them with someone of the same gender and cultural 
background. 
130 
• The language(s) used by the peer educators must be taken into account: people need 
to be educated in a language that they feel comfortable using. 
• Peer educators should be trained as necessary, either in-house or externally through 
an AIDS training organisation. 
• Family members of employees or others outside the workplace may also work as peer 
educators, working in the broader community to educate sex workers, school children 
and non-working mothers. 
5.6.7.3. Issues to be covered in an education programme 
There are a number of issues that should be covered within an education programme. 
Transmission of HIV 
• How can HIV be transmitted between people; 
• How HIV is not transmitted; and 
• Most common mode of transmissions (unprotected sex). 
STDs 
• The role ofSTDs in transmission ofHIV/AIDS; 
• The importance of prompt treatment for STDs; 
• Where to get treatment; 
• Importance of using condoms during treatment; 
• Informing your partner that you have an STD; and 
• The importance of your partner being checked and treated too (see Section 6.1) 
Safer sex 
• The advantages of safer sex for preventing HIV I AIDS, STDs and pregnancy; 
• Problems people may encounter in introducing safer sex into a relationship; 
• How to deal with a partner who does not want to practice safer sex; 
• Communication around safer sex; and 




• The role of condoms in preventing HIV/AIDS, STDs and pregnancy; 
• How to use the condom; and 
• Practice in applying a condom. The use of both male and female condoms should be 
explained. 
Attitudes, myths and misconception 
There are many myths and misconceptions about HIV/AIDS and STDs which should be 
addressed by an education programme. 
Legal and ethical issues 
Information on the rights and obligations of employers and employees with regard to 
HIV/AIDS and STDs should be provided and discussed. 
Women's rights 
In educating women about their rights with regard to sexuality and reproduction, specific 
efforts should be made: 
• To provide women with skills for employment; and 
• To empower women to m ake their own informed decisions about their bodies and 
their sexuality. 
Practical suggestion 
Existing training courses can be used to educate employees at all levels about HIV/AIDS 
and STDs. For example, during a training course on management skills, participants 
could be asked to discuss how they would approach an employee whose supervisor had 
reported that she had been absent from work for four days in the past month and was not 
as productive as usual. 
Links with educational services outside the workplace 
Many organisations provide HIV/AIDS and STD educational materials and/or educators 
who will visit workplaces on a regular or once-off basis. These organisations may also 
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help to further develop the R&H New Germany HIV/AIDS policy and initiate a 
workplace programme. A database of organisations which provide these resources is 
should be developed. 
5.6.7.4. DOTS in the workplace - TB education, diagnosis, treatment and 
counselling 
Tuberculosis is the most common opportunistic infection and the biggest killer of people 
living with AIDS. Tuberculosis is often the first AIDS-defining illness which changes a 
person's status from HIV-infected to AIDS. By attacking the immune system, HIV makes 
a person 30 times more likely to progress from TB infection to TB disease. Fortunately, 
TB can be cured as successfully in people who are infected with HIV as in those who are 
not. However, if a patient with HIV and TB is not treated promptly, the patient may die in 
weeks or months. People with TB or HIV face similar problems of stigma, fear and 
discrimination, and have shared needs for counselling, care and support. The link 
between TB and HIV is so strong that all workplace programmes for HIV / AIDS and 
STDs should include the following elements: 
Education 
Employers and employees should be taught the symptoms of TB and should be 
encouraged to go to a clinic to have their sputum examined if they develop TB 
symptoms. The symptoms of TB are: 
• Cough for more than 3 weeks; 
• Chest pain; 
• Loss of appetite and weight; 
• Night sweats; 
• Feeling tired and weak; and 
• Coughing up blood 
Education about TB should also include the following: 
• HIV increases the risk of developing TB, but not all HIV -infected people have TB 
and not all people with TB are HIV -infected. 
133 
• TB can be cured as easily in HIV -infected people as in people who are not HIV-
infected. 
• TB patients on appropriate treatment are not infectious. 
• TB patients can continue working and can receive TB treatment by the treatment 
supporter in the workplace. 
Diagnosis 
A person with symptoms of TB should go to a clinic or hospital to be investigated. The 
person will cough material (sputum) up out of the lungs which will be examined under a 
microscope. If the TB germ is seen under the microscope, the person should be started on 
TB treatment. Chest x-rays and sputum cultures may also be used for diagnosis of TB. 
People diagnosed with TB should be given at least 2 weeks of sick leave to allow them to 
recover. After 2 weeks of treatment, the person should be reassessed by a health worker 
to determine is shelhe can return to work. At this time most TB patients are able to return 
to work on TB treatment without putting their co-workers at risk. TB patients on correct 
TB treatment will not infect other people. 
Contacts 
Contact tracing is not necessary for adults who have been working with someone who 
develops TB. 0 nly children under 5 years 0 Id who have been in close contact with a 
person with TB should be investigated at a clinic. TB patients should be encouraged to 
tell their adult contacts that they should seek care if they develop symptoms of TB. 
Treatment - DOTS in the workplace 
TB can be cured with a strategy called Directly Observed Treatment, Short-course 
(DOTS). The most important part of the DOTS strategy is that a treatment supporter 
observes a TB patient swallow each dose of TB treatment for the entire 6 to 8 months of 
treatment. Anyone who is dependable and accountable to the health system can be a 
treatment supporter. Besides health workers, treatment supporters can be managers, 
supervisors, co-workers, peer educators, community members, teachers shop keepers and 
family members. A treatment supporter can be chosen by the TB patient in consultation 
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with the health worker. For R&R employees, it is often most convenient to receive their 
TB treatment at the workplace. The increased convenience of receiving TB treatment at 
work makes it more likely for the person to complete their TB treatment and be cured. 
Because people who are on correct TB treatment do not infect other employees, 
providing DOTS in the workplace prevents the spread of TB. 
The TB patient has the following responsibilities: 
• Swallow each dose of TB treatment. 
• Report side effects and any other problems promptly 
• Attend the clinic for appointments. 
• Inform the clinic if resigning, going on leave, absent from work or unable to receive 
TB treatment for any reason. 
The employer has the following responsibilities: 
• Support and encourage DOTS in the workplace. 
• Allow time for employees to be trained by health workers to provide DOTS in the 
workplace. 
• Allow time for employees to go to the clinic. 
• Attempt to provide a private space where a TB patient can receive TB treatment. 
Counselling services 
People who are RIV-infected are more likely than other people to get sick with TB. As 
part of post-test counselling, people infected with RN should be counselled to seek care 
if they develop symptoms of TB. Employees who have TB or who are RN -infected 
should be counselled on their legal rights. Specifically, they should be made aware that it 
is illegal to fire a person because they have TB or because they are infected with RN. 
Confidentiality should be ensured for TB patients and people infected with RN. 
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5.6.8. Monitoring and evaluating a programme 
In this section we look at why it is important to monitor and evaluate a programme and 
how to go about it. We will also look at some indicators that R&H New Germany can use 
to see what changes have come about in employees .. behaviour, attitudes and 
knowledge in relation to HIV/AIDS and STDs. 
Monitoring is a systematic and continuous assessment of a programme over a period of 
time. An evaluation on the other hand, is an assessment of the impact of the programme 
at one point in time. Monitoring and evaluation complement each other. There are two 
aspects to be monitored by the R&H New Germany HIV/AIDS committee: 
1. The impact of HI V/AIDS in the workplace; and 
2. The effectiveness and impact of the HIV/AIDS and STD programme 
5.6.8.1. Importance of monitoring and evaluation 
Monitoring and evaluation have an important role to play in ensuring that a programme is 
appropriate and effective. R&H New Germany cannot continue running a programme 
without, at some point, standing back and checking on what we are doing. Monitoring 
and evaluation are ways of assessing how well the programme is running, the effect of 
the programme on the workplace and how effective it is in changing people's behaviour 
with regard to HIV / AIDS and STDs. 
5.6.8.2. Baseline information 
It is important to have baseline information on HIV/AIDS and STDs in the workplace in 
order for the HIV / AIDS committee to develop a good monitoring and evaluation 
component to the company's HIV/AIDS and STD programme. Baseline information can 
be obtained by doing a baseline or KAP study. Refer to Appendix for a copy of the 
questionnaire that can be used in the KAP study at R&H New Germany. This is a survey 
of the indicators of interest (for example, number of condoms distributed) at the start of 
the programme. This provides the starting point against which all future measures of the 
indicators can be compared. The difference between the baseline measure and future 
measures tells you how effective the HIV/AIDS and STD programme has been. It is 
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much more difficult to see the impact of the programme if the committee does not have 
the baseline information. The baseline must include measurements on a 11 indicators of 
interest. Much of the information needed for the baseline can be obtained from the needs 
analysis which is undertaken as part of the policy and programme development process. 
5.6.8.3. How to monitor an HIV / AIDS & STD programme 
In this section we look at some examples of indicators that could be used to monitor and 
evaluate the programme. It is important that indicators are chosen in that they are useful 
and appropriate. Condom distribution and aspects of peer counselling and education may 
be used as indicators at the New Germany operation. 
Reasons for monitoring & evaluating 
• Monitoring and evaluating a programme is necessary to show that the programme is 
cost effective. 
• Ongoing monitoring allows the RIV / AIDS committee to see how and where the 
programme must change. This process also generates an awareness of the programme 
and gets people thinking about what needs to change and how to bring it about. 
• Evaluation is usually done after the programme has been in operation for a while, and 
it provides a way of measuring the impact. This is important in terms of planning for 
the company's budget allocations. 
Useful and important indicators for monitoring & evaluating : 
• Condom distribution; 
• STD prevalence; 
• Attendance at STD clinics; 
• Absenteeism; 
• Deaths in service 
• Number of awareness and education sessions provided (usually by an outside 
agency); 
• Anonymous attitude survey; and 
• Acceptance of employees with RIV by their peers 
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In addition, there are different levels of analyses which R&H New Gennany can 
undertake. Remember that the easier an indicator is to measure, the more likely it is to be 
used effectively in the future. However, a complex and detailed analysis requires one to 
collect more infonnation and therefore is more time consuming. The indicators above 
highlight the most straightforward and infonnative indicators to measure. 
Definition of an indicator 
An indicator is a direct or indirect measure of change. Behaviour change with regard to 
safer sex practices is the change that is of ultimate interest in an HIV I AIDS and STD 
programme. Monitoring and evaluating must answer the question: "Has the programme 
changed behaviour and reduced the prevalence of HI VI AIDS and STDs?" 
Other changes that may also be of interest include: 
• Prevalence of HI V-infection among employees; 
• The appropriateness and effectiveness of the workplace programme; and 
• The efficiency or progress of the programme. 
Monitoring the impact of HIV I AIDS 
The impact of HIV I AIDS can be monitored by maintaining records on sickness or 
absence and looking at causes of the absence; how often employees take special or 
compassionate leave; staff turnover by reason for departure (including early retirement); 
and death by cause 
Monitoring the HIV/AIDS & STD programme 
There are some important considerations to bear in mind when monitoring a programme: 
• Decide which indicators will be measured. In other words, how will behaviour 
changes be measured? 
• Decide how the indicators will be measured, for example, in-depth interviews with a 
sample of employees or a questionnaire handed out to all employees. What questions 
will be included in the questionnaire? Will the R&H New Gennany keep records of 
attendance at work, sick leave, compassionate leave and so on? 
• Calculate the costs of the monitoring process steps. 
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• How often will monitoring take place to give the maximum amount of infonnation 
with the least disruption and cost? 
• Quantitative indicators include the number of people attending the education 
programme and the number of condoms distributed. (it is important to identify a 
range of indicators). Qualitative infonnation requires input from all role players as to 
the effectiveness and efficiency of the programme. 
5.6.8.4. Evaluating an HIV/AIDS & STD programme 
Evaluations usually measure the impact of an intervention or programme to see if it has 
an effect or not. Evaluations are usually done after the programme has been in existence 
for some time. The infonnation gathered through ongoing monitoring can be very useful 
as part of the evaluation. Evaluations also provide infonnation which can be put together 
with other sources of infonnation to provide a picture for the whole country. However, it 
is not easy to detennine the exact effect of a programme. All that the organisation can do 
is measure various changes and try to establish whether they are related to the 
implementation of the programme. It is very difficult to pinpoint exactly which factors 
mayor may not have had an impact. For example, you cannot assume that people are 
using more condoms just because more condoms are being distributed in the workplace; 
you also need to look at whether the incidence of STDs is decreasing. 
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5.7. OPERATIONAL PLAN AND ACTION ITEMS 
R&H New Germany can reinvigorate its HIV/AIDS Awareness and Prevention 
Programme by following these steps in the program. 







5.7.1. Convene HIV/AIDS Committee 
The HIV/AIDS Committee, within the R&H New Germany organization should be 
comprised of a representation of the workforce, from management to loaders and drivers, 
men and women, HIV positive and not. In addition, the Committee should include 
representatives from its worker's union. The Committee should begin a dialogue early in 
the planning to partner with the union as much as possible to ensure programme success. 
As the meetings are ad-hoc, the Committee must meet frequently during the planning and 
first year's implementation of the programme. The Committee is responsible for 
orchestrating the four employee education sessions to occur within the first six months to 
a year and the other programme activities. In addition to planning and executing the 
program representatives of the committee have an important role of being visible at 
programme seminars and activities. 
5.7.2. Appoint a programme coordinator 
A programme coordinator from the HIV/AIDS Committee or the on-site healthcare or 
human resources staff may carry out the programme implementation in conjunction with 
an HIV I AIDS education expert. Ideally, the programme would be incorporated with 
existing healthcare or human resources programs considered inherent to good business. 
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5.7.3. Contract with an HIV/AIDS education organization/experts 
Before endeavouring too far along in the programme, the RIV/AIDS Committee should 
identify and contract with an organization able to assist with the implementation. The role 
of the consulting agency would be to provide expertise on RIV/AIDS, assist with general 
planning and implementation, conduct training and communications activities, provide 
condoms, establish in-house or external links to STI and VCT clinics, and even partner 
on community outreach activities. 
Criteria for consultant selection can include experience in RIV / AIDS in Africa, peer 
educator training, communications and behaviour change programmes, condom social 
marketing, STI and VCT programmes, community outreach and research. 
5.7.4. Conduct workplace needs and resources assessment 
A needs and resource assessment will help to tailor and augment the R&R New Germany 
planning and approach. The RIV/AIDS Committee, led by the Programme Coordinator, 
and the consultant should undertake this effort. 
The assessment will help to determine basic information such as: 
• Number and gender of employees; 
• Existing health staff and facilities; 
• Existing health, safety and AIDS policies; 
• Availability of local agencies (country and city levels) equipped to take 
• referrals for voluntary counselling and testing; 
• Arrangements for training activities during the workday; 
• Potential to introduce voluntary RIV counselling and testing on the 
• premises; and 
• Potential to distribute male and female condoms on the premises. 
Assessing the R&R New Germany company as related to RIV/AIDS may identify 
prevalent beliefs regarding RIV/AIDS, lack of available places for referrals for testing, 
etc. The programme can then be modified to compensate for missing resources or 
augmented by special skills or even avoid redundancies or conflicts. 
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In addition, the resource assessment will help to gather existing videos, brochures, 
posters and other materials, within the company and from among other organizations. 
The assessment will help to collect contact information for external agencies and support 
groups to be included on educational materials. It will help to identify potential condom 
procurement sources (if not provided by the consultant organization) and quantity of 
condoms to order, and learn of in-house RIV / AIDS prevention volunteers. It is worth the 
effort to find out if other businesses in the community have developed RIV / AIDS 
programs, as they may serve as a resource about successes, problems, and other relevant 
Issues. 
5.7.5. Tailor plan to fit company (Responsibilities, Timetable) 
The best programs answer the most pressing questions employees have, clarify R&R 
New Germany's position on RIV/AIDS, provide insights and guidance from respected 
and believable AIDS experts and sources, and build a safe and supportive environment 
for employees. Also, the best programs take place over time, engaging employees in 
various RIV / AIDS-related issues. This will require periodic employee programmes to 
address these issues. Though the employee RIV / AIDS education programme can and 
should be conducted in a variety of ways- ranging from formal presentations by outside 
experts to distributing brochures -group meetings for employees are the backbone of an 
effective RIV / AIDS programme. Brochures and other materials can be used to reinforce 
and supplement the group meetings. 
5.7.6. Announce programme to employees 
Once the programme has been tailored, the letter from senior management to employees, 
perhaps included with the payslip, will announce the: 
• RIV/AIDS Awareness and Prevention Programme 
• Kick-offweek events and activities, 
• Training schedule 
• RIV / AIDS consultant organization participation, and 
• Request for nominations of potential peer educators. 
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5.7.7. Educate managers, supervisors and company healthcare providers 
Of all the best practices, perhaps the most critical to success is the recognition by 
management of the importance of senior management's involvement in the programme. 
Managers don ot need to b e AIDS experts, but they don eed to understand the basics 
about HIV I AIDS before requiring it of others. 
Supervisors and managers must understand the facts about HIV and AIDS and the 
company's policy to be able to do the following: 
• Be prepared to answer employee questions, 
• Know where to refer employees for assistance or additional information, 
• Be able to reinforce the company's position on HIV/AIDS support, 
• Encourage their employees' participation in education sessions, and 
• Be prepared to supervise and manage their work groups. 
The programme must have support from the R&H New Germany management level that 
all employees, including management, should participate, thus helping to remove the 
stigma associated with HIV I AIDS that might potentially keep someone from attending. 
Management education, including health and human resources staff, will include all of 
the topics covered under employee education and will additionally include issues related 
to employment, benefits, discrimination and other HIV I AIDS workplace issues. 
Healthcare provider briefings will also cover medical, and STI and VeT clinic issues. 
Management education is an intense version of the employee education sessions with 
additional management sessions that are held during the first quarter, rather than over the 
course of the year. It needs to be run by an external organization that is experienced in 
HIV I AIDS workplace programmes and able to work with management on the difficult 
issues they are likely to encounter. The sessions could run several different ways, 
including half days for a week, evenings or weekends, to minimize the impact on regular 
workplace activities. In all, approximately, an estimated 20 hours in the first year will be 
necessary to educate management. Throughout the year, management should visit 
employee sessions to show support, but not stay so as to allow free discussion among and 
questioning by employees. 
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5.7.8. Appoint a training coordinator 
There are various ways to accomplish training and R&H New Germany will want to 
implement what best fits the environment. There are many lessons learned regarding 
training, however, and they are reflected in these guidelines. It is important to appoint 
someone in charge of the training (who mayor may not be the programme coordinator), 
perhaps someone from human resources, who will work with the RIV / AIDS education 
consultant. The training programme is described in more detail in the Training Manual. 
5.7.9. Select peer educators 
Best practices show that peer educators are best selected by their peers. Therefore, as 
mentioned, employees should receive peer educator nomination forms well in advance of 
peer educator training. The HIV/AIDS Committee may want to verify the nominees' 
ability and desire to present materials without judgment. In addition, the Committee may 
want to add additional individuals to ensure that all levels and groups within R& H New 
Germany are represented, from entry-level to management, openly HIV-positive 
employees, women, and minority culture/ethnic groups. An HIV -positive or AIDS 
patient who is willing to disclose his or her health status after risk factors have been 
described should be invited to be trained as a peer educator. One workplace model is 
based on the principle that the personal experiences of HIV positive individuals can help 
shape attitudes toward the disease. In addition, it is key that management select a peer 
educator from among colleagues, as a demonstration to employees of commitment and so 
that management will have a peer educator. 
5.7.10. Train peer educators 
After training management and supervisors, consultants should train peer educators. 
Potential peer educators, some of whom will become peer trainers themselves, will be 
identified through colleague nomination recommendation forms. Enough peer educators 
should be trained to ensure every employee receives the full cycle (4 sessions) of training 
during the first year. 
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5.7.11. Programme Kick-off 
The HIV/AIDS Committee and consultant partner kick-off the programme in a grand 
way over the period of a week to gamer employees' attention. This is a key activity 
that sets the t one for the w hole programme a nd brings the HN / AIDS issue to the 
forefront of employees' thoughts. Suggested activities include contests, awards for 
programme ideas, recognition of those working in HN/AIDS prevention, if any, 
holding a vigil for those lost to HN/AIDS, engaging guest speakers or celebrity 
appearances during lunch or tea breaks, hosting families for a weekend day, etc. 
Posters and brochures should be on display throughout the worksite. Ideally, the 
frame of mind is to view the programme as a celebration of being empowered to fight 
HIV / AIDS together. 
To lend credibility to the programme, a company official (preferably the Managing 
Director) should introduce the programme. After an introduction, he may present the 
R&H New Germany' s position statement and ask for questions, clarification, and 
discussion. 
Through the press and the community, make the launch of the programme a high 
profile, well-publicized event: this shows the determination of R&H New Germany 
and starts to combat secrecy and denial. 
5.7.12. Conduct non-formal and formal education for employees 
Non-formal education will occur through brochures, posters at plant sites, and 
management offices, one-to-one peer educator and health counselling, and community 
outreach activities. The formal educational components, are to be presented during the 
first six months to a year of the programme as part of the formal education 
programme. HIV / AIDS awareness and prevention, is to be presented in a large group 
setting, introducing the programme and providing basic information on policies, 
impact, transmission, and prevention. The next session: Condom use and 
negotiation, will follow shortly thereafter, as condoms are introduced (or 
reintroduced) in the workplace. The subsequent session: STI diagnosis and treatment 
and VCT, is presented once diagnosis and treatment education and referral systems 
are set up either in the workplace or elsewhere. The fourth session: Working with 
and living with HIV/AIDS and community outreach are presented in year-end larger 
group sessions. The content of each session is developed by the site HN/AIDS 
committee in consultation with external experts. 
145 
5.7.13. Train peer educator trainers 
Peer educators w ill need tor eceive refresher t rainings and need to be replaced for 
various reasons (leave job, death, disinterest, volunteer fatigue, etc.), so there is a 
need for peer educator trainers. After education sessions are underway, from among 
the peer educators potential trainers can be identified (observed for their ability, 
leadership, interest, etc.), who will train new peer educators. 
5.7.14. Condom distribution 
Most HIV/AIDS education activities include condom promotion as a part of their safe 
sex message. Unless condoms are widely available in the community and at 
reasonable cost, condom distribution in the workplace is an important component of a 
comprehensive prevention programme. Though this may seem to be a sensitive issue 
at first, experience shows that employees appreciate and support condom distribution 
in their workplaces. Ideally, male and female condoms would be available. 
5.7.15. Provide Voluntary Counselling, Testing and Treatment 
Counselling and support services for concerned workers and for HIV -infected 
workers and their families are usually part of a comprehensive workplace HIV/AIDS 
programme. Not only are these services beneficial to the physical and mental welfare 
of employees and their families, but also they increase the probability of sustained 
behaviour changes that will help prevent the transmission of the AIDS virus. 
Voluntary, informed, and confidential HIV testing, known as voluntary, counselling 
and testing (VCT), may be one service offered employees and their partners. 
Many employees suffer debilitating illnesses that increase absenteeism and reduce 
productivity as a result of undiagnosed or untreated STI's. Not only are STIs injurious 
in their 0 wn right, but t hey also greatly increase the possibility 0 f transmitting the 
AIDS virus during unprotected sex. Thus, voluntary STI diagnosis and treatment 
become part of a comprehensive workplace HIV / AIDS prevention programme. 
5.7.16. Leverage training & materials to benefit communities-outreach activities 
Outreach complements worksite HIV/AIDS education and awareness efforts by 
reaching employees in their homes and their communities, thereby reinforcing the 
messages delivered at the worksite. 
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5.7.17. Conduct ongoing monitoring and evaluation 
Reporting on statistics and accomplishments within the company can be motivating 
for employees. Key to evaluating the programme and demonstrating the need for 
intervention and behaviour change among employees is a voluntary, anonymous 
surveillance test of employees. The workers are tested for HIV but are not 
individually informed of the results. Composite results are shared with the 
organization and help to provide a baseline for the scale of implementation necessary 
and medium for evaluating the programme. This type of surveillance testing is done 
with consent of the trade unions and is 100 percent voluntary for employees. The 
testing is also supported by the ILO and conducted by many companies. An added 
feature of the testing is that it can lead to a desire to know individual HIV status and 
uptake ofVCT. 
5.7.18 Next Steps 
An HIV/AIDS education programme is not a one-time event. In fact, it has been 
found that short, one-time HIV I AIDS education programs are not effective. Plan 
beyond a year into the future, and see how it can reinforce the programme. This last 
part 0 f the planning phase is essential for t he success 0 f the programme. Consider 
using HIV I AIDS as the reason to begin addressing other health concerns and 
developing a long-range health-promotion programme for the company. Employers 
have found that health care costs for employees and their dependents can be reduced, 
and productivity increased, through health-promotion programs. 
Plan to provide HIV/AIDS information to employees on an ongoing, regular basis. 
Send out new brochures periodically. Copy and distribute factual news reports of 
importance. Encourage employees to volunteer for HIV/AIDS programs in the 
community through their churches, schools, civic clubs, or other organizations. 
Provide HIV/AIDS education to all new employees. Decide when the next series of 
small-group meetings will take place. As the planning phase continues, check to see if 
anything has been overlooked that might be important to your company: 
• Have the particular needs of employees been considered? 
• Has the programme been planned to fit the R&H New Germany company culture? 
• Is the team in agreement about the plan? 
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The challenge of planning an HIV/AIDS programme IS a great opportunity to 
demonstrate how well the business functions. A sense of shared pride in having 
tackled a touchy issue with sensitivity, intelligence, courage, and compassion will 
help create a receptive environment. Companies state the camaraderie from 
HIV / AIDS programmes s pill over into other w orkplace relationships a nd even into 
productivity. 
5.7.19. Follow Up 
Keep the momentum going by scheduling two hours every few months to monitor and 
plan your 0 ngoing programme. If using a t earn approach, plan a t wo-hour meeting 
every few months with t he team members: Review what has been done (responses 
and comments from employees, successes, failures). Review newly developed 
materials, such as programs, videotapes, or brochures. Plan the next steps of the 
programme. Follow-up is very important to the success of an HIV/AIDS education 
programme. The most successful HIV/AIDS programs offer varied approaches over 




Now that the RIV/AIDS education programme is initiated, some employees will want 
infonnation to take home to their families and friends. Most employees will say that the 
programme was worthwhile and many will talk about RIV/AIDS more openly, accurately, 
and responsibly and will be more accepting and supportive of a person with RIV / AIDS. 
Most people who have developed RIV/AIDS education programs have been surprised by 
how interesting and useful the process was for them. They also found that it was much 
easier than they thought it would be. And for many employers, an unexpected benefit has 
been that employees and their families really appreciate the concern their companies have 
shown by taking action on RIV/AIDS. Clearly, the AIDS epidemic continues to be a 
significant health concern and employers cannot avoid the issue. No workforce is immune 
to the possibility of RIV infection within its ranks. Through an investment of time, energy, 
and money, however, R&R New Gennany can prepare the business and employees to 
manage the impact of RIV / AIDS at work effectively. By confronting RIV / AIDS up front, 
directly, and responsibly, R&R New Gennany would join thousands of other businesses 
making an effort to end the AIDS epidemic. Successful training and management of this 
extremely sensitive, difficult issue helps to set the stage for future programs and policies 
on all health concerns. 
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APPENDIX 1 
KNOWLEDGE, ATTITUDES and PERCEPTIONS BASELINE SURVEY 
This study is intended to guide the Rohm and Haas New Germany HIV/AIDS 
Committee with regards to its intervention programmes. 
The survey serves as a pre- and post-test baseline study against which to 
evaluate the impact of the successive intervention programmes at 
specified periods of time. 
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KAP SURVEY QUESTIONAIRE 
Section A: Biographical information and sample demographics 
Please tick the box which best represents your profile. Unless specified, please only tick 
per question. 
1. Age 
<20 21-30 31-40 
2. Gender male 0 
3. Population Classification 
White Black 
4. Job Grade 
5. Level of Education 
Some years primary school 
Finish primary school 
Some years high school 
Finish high school 
Incomplete tertiary education 
Finish tertiary education 
Other 




7. Family Structure 
Married one spouse 
Married more than one spouse 
Long-term partner (never married) 
Single (never married) 
Widow/er 
Di vorcedl separated 
Live with my spouse/s 
Live with my partner 
Live apart from my spouse for 
more than 1month at a time 
Live apart from my spouse for 
less than 1 month at a time 
Live apart from my partner for 
more than 1 month at a time 
Live apart from my partner for 
less than 1 month at a time 
Single and live alone 
Single and live within a household 








11. How many people do you share a room with? 
None 
1 other person 
2 other person 
3 other person 
4+ other person 
Section B: Sexual History 
12. With whom did you have sex with in the last 3 months? 
Spouse 











Section C: Condom Usage and general Sexual Practices 
1. Condom Usage 








16. How often have you used a condom over the last three months? 
Every time 
Almost every time 
Sometimes 
Never 




18. Why did you wear a condom? 
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2. Knowledge pertaining to condoms 

















22. Using condoms is the best way to prevent STDs 
Definitely 
Probably 





























27. Before I have sex I often: 
a. Consume alcohol Yes D No D 






Section D: Knowledge of HI VI AIDS and STDs 




29. You can get a STD if you have sex just once without a condom? 
True 
False 
Don' t Know 




31. A person dying of HI VI AIDS does not look the same as a newly-infected person? 
True 
False 
Don' t Know 
32. What happens when a person contracts AIDS? 
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Section E: HIV/AIDS related information and health seeking behaviour 






















51. With who, and how often, do you talk about AIDS? (more than one box may be ticked) 
I discuss At least once At least once At least once Never 




Employees at the 
health clinic 
Medical employees 
Employees at and 
AIDS NGO 
My medical doctor 
Other 
52. What were the main discussion topics concerning AIDS? 
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Health Care at work 




Health Care at work 
56. Why would you not seek medical care from the ~pDr~~litml;m;JJ!I!hr~!)? 
Section F: STD related information and treatment 






















60. With who, and how often, do you talk about AIDS? (more than one box may be ticked) 
I discuss At least once At least once At least once Never 




Employees at the 
health clinic 
Medical employees 
Employees at and 
AIDS NGO 
My medical doctor 
Other 
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61. Have you ever required treatment for a STD? 
Yes 
No 




Health Care at work 
Section G: TB related information and treatment 






















66. With who, and how often, do you talk about TB? (more than one box may be ticked) 
I discuss AIDS with: At least once At least once At least once Never 




Employees at the 
health clinic 
Medical employees 
Employees at and 
AIDSNGO 
My medical doctor 
Other 
67. Have you ever required treatment for a TB? 
Yes 
No 




Health Care at work 
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Section H: Perceptions of Risk 
69. Efficacy frequencies 
Statement 
Using condoms is effective 
in preventing the AIDS virus 
Abstaining from sex prevents getting 
the AIDS virus 
If I use condoms I am less likely to get 
the AIDS virus 
70. Perceived self-efficacy frequencies 
Statement 
I am able to abstain from sex to 
prevent getting the AIDS virus 
I can maintain a faithful relationship 
to prevent getting the AIDS virus 
I can easily be faithful to my partner 
to avoid getting the AIDS virus 
71. Perceived severity frequencies 
Statement 
I believe getting an STD is extremely 
harmful 
I believe getting the AIDS virus has 
serious consequences 
I believe that getting the AIDS virus is 
a disgrace 
72. Perceived susceptibility 
Statement 
It is likely that I will get AIDS 
I am at risk of getting AIDS 
It is possible that I will get AIDS 
Strongly Agree Disagree Strongly 
agree Disagree 
Strongly Agree Disagree Strongly 
agree Disagree 
Strongly Agree Disagree Strongly 
agree Disagree 
Strongly Agree Disagree Strongly 
agree Disagree 
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73. Perception of the inevitability of AIDS 
Statement Probably Don't Probably Definitely 
Know not not 
The chances are that I will 
eventually get AIDS 
74. Perception of having AIDS 
Statement Probably Don't Probably Definitely 
Know not not 
The chances are that I already 
have AIDS 
Thank you for taking the time to complete this questionnaire 
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